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Articles and Congresses 261
Aim of the Thesis
Cancer is one of the leading causes of death in our modern society. The develop-
ment of new anticancer drugs has been central in scientific research. Although
a huge number of metal complexes have been continuously synthesized, only a
slight number of them have entered in clinical trials, and only few of them have
been accepted as anticancer drugs.
Aim of the Thesis is the study of the interaction between metal complexes and
nucleic acids, namely RNA and DNA, from thermodynamic and kinetic stand-
points. Different metal centers and classes of complexes have been taken into
account.
But...why RNA? why DNA? Although the study of new molecular targets (e.g.
proteins) has increased over the last years, nucleic acids are considered the most
important biological targets inside the cell. Actually, DNA and RNA drive the
essential steps of the central dogma of molecular biology, being involved in the
replication, transcription and translation processes. The possibility to alter the
functions of polynucleotides by interaction of small molecules is a fascinating
tool for the anticancer strategy: the interaction of a huge number of organic,
inorganic and organometallic molecules with DNA and RNA has been tested in
order to obtain information about the effects of such drugs.
Concerning the nature of the drug, metal complexes are generally less employed
respect to organic molecules in many biological applications. Nevertheless, metal
compounds exhibit more suitable properties in so many aspects respect to
organic-based drugs, offering wide structural diversity (e.g. ligand type and
geometry), different redox states, optimal photophysical properties and the pos-
sibility to sum the intrinsic properties of the metal center and of its organic
ligands.
The structure of the Thesis is composed by:
• Introduction, where we introduce the reader to the different species
involved in the Thesis, namely nucleic acids, metal cations and metal
complexes, and their interactions. In particular, a section was dedicated
to two newly proposed strategies in anticancer therapy, which will be
treated in our study: selectivity towards G-Quadruplex and Photodynamic
Therapy;
• Materials and Methods, where we briefly listed the chemical reagents
we used and the theoretical bases of the techniques we have employed;
• Results and Discussion: even though the Thesis has a unique focus,
namely the interaction of metal complexes with nucleic acids, we divided
the results into two Parts. First of all, the effect of aluminium ions were
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tested in the presence of synthethic RNA in Part I. Aluminium is a toxic
element which is believed to be potentially reliable to various disorders,
such as Parkinson’s and Alzheimer’s diseases and, recently, breast cancer.
The characterization of the complex formed between aluminium and ca-
codylate anion is exposed in Chapter 3. Cacodylate stabilizes aluminium
and avoids its precipitation, even at neutral pH. This finding enables the
study of the effect of aluminium/cacodylate complex under physiological
condition, and the interaction towards synthetic RNAs is examined in
Chapter 4. This topic was developed in collaboration with Prof. Tarita
Biver of Dipartimento di Chimica e Chimica Industriale, Università di
Pisa, Italia.
In Part II, our study was focused on metal complexes of ruthenium, iri-
dium and rhodium. The classes of complexes taken into account have been
extensively studied as anticancer drugs. Our work is the study of novel
compounds obtained by changing the nature of the ligands bound to the
metal center.
Firstly, the study of the new [(p−cym)Ru(L−1)SCN] ruthenium η6-arene
complex (HL-1 = 2-(2’-hydroxyphenyl)benzothiazole), was carried out in
Chapter 5. Interaction of the metal complex and its ancillary ligand was
examined with CT-DNA. In addition, a study of the photoreactivity was
performed.
After the arene complexes, we focused on a new class of metal compounds,
namely the biscyclometalated complexes. Iridium and rhodium biscyclome-
talated complexes have been considered in this study. Firstly, a comparison
of two complexes, [Ir(ppy)2(pyboz)]Cl and [Rh(ppy)2(pyboz)]Cl (pyboz =
2-(2’-pyridyl)benzoxazole), differing by the nature of the metal center, was
carried ou in Chapter 6. Interaction of the metal complexes with CT-
DNA was conducted in the dark by means of different analytical methods,
whereas cleavage study of plasmid DNA was used to test the photoreactiv-
ity of the compounds.
Since remarkable photoreactive effects have been found for the biscyclome-
talated complexes, the last part of the Thesis was centered on the synthesis
of new iridium and rhodium complexes, varying the ligands. The synthesis
and the characterization of the new compounds were developed in collab-
oration with Prof. Gustavo Espino of the Inorganic Chemistry Lab. of
Universidad de Burgos. Then, the photoreactivity and the selectivity to-
wards the non-canonical forms of DNA, namely the G-Quadruplexes, were
tested. The results are summarized in Chapter 7. Part of this project was
carried out in collaboration with the laboratory of Istituto per la Sintesi
Organica e la Fotoreattività, Centro Nazionale delle Ricerche, Bologna,
Italy, under the supervision of Dr. Ilse Manet.




Nucleic acids are natural polymers formed by repetitive monomeric units, the
nucleotides (Figure 1.1).
Figure 1.1: Molecular structure of the nitrogenous bases and the nucleotidic units.
The nucleotides are composed by:
• a nitrogenous base, namely, adenine, guanine, cytosine, thymine (the last
one is exclusive to DNA) and uracyl (exclusive to RNA);
• a sugar molecule, which is 2’-deoxyribose for DNA and ribose for RNA.
Purinic nitrogenous bases (Adenine and Guanine) are covalently bound to
3
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C1’ of the sugar moiety through N9, whereas pyrimidinic bases (Cytosine,
Thymine and Uracyl) bind through N1. This bond is called N-glycosidic.
In addition, all the nucleotides are β-anomers, as to say, the bases are
placed upon the plane of the cyclic sugar, on the same side of C5’.
• a phosphate group, bound to C5’ of the sugar ring.
Such a structure permits two possible orientations for the nitrogenous bases:
the syn conformation, where the base is oriented towards the sugar molecule,
and the anti conformation, where the base is on the opposite side of the ribose
(Figure 1.2). The torsion angle χ, defined as the angle of the base orientation,
is 90°/180° in anti and −90°/90° in syn conformation.
Figure 1.2: Syn and anti conformations of nucleotides.
In addition, the C2’ and C3’ carbons can be placed upon the plane of the sugar
cycle, on the same side of C5’, in endo position, or down the plane, in exo posi-
tion (Figure 1.3). The generally available nucleotide conformation in DNA has
C2’ in endo geometry and nucleotides have anti conformation because of steric
hindrance.
Figure 1.3: Endo and exo positions of C2’ and C3’ in the sugar moiety.
Nucleotides are linked together by a phosphodiester bond between the phos-
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phate group and the hydroxyl group in C3’ position. The repetition of this bond
between the monomeric units leads to the polynucleotidic chain.
Concerning nucleotides properties, the nitrogenous bases exhibit acid base be-
haviour and their pKA values are listed in Table 1.1 [1]. On the other hand, the
phosphate group has two different pKA values, around 1.0 and 6.2.
Table 1.1: pKA values of the functional groups of the nitrogenous bases [1].
Base Atom pKA Base pKA Nucleotide
Adenine N1 4.1 3.8
Cytosine N3 4.5 4.4
Guanine N7 2.9 2.4
N1 9.4 9.5
Thymine N3 9.8 9.9
Uracil N3 9.5 9.6
Moreover, the nitrogenous bases display absorption in the UV region and the
maximum of absorption is different for each nucleotide (Table 1.2 [2]). It follows
that the nucleic acids have also certain photophysical properties. Actually, when
the nucleotides are bound together to form DNA, a resulting absorption peak at
λ = 260 nm arises as the sum of the absorption spectra of the mononucleotides.
Table 1.2: Absorption maxima and extinction molar coefficients of nucleosides [2].









Except to nucleic acids, nucleotides compose other biologically relevant com-
pounds involved in various biochemical processes (Figure 1.4). For instance:
• ATP: ATP or adenosine 5’-triphosphate is the most important molecule
involved in energetic processes. Actually, energy can be stored by formation
of ATP from ADP and phoshporic acid inside the cell. Then, the energy
is released by hydrolysis of ATP, together with the formation of ADP
(release of a phosphate group) or AMP (release of a pyrophosphate). The
hydrolysis process is exothermic, having ∆G = −7.3 kcal mol−1 and ∆G =
−10.9 kcal mol−1 for ADP and AMP production, respectively;
• cNMP: cyclic nucleotides are 5’-monophosphate nucleotides where the
phosphate group forms a further interaction with the oxygen in position 3’
6 CHAPTER 1. INTRODUCTION
Figure 1.4: Examples of biologically relevant molecules composed by mononucleotidic
units.
of ribose. cAMP, cGMP and cCMP are the most present cyclic nucleotides
inside the cell and they are seen to interact with many proteins in specific
sites, altering the protein structure and, consequently, its activity;
• NAD+: the Nicotinamide Adenine Dinucleotide is a coenzyme whose
function is based on its redox property. NAD+ is the oxidizing species and
NADH the reducing agent. The redox reaction is (Reaction (1.1)):
NAD+ + H+ + 2 e− −−→ NADH (1.1)
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which involves the nitrogen in the aromatic ring of the nicotinamidic moiety.
NAD is used in different processes;
• FAD: FAD is composed by an adenosine group bound to a riboflavine
molecule by a pyrophosphate group. As the NAD+ molecule, FAD is
involved in many redox biological reaction (Equation (1.2)). The reaction
mechanism leads to the reduction of both nitrogens of the riboflavine;
FAD + 2 H+ + 2 e− −−→ FADH2 (1.2)
• CoA: coenzyme A is a transporter of acyl groups (under Acetyl−CoA
form), and its function is remarkable in metabolism processes.
1.1.1 DNA
1.1.1.1 Double-Stranded DNA
DNA has a topic function in molecular biology: it contains the genetic heri-
tage, and it is involved in the replication (DNA −→ DNA) and transcription
(DNA −→ RNA) processes, being these the foundation of the central dogma
of molecular biology, together with the translation process, leading to protein
synthesis (Figure 1.5).
Figure 1.5: The dogma of molecular biology.
In DNA replication, the double-helix structure of DNA is opened and, by means
of the DNA polymerase enzyme, complementary DNA strands are synthesized
using triphosphate mononucleotides. It leads to the formation of two double-
helices, each one containing an old and a new synthesized strand (semiconserva-
tive process).
DNA transcription is the process capable of transferring genetic information
from DNA to RNA. In transcription process, the DNA opens in a transcription
bubble and the RNA polymerase enzyme catalyzes the synthesis of the RNA
strand from the complementary DNA strand.
The synthesized RNA is called messenger RNA (mRNA) and brings the gene
information from the nucleus to the cytosol for the protein synthesis. Outside
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the nucleus, the mRNA interacts with ribosome, a macromolecular system com-
posed by proteins and nucleic acids. Every three nucleotides of mRNA, named
codon, encode for a specific peptide, the monomeric unit of proteins. Peptide
bond is formed by the interaction of a new kind of RNA, called transfer RNA
or tRNA, with mRNA. Transfer RNA is composed by a stem, where the amino
acid is linked, and three arms, the D-loop, the T-loop and the anticodon loop.
The anticodon loop is placed on the opposite direction of the stem, and it is the
reaction site for mRNA. The type of peptide depends on the combination of
three nucleotides at the end of the anticodon loop. When a codon codifies a de-
fined peptide, the tRNA having such peptide interacts with mRNA by means of
its complementary anticodon sequence. When two tRNAs are close, the adjacent
peptides form a bond between themselves by means of the peptidyl-transferase
enzyme. The peptide chain remains in a RNA moiety and another tRNA is
inserted inside the ribosome, which enables further peptide bond to the protein
chain. The process continues until the entire protein is synthesized.
The DNA secondary structure was discovered by Watson and Crick in 1965 [3].
From the X-ray results the following characteristics can be derived:
• DNA consists of a right-handed helix formed by two strands running around
the same axis. The strands are antiparallel, as to say they run in opposite
directions, one having 5′ −→ 3′ direction and the other one 3′ −→ 5′. Each
turn of the helix measures 34Å, involving 10.5 basepairs;
• the sugar and the phosphate groups make the external hydrophylic back-
bone up, whereas nitrogenous bases are placed quasi-perpendicular to the
helix axis inside the structure. Such a geometry generates a minor and a
major groove in DNA;
• the double-helix structure is maintained by hydrogen bonds between the
nitrogenous bases. In particular, a complementary interaction between
the bases exists, being Adenine-Thymine (AT) and Guanosine-Cytosine
(GC) base pairing, as shown in Figure 1.6 (the so-called Watson-Crick
basepairs);
Figure 1.6: Hydrogen bonds between DNA nitrogenous bases.
• further stabilization of the structure is achieved externally by electrostatic
interactions with metal ions (it generally involves Na+ and K+ in biolo-
gical systems), and by stacking interactions between the bases inside the
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structure, which predominantly are vertical interaction, such as London
dispersion forces.
1.1.1.2 Further Double-Stranded Structures
Watson-Crick model is the so-called DNA B Form, and it is the normally available
secondary structure of DNA in physiological conditions. However, other forms
have been discovered. Regarding to double-helix conformations, the right-handed
A Form and the left-handed Z Form are the most known. A Form derives from B
Form because of environmental changes, such as low ionic strength and low water
percentage. The A conformation is a crystalline structure, where the nitrogenous
bases are 20° tilted respect to the helix axis and the difference between the major
and minor grooves is more pronounced. On the other hand, DNA Z Form was
discovered for the first time for a d(GC)3 fragment, whose X-ray structure showed
a left-handed double helix. In the Z Form, the purinic bases assume syn and C3’
endo conformation, while the pyrimidinic groups remain in the anti and C2’ endo
conformation, and the secondary structure exhibits grooves of equal width [4].
Z Form is found to be a high-energy structure promoted in the transcription
process by polymerase enzyme. The structural data of the different forms are
listed in Table 1.3 [5].
Table 1.3: Geometry values of the A, B and Z Forms of DNA [5].
Properties A Form B Form Z Form
Helix sense right-handed right-handed left-handed
Rotation per bp 32.7° 34.3° 30.0°
bp per turn 11 10.5 12
Inclination bp-axis 19° −1.2° −9°
Height bp 2.6Å 3.4Å 3.7Å
Height turn 28.6Å 35.7Å 45.7Å
Phosphate distance 5.9Å 7.0Å C 5.7Å, G 6.1Å
Glycosidic angle anti anti C,T: anti, A,G: syn
Sugar pucker C3’-endo C2’-endo C C2’-endo
G C3’-endo
Diameter 23Å 20Å 18Å
1.1.2 Non-Canonical DNA Structures
Besides the above-mentioned structures, other non-canonical forms exist. In
particular, triplex and quadruplex moieties have been discovered in solution and
it has been verified that they can be formed in specific genome regions under
suitable conditions.
Concerning triplex structures, they are promoted from the pairing of nitrogenous
bases by means of hydrogen bonds named Hoogsteen basepairs, different from
the conventional Watson-Crick basepairs (Figure 1.7) [6]. DNA triplexes can
be formed by insertion of a strand on the major groove of a double-helix DNA,
where the pyrimidinic groups of the single helix interact with the purinic moieties
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of the duplex, forming hydrogen bonds between N3 and O4 of thymine and N7
and O6 of guanine, respectively, and between protoned N3 and amino group
of cytosine with N7 and O6 of guanine, respectively. Single-stranded chains
able to form triplex structures with the double helix of DNA are called TFO
(triplex-forming oligonucleotide) [7] and these systems are of interest for their
role in biological processes and for delivering drug strategies. From these, the
antisense strategy involves the use of an oligonucleotide able to bind to specific
bad functioning genes, inhibiting their expression [8].
Figure 1.7: Hoogsteen basepairs in triple-stranded structures.
On the other side, quadruplex structures were hypothesized in 1962 [9]. Their
stabilization is achieved by hydrogen bonds between the guanine moieties placed
on the same plane (called G-tetrad). In particular, hydrogen bonds are formed
between the amino group and N7 and between the carbonyl group and the
hydrogen of N1 (Figure 1.8).
Figure 1.8: Hydrogen bonds of a G-Quadruplex moiety.
The insertion of monovalent cations, such as Na+ and K+, stabilizes the struc-
ture by interaction with the four carbonyl groups of the G-tetrad, being the
preferential order affinity K+>Na+ [10]. G-Quadruplex (or G4) can be com-
posed by one (unimolecular), two (bimolecular) or four (tetramolecular) strands.
However, unimolecular forms are generally studied in laboratory. Their formula is
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GmXnGmXoGmXpGm (1.3)
being m the number of guanosines and n, o and p the number of the remaining
X nucleotides, named connectors, which can also include guanosine [11]. Since
Gm and Xi can be of different lengths, the number of possible G-Quadruplex pri-
mary structures is almost infinite. Furthermore, variations in the primary motif
imply different secondary structures. Actually, differences in the G-Quadruplex
geometry are due to:
• orientation of the guanosines: if the guanosinic chains have the same
orientation (3′ → 5′ or 5′ → 3′), a parallel structure is obtained; otherwise,
it is named antiparallel. The mixture of both orientations is defined as
hybrid structure;
• disposition of the connectors: there are different possible types of
connection of the G-tracts (Figure 1.9). Connectors can form lateral,
diagonal and propeller loops, which determine parallel and antiparallel
orientations. Lateral (or edge-wise) loops connect adjacent G-tracts while
diagonal loops link opposite G-tracts, both forming antiparallel structures.
Propeller (or chain-reversal) loops connect adjacent parallel strands.
Figure 1.9: Connectors of G-Quadruplex.
The glycosidic angle in G-Quadruplex displays always anti geometry for the
parallel conformation, while the antiparallel structure has an equal number of
anti and syn. Many G-Quadruplex structures are named in specific ways because
of their form, such as basket, chair or propeller forms (Figure 1.10).
Figure 1.10: Different G-Quadruplex structures.
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The resulting G-Quadruplexes have 4 grooves and exhibit different polarity,
groove size, depending on the primary and secondary structure. It follows that
the reactivity of G-Quadruplexes changes depending on the type. In addition,
the structure can change depending on the metal ion inserted in the plane.
For example, different conformations are found for the telomeric G-quadruplex:
the presence of Na+ leads to an anti-parallel structure, with a diagonal and
two propeller loops [12]; X-Ray diffraction studies of a crystalline telomeric G-
Quadruplex in the presence of K+ show a parallel conformation having three
propeller loops [13]; finally NMR analysis in K+ solution reveals a hybrid struc-
ture [14]. Moreover it is found that sodium inserts into the G-tetrads, whereas
potassium size is too large to fit in it, and it is positioned upon the plane.
A valuable tool in the knowledge of G-Quadruplex structures is the Protein
Data Bank Database (PDB) [15]. This web site contains all the discovered
G-Quadruplexes structures, characterized by NMR or X-Ray diffraction, and
the files can be visualized by the Jmol free program [16].
Various guanosine-rich tracts are present in the genome, overall in telomere
and in some proto-oncogene genes. Despite this, G-Quadruplex conformation
has been demonstrated in vivo in prokaryotic and eucaryotic cells only in the
last years [17]. Regarding the telomere, they are nucleoproteins found at the
end of the chromosomes, and such DNA tracts are generally single-stranded.
The telomere function is to prevent disruption of DNA sequences during DNA
replication, which could cause loss of important genetic information. On the
other hand, proto-oncogene genes are generally present in double-stranded tracts.
Consequently, modifications have to occur in order to break Watson-Crick base
pairs and form G-quadruplex motifs, and these are reached during the DNA
replication and the transcription processes. For instance, c-myc is an example of
proto-oncogene gene [18] and the nuclease hypersensitivity element (NHE) III1
of this gene is accountable to 90 % of its transcriptional activity. It has a duplex
conformation but, under certain circumstances, it can fold into a quadruplex
structure.
1.1.2.1 Quaternary Structure
Inside the nucleus of eukaryotic cells, DNA organizes itself to form packed
structures. Actually, DNA is coiled around histone proteins to form nucleosomes,
which are structured as chromatin fibers, composing the chromosomes. The
chromosomes are highly compacted and organized structures; however, they
need to unwind in the transcription and replication processes.
1.1.3 RNA
1.1.3.1 Natural RNA
When RNA is synthesized inside the cell it displays a single-stranded conforma-
tion. However, a specific secondary structure does not exist for RNA, and local
structures, such as internal double strands, inner loops, stem-loops or hairpin
motifs, are possible (Figure 1.11). These conformations enhance the stabilization
of RNA. Actually, hydrogen bonds can be formed between the nitrogenous bases,
as well, being Guanine-Cytosine and Adenine-Uracil pairing (and, sometimes,
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Guanine-Uracil, as well). RNA plays different roles inside the cell: it takes
part in the transcription and translation processes and it is present in many
nucleoproteins, such as the ribosomes.
Figure 1.11: Examples of RNA secondary structures.
1.1.3.2 Synthetic RNA
Different types of synthesized RNA have been prepared over the years. In the
present Thesis, we have focused on the poly-riboadenylic (poly(rA)) and poly-
ribourydilic (poly(rU)) acids.
Poly(rA) is formed by the repetition of Adenosine 5’-Monophosphate monomeric
units. Its secondary structure has been studied by means of various techniques,
such as UV-vis spectrophotometry, X-Ray diffraction, circular dichroism and
thermal stability measurements, in solid state [19–21] and in aqueous solution
[22,23], as well.
Poly(rA) exists as single-stranded form [22,24] at room temperature and neutral
pH, with partially ordered conformation due to stacking interactions between
the nitrogenous bases. However, the poly(rA) secondary structure changes with
pH: poly(rA) converts itself into the [poly(rA)]2 bimolecular form at acidic pH
(Figure 1.12 [20]).
Figure 1.12: Hydrogen bonds in the [poly(rA)]2 structure [20].
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The formation of [poly(rA)]2 is due to protonation of the N1 site of the single
helix (pKA = 3.8, Table 1.1), obtaining poly(rA−H+). This form evolves to a
double helix by hydrogen bonding between the protons of N10 of a single strand
with an oxygen of the phosphate group and the N1 of the adenine of the second
strand. The transition to [poly(rA)]2 can be followed via spectrophotometry
by the shift of the maximum, from λ=257 nm of the single helix to 252 nm
of the double-stranded system, together with the appearance of a shoulder at
270 nm [25].
The reported equilibrium between the single and the double-stranded conforma-
tions is influenced by ionic strength and presence of small amount of divalent
cations as well, promoting the formation of the single helix (Reaction (1.4)) [26].
poly(rA−H+) + poly(rA−H+) −−→←−− [poly(rA−H+)]2 (1.4)
At high temperature, the partially ordered structure of poly(rA) is disrupted
to form a random coil system because of breakage of the stacking interactions
between the adenine bases [23].
Extensive information is present on the interaction of poly(rA) with mono- and
divalent cations as K+, Mg2+ [27], Ni2+ [28]. Moreover, strand-aggregation of
poly(rA) is observed in the case of high concentration of Mg2+ [27], Ca2+ [29]
and Mn2+ [30].
Poly(rU) is composed by repetitive units of Uridin 5’-Monophosphate. It has a
single-stranded random coil structure at room temperature and neutral pH [31].
However, at low temperature variation of the dichroic signal and hypochromic
effect of the absorption maximum at 260 nm suggest the transition to an ordered
or a partial-ordered structure [32, 33]. This behaviour is seen in the presence of
certain ions like Mg2+ [34]. Such an ordered conformation is not due to the for-
mation of double or multiple helices, but rather to intramolecular arrangements,
with the formation of hairpin loops [31,35].
1.2 Nucleic Acids Reactivity
1.2.1 Interaction with Metal Ions
In the biological environment DNA and RNA are surrounded by metal cations
and the phosphate groups interact with sodium or potassium monocations. How-
ever, the presence of different metal ions (Mn+) can displace the monocation
from the mononucleotide (NMP), as reported in the following Reaction (1.5).
Mn+ + Na+(K+)NMP− −−→←−− Na+(K+) + Mn+NMP− (1.5)
Concerning the nature of the interaction, a mere electrostatic interaction with
the phosphate is typical of the Group I metal series and the majority of Group
II, like Mg2+ [36, 37] and Ca2+ [38], even if a certain interaction with the
nitrogenous base is sometimes found [39]. On the other side, the increase of
the ionic charge and the covalent properties of the species render prevailing the
interaction with the nitrogenous bases, as seen for the transition metal cations.
For instance, interaction with the nitrogenous base is observed for Ni2+ [36],
Cu2+ [40], Mn2+ [37, 41], Zn2+ [38] and Cd2+ [38]. The coordination sites are
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various because of the nucleophilic and the basic properties of the nitrogenous
bases [42]:
• Adenine: the main interactions involve N1 and N7 coordination sites at
neutral pH, while at basic pH the interaction can occur with the deprotoned
amino group (pKA > 12);
• Cytosine: the interaction is possible at N3 position at physiological pH
and with amino group at basic pH. In addition, the carbonylic group
of cytosine exhibits good electron donor properties, which can promote
interaction with metal ions;
• Guanine: interaction by means of N3 and N7 at neutral pH;
• Uracil: the carbonyl groups are the typical coordination sites for the
uracyl base.
Less common interactions are found for Hg2+ with C5 of cytidine or uridine [43]
and C5 of thymine by Os(VI) and Mn(VII), provoking oxidation [44].
Some attempts to rationalize the behaviour of monovalent and divalent ions have
been carried out in order to obtain some general trend for the metal ion-nucleic
acid reactivity. In particular, interest has been addressed on how the presence
of a metal ion can modify polynucleotides secondary structures.
Shin et al. [45] report the interaction of various metal ions in the presence of
single-stranded poly(rA), using absorption and circular dichroism. Concerning
the interaction with the phosphate group, a slight decrease of poly(rA) absorption
and circular dichroism is seen. The small variation of the signals points up that
little modification on the secondary structure of the single strand system occurs.
Differently, the interaction with the nitrogenous bases provokes a hyperchromism
of absorption maximum together with a notable decrease of the dichroic signal.
The decrease of the dichroic signal is due to modifications of the partially ordered
poly(rA) structure because of unwinding of the nitrogenous bases, obtaining the
following Reaction (1.6).
poly(rA)SINGLEHELIX −−→←−− poly(rA)RANDOMCOIL (1.6)
This transition is promoted by temperature, but the presence of metal ions
interacting with adenine favours the reaction, even at room temperature.
Denaturation studies of DNA in the presence of metal ions show three different
trends [46]:
• increase of the melting temperature (Tm) for increasing metal ion concen-
trations. Stabilization of double-helix DNA is observed for the metal ions
exclusively interacting with the phosphate group. It is ascribable to the
decrease of the linear charge, even if other kinds of stabilization are argued,
like the stabilization of the ion-solvent-nucleic acid system [47];
• an initial increase of Tm followed by decrease at high concentration. The
metal ions interact with phosphate and have some nitrogenous base affinity.
Examples of metal ions interacting in such a way are Co2+, Ni2+, Mn2+
and Zn2+;
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• a decrease of the Tm, for the metal exhibiting high affinity with nitroge-
nous bases. Such a behaviour is seen for Cd2+ and Cu2+. Actually, the
interaction with nitrogenous bases destabilizes the double-helices.
Regarding the double-stranded [poly(rA)]2, the presence of a metal cation al-
ways provokes a decrease in melting temperature. It is due to the fact that the
poly(rA) double-stranded conformation involves both phosphate and adenine
groups. Consequently, the interaction of a metal ion destabilizes the hydrogen
bonds, displacing the equilibrium towards the single-stranded RNA.
Sigel and his group [48] schematize the interaction of nucleotides with divalent
ions, obtaining the global affinity for each nitrogenous base (Figure 1.13).
Figure 1.13: Affinity of divalent metal ions towards the nitrogenous bases and coordi-
nation sites [48]. Listed numbers are logarithmic values.
The whole interaction of a metal cation with a nucleotide is the sum of three
interactions, as proposed in Equation (1.7).
LogkNa−cavity = LogkPO2 + Log∆ + SFLog∆ (1.7)
where
• kNa−cavity is the total affinity constant of the metal ion-nucleic acid system;
• kPO2 is the affinity towards the phosphate group (electrostatic interaction);
• ∆ is the affinity for the nitrogenous base;
• SFLog∆ is a correction parameter due to the saturated coordination
sphere;
In some cases a metal cation can interact with two phosphate moieties or a
phosphate and a nitrogenous group at the same time. The resulting adducts are
called chelate and macrochelate complexes, respectively.
Once the metal ion interacted with the nucleic acid, further interactions can
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occur. One of these is the association of single or double-helix to form double,
triplex and quadruplex systems [49]. Aggregation of poly(rA) and poly(rU)
strands to form double poly(rA) · poly(rU) and triplex poly(rA) · 2 poly(rU) is
known. Triplex structures are stabilized by ionic strength and the presence
of small amount of divalent ions such as Mg2+ and Ni2+ [50–52]. Finally, as
we have previously reported, G-Quadruplexes are stabilized by the presence of
monovalent cations interacting inside the guanine tetrads [53–55].
1.2.1.1 Trivalent Metal Ions: Aluminium
In the above reported context, thermodynamic and kinetic studies of trivalent
metal ions with nucleic acids are rather scarce, possibly due to their complex
behaviour in aqueous solution (e.g. hydrolysis processes) [56]. The most in-
vestigated trivalent species are the lanthanides cations because of their use in
medical fields and owing to their luminescent properties. Actually, enhancement
of fluorescence is observed in the presence of mononucleotides and nucleic acids,
together with an energy transfer process towards the nitrogenous base [57, 58].
On the other hand, only few articles on the reactivity of aluminium with polynu-
cleotides have been published [59,60]. In these studies the effect of aluminium
ions was tested only for low metal concentrations, i.e. low metal/DNA ratio;
noteworthy, possible interactions of aluminium with anionic ligands present in
the reaction medium were disregarded [61].
Aluminium ion is prone to forming a variety of hydrolytic species [56] including
the Al13O4(OH)247+ polymeric form; it exhibits certain tendency to precipitate
as Al(OH)3 even at relatively acidic pH, and reacts with oxygen-containing li-
gands [62,63]. The presence of different hydrolytic forms entails involvement of
a number of equilibria and, consequently, many other possible complexes. These
features render aluminium a very complex system.
Concerning biological effects, it should be noted that the hexahydrated and
hydroxylic aluminium forms are toxic [64–66] and can affect human organs such
as liver, heart and kidney [67–69]. In addition, aluminium is believed to be
responsible for health disorders such as Alzheimer and Parkinson [70,71], even
though general agreement could not be found so far [72]. Lastly, increasing
interest has been addressed in the last years towards aluminium for its possible
relation with breast cancer because of its use as antiperspirant agent in underarm
cosmetics [73–75]. Inside the cell, its bioavailability is significantly reduced not
only because of precipitation, but also due to complexation with oxygenated
functional groups present in biological molecules [76–78]. Despite all this, free
aluminium can interact with the cell membrane and enter the cell [79].
In Chapter 3 and Chapter 4 (Part I of the Thesis) we focus our study on the
interaction of aluminium and synthetic RNAs, and a preliminary complexation
study was carried out with the dimethylarsinate anion, in order to obtain a
stable aluminium compound in solution, in a suitable range of pH. Dimethylar-
sinic (cacodylic) acid, (CH3)2AsOOH, is largely used to study the interaction
of biological molecules with organic dyes or metal ions [80]. Cacodylic acid
(HCac, pKA = 6.2 ± 0.1), with a buffer window ranging pH 5.2-7.2 [81, 82], is
quite a valuable tool to study nucleic acids and proteins under physiological
conditions. On the other side, the cacodylate anion is unreactive towards many
divalent metal ions [36]; for this reason it is thought to ensure buffer inactivity
for many biomolecule/metal ion (or metal complex) systems. On the other
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hand, there is evidence that the cacodylate anion can bind metal ions such as
Sb(III), Bi(III) [83], Pd(II) [84] and some rare earth metals [85]. Formation
of Al(III)/Cac complex [86] and, more recently, the synthesis of complexes of
the dimethylarsinate anion and metal ions of the XIII group (Al, Ga, In, Tl)
has been reported [87]. However, to the best of our knowledge, systematic ther-
modynamic studies of the aluminium/cacodylic acid system in solution under
different experimental conditions are still lacking.
1.2.2 Interaction with Small Molecules
The interaction of a small molecule with nucleic acids can be sorted into covalent
and non-covalent binding.
1.2.2.1 Covalent Binding
An electrophilic molecule can form a covalent bond with the nitrogenous base.
The most accessible coordination site in DNA is the N7 atom of the guanine
and molecules having more than one coordination site can interact with both
DNA chains, forming an intra-strand crosslinking. Such an interaction impedes
the separation of the strands and inhibits biological processes, being this the
mechanism of action of many anticancer drugs, such as cisplatin (see Section
1.3).
1.2.2.2 Noncovalent Binding
Organic and organometallic compounds can bind reversibly to DNA in different
ways (Figure 1.14):
Figure 1.14: Noncovalent interactions with DNA.
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• External binding: it is an electrostatic binding between the molecule
and the phosphate backbone. It generally involves a positive charged
molecule, displacing a sodium ion to interact with the DNA skeleton. The
electrostatic interaction only seldom produces modifications on the DNA
structure;
• Groove binding: the molecules insert into the DNA grooves. Since
a major and a minor groove are present in B DNA form, two different
binding sites are available. In general, molecules able to insert inside the
minor groove are long molecules, with various coordination sites to pair
inside the cavity. In particular, minor groove binders exhibit selectivity
towards adenine-thymine basepairs [88]. This is explained because of the
more rigid conformation of the GC pairing due to the presence of three
hydrogen bonds; in addition, the amino group present in the minor groove
of the GC tracts impedes a suitable positioning of the molecule. On
the other side, the AT groove is more flexible and smooth than GC tracts,
favouring a deep contact between the molecule and the bases of the groove.
Major groove binders are less studied; nevertheless, as the major groove is
a common recognition site for proteins, the research of systems binding to
the major groove is of interest in the view of inhibition of the DNA-protein
interactions. Various natural molecules and organometallic species are
seen to interact in the major groove [89];
• Intercalation: intercalation is the insertion of the molecule between the
DNA basepairs. Small aromatic molecules and organometallic complexes
having extended and plane heteroaromatic ligands are viewed exhibiting
good intercalative properties because of the extended π-stacking interaction
with the bases [90]. In addition, the presence of a positive charge on the
molecular structure enhances the interaction, promoting the approach
of the molecule towards the DNA backbone. The intercalation can be
total if the whole molecule is inserted between the basepairs, or partial,
if the compound enters only partly. Intercalation generally provokes the
biggest modification on the nucleic acid secondary structure and, because
of this, it is the most interesting and inquired mode of binding. A non-
common way of intercalation is the binding to the DNA base mismatches.
It occurs because of failure in the replication process or for external agents
(UV-radiation, genotoxic chemical regents). Systems with sterically bulky
ligands preferentially bind to it, and they can be used as recognition site
molecules of these regions [91]. Even more, some molecules are viewed to
flip a base out by its insertion inside the DNA, provoking the positioning
of the nitrogenous base outside the DNA helical stack [92].
For noncovalent binding it is possible to obtain an equilibrium constant (K),
quantifying the affinity of the drug to DNA, and a site size (n). The site size
is expressed as the number of adjacent basepairs being inhibited to a further
interaction. For example, it is observed that bromide ethidium, an intercalating
organic molecule, has a site size value of ≈2, which means that the interaction
of each ethidium bromide involves a mean of 2 basepairs, which cannot further
interact with other ethidium bromide molecules [93].
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1.3 Metal Complexes in Anticancer Strategy
1.3.1 From Platinum Complexes...
The anticancer activity of cisplatin has been known since 1965 [94]. The mecha-
nism of action involves a pre-reaction of the squared complex, which consists of
substitution of the chloride anions by water molecules (Figure 1.15) [95]. The
aquo-complex reacts with DNA of the cell through intra-strand cross linking,
coordinating to two guanine groups in N7 position. Such interaction inhibits the
replication and the transcription of DNA [96], leading to the cell death.
Figure 1.15: Mechanism of activation of cisplatin: formation of aqua-complex interact-
ing with DNA via intra-strand binding.
From this serendipitous discovery, various Pt(II) complexes have been developed:
cisplatin, carboplatin, oxaliplatin and nedaplatin are the currently marketed
ones [96] (Figure 1.16).
Figure 1.16: Marketed Pt(II) drugs.
However, Pt(II) complexes exhibit many inconveniences. Despite of the relent-
lessly research to bypass them, Pt(II) based drugs can display cellular resistance,
side-reactions effects (e.g. proteins), low solubility and low lipophilicity [97]. Sci-
entific studies have been continuously developing in order to overtake or minimize
such negative features, and various Pt(II) complexes have been synthesized.
1.3.2 ...to Non-Platinum Complexes
1.3.2.1 Ruthenium Metal Complexes
Besides platinum complexes, new metal centers have been proposed in drugs
delivery research in order to bypass the above mentioned side effects [98]. Except
platinum(II), ruthenium(II) compounds are the most investigated metal drugs in
anticancer strategy [99]. Actually, Ru(II) exhibits quite the same ligand exchange
kinetics as Pt(II) and, in the meantime, ruthenium compounds are generally
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less toxic than Pt(II) [100]. In addition, a valuable ruthenium property is the
mimicking of iron [101], allowing ruthenium to interact with the iron-transport
protein transferrin. Consequently, the interaction promotes the diffusion of the
drug through the biological system. Even more, the discovered higher demand
of iron and the higher concentration of transferrin receptor inside the cancer cell
provide to the ruthenium based drugs certain selectivity towards cancer cells [99].
For these reasons ruthenium(II) complexes represent an ideal alternative to
the platinum(II) compounds. Despite this, only two Ruthenium compounds
have entered clinical trials, the [ImH][trans−RuCl4(DMSO)Im] (NAMI-A) and
[InH][trans−RuCl4In2], where Ru has oxidation number III.
The firstly synthesized Ru(II) complexes with anticancer property are Ru-amine
[102] and RuCl-DMSO-complexes [103]. Interestingly, trans-[Ru(Cl)2DMSO4]
is more cytotoxic than its cis-isomer. As the cisplatin results more toxic than
transplatin, so it suggests a different pathway of reaction of Ru(II). In fact, on
the one hand cisplatin reacts with DNA trough an intrastrand cross link; on the
other hand, Ru(II) complexes generally react through a cross link between DNA
strands.
1.3.2.2 Further Metal Centers
In the last years, other metal centers have been taken into account in anticancer
strategy. Metal complexes having Osmium [104], Rhodium [105], Iridium [105],
Copper [106], Cobalt [107] Gold [108] as metal center are present in literature.
The metal center proportion to the metal complex different properties, such
as the charge, the geometry, the photophysical properties (favouring MC or
MLCT transitions) and the kinetics of ligand exchange. It follows that the
choice of the metal center is essential when we plan to synthesize a new drug.
Surely, the ligands bound to the metal center are also relevant, since they can
favour interaction with the target (for example, the ligand can supply π-stacking
interaction with the nucleic acids) and can influence other properties (solubility,
kinetic rate of reaction and photoproperties, as well).
1.4 Enhancement of Compounds Selectivity
The strength of the interaction of a metal drug towards biological targets is not
the only single paramater which must be taken into account in the development of
an anticancer strategy. Actually, a selective interaction towards the cancer cells
and a slight reactivity with the health cells should also be desirable. Selectivity
can be enhanced by means of different methods:
• increase of the selectivity towards a specific target and slight interaction
with other biomolecules [109,110], in particular in the case of the target is
overexpressed in some way inside the cancer cells;
• use of prodrugs. The exploitation of prodrugs is a valuable strategy, based
on molecules which have no (or little) activity, but their reactivity is
switched on under suitable conditions. The activation can be promoted by
an internal stimulus, such as the pH or the presence of reductants inside
the cell [111], or an external stimulus, such as the light [112]. Aim of the
prodrugs strategy is the activation of the drugs in a specific region, in
order to make the drug available only for the cancer cells.
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Part of the Thesis is focused on two different ways of selective strategy: (i) selec-
tivity towards G-Quadruplex structures and (ii) enhancement of the reactivity
by means of photoirradiation. Both strategies will be explained in the following
paragraphs.
1.4.1 Selectivity Towards Specific Targets: G-Quadruplex
Binders
G-Quadruplex is a recently considered target for new drugs. G-rich tracts are
present in the telomere of the genome and it is found that the majority of
cancer cells overexpress telomerase, contributing to the immortalization of the
cells [113]. In addition, it is verified that specific DNA regions, called proto-
oncogenes, being these malfunctioning genes which can promote cancer cell
formation, have G-rich tracts. Examples of proto-oncogenes are the c-myc [114]
and the c-kit [115] regions. Mutations or overexpressions of such genes alter cell
growth and proliferation.
In the last years, it has been demonstrated that G-Quadruplex formation can
affect the gene functions. For instance, G-Quadruplex structure of the telomere
inhibits the function of the telomerase enzyme [116]. Consequently, systems
able to stabilize the G-quadruplex telomere conformation and inhibit genome
lengthening could be exploited to obtain a selective cancer cell death. In addition,
the expression of the c-myc promoter, which has a native duplex structure, can
be silenced by stabilization of its quadruplex conformation [117,118].
Different organic [119, 120] and organometallic complexes [121, 122] have been
proposed as G-Quadruplex binders. Concerning metal complexes, various classes
have been tested:
• Metallo-porphirins. Porphirins have been broadly tested with Quadru-
plexes. A well known porphirinic compound is TMPyP4 (5,10,15,20-tetra-
(N-methyl-4-pyridyl)porphyrin), which is verified to inhibit the telom-
erase [123]. Metallo-porphirins analogues of TMPyP4 are able to interact
externally of the G-tetrads by means of π-stacking interactions. In addi-
tion, the presence of a metal ion in the porphirinic structure enhances the
interaction strength, proportioning electrostatic interaction [124];
• Planar metal complexes. Such classes of complexes are metal ions
coordinated with ligands which are not planar when they are unbound.
Differently to porphirins, the free ligands slightly interact with the G-
Quadruplex, since they cannot form extended stacked interaction. However,
the complexation renders the ligand geometry planar, increasing the affinity
towards G-Quadruplex, coupled to the electrostatic interaction of the metal
ion. Examples of planar metal complexes are salphen, salen [125, 126],
phenantroline [127] and terpyridine [128] ligands coordinated to various
metal centers (Ni2+, Cu2+, Zn2+, V4+, Pt2+ and Ru3+). The degree
of planarity induced by the metal center influences the affinity with the
G-Quadruplex;
• Supramolecular systems. Nonplanar systems can exhibit a certain se-
lectivity for G-Quadruplex moiety. Some examples are the supramolecular
squares of multinuclear Pt(II) [129], cylinders formed by the interaction of
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ditopic ligands with two metal ions, with general formula M2L3 [130], and
supramolecular cubes, obtained by association of two Zn-porphyrins [131];
• Octahedral systems. Mono- and bimetallic Ruthenium polypyridyl com-
plexes show good interaction with G-Quadruplex. In addition to these,
biscyclometalated complexes display remarkable affinity [132,133]. In par-
ticular, the modification of the ancillary NN and the CN ligands reflects
in the selectivity towards G-Quadruplex [134].
1.4.2 Photodynamic Therapy Strategy
In this Thesis, part of the efforts has been devoted to the study of photoactivation
of the metal complexes, which is the topic of Photodynamic Therapy, or PDT.
In PDT strategy a photosensitizer S is excited to S*. The excited S* can react
through different pathways with DNA (Figure 1.17) [135,136]:
Figure 1.17: Possible mechanisms of action of a photosensitizer (S).
• Type II mechanism: it is a dioxygen-dependent pathway, occurring
in classical photodynamic therapy. The excited photosensitizer transfers
its energy to the oxygen in its triplet ground state. Consequently, the
triplet oxygen converts into singlet oxygen, a reactive species damaging
DNA [136,137]. Singlet oxygen target generally is the guanine nucleobase,
producing 8-oxo-guanine;
• Type I mechanism: it is a dioxygen-independent pathway, which occurs
in the nonclassical photodynamic therapy. In this case, the compounds
can photorelease radicals, or they are photooxidant or photoreductant
molecules. So, they cause DNA photocleavage without the presence of
dioxygen. Note that an oxygen-independent mechanism of action is of
remarkable interest for the reason that the majority of the cancer cells are
generally hypoxic, reducing the effect of an oxygen-based mechanism;
• Photoredox pathway: the molecule evolves due to a photoredox reaction,
releasing an electron. The electron can directly reduce a nucleobases or
reduce the molecular oxygen to superoxide or hydroxyl radicals, which
react with the nucleic acid;
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• Other pathways: other pathways can involve the release of specific
molecules. For instance, photo-NO-releasing molecules [138] and the photo-
CO-releasing molecules [139] can release nitric oxide (NO) or carbon monox-
ide (CO) after irradiation, respectively. Concerning the NO molecule, even
if it promotes the cell growth, at higher concentration (high µM to mM) can
cause the cell death. The effect of the NO molecule involves an irreversible
reaction with DNA, promoting his fragmentation.
Various parameters are involved in the photoreactivity of a molecule and the
sum of them makes the compound suitable for PDT. The optimal properties of
a photosensitizer are [140]:
• no or low activity in the dark;
• photostability;
• activation at λirr > 300 nm because high energy irradiation can provoke
damage to the skin. In particular, the optimal region is the red visible
region (600 nm < λirr < 900 nm) because below 600 nm the radiation is
partially absorbed by the tissue, especially by haemoglobin and myoglobin
[141];
• high absorption at the wavelength of irradiation;
• high quantum yield of the transition to the photoactive excited state;
• for the oxygen-dependent photosensitizer, high singlet oxygen quantum
yield.
Although the photoactivation strategy was developed for organic molecules (e.g.
porphyrins), in the last years various classes of metal complexes have been taken
into account.
Platinum complexes were the first class of metal complexes to be tested for
the Photodynamic Therapy, using Pt(IV) [95, 140,142]. Pt(IV) octahedral com-
plexes are mainly inert, but they can be activated by the photorelease of the
axial ligands, to obtain the squared Pt(II) active species. The first generation
of photoactivatable Pt(IV) complexes were the diiodo complex [142], such as
cis,trans-[PtCl2(en)I2] [143] and cis,trans-[Pt(OAc)2(en)I2] [144], which react
with DNA after irradiation with a source of light (λ > 375 nm), provoking the
loss of both iodides. The second generation of photoactivated Pt(IV) complexes
were the Pt(IV) diazido complexes (λ > 300 nm) [145]. These complexes exhibit
higher stability in the dark and in the presence the biological reductants than
diiodo Pt(IV) species. Moreover, the N3 radicals from the photolysis of the metal
complex generally evolve to N2 [140]. Further studies involve combination of
different functional groups inside the ligands in order to increase the antitumoral
effect of the drug and in order to decrease the irradiation wavelength by means
of the multiphoton excitation [140].
Furthermore, the anticancer activity can be enhanced by the presence of target-
ing or bioactive axial ligands having anticancer or pharmacokinetic properties,
as well [146–148]. In general, the use of an inactive metal centre, which is
able to release small molecules with biological and anticancer activity (called
caged metal compounds), is the topic of a large study in contemporary litera-
ture [149, 150]. The use of such a kind of ligands is powerful with Platinum
1.5. THE METAL COMPLEXES IN THE THESIS 25
(IV), for the reason that the release of bioactive organic molecules follows the
reduction of the ineffective Pt(IV) form to the active Pt(II) form (Figure 1.18),
obtaining a dual mode of action [150].
Figure 1.18: Scheme of the release of a bioactive ligand.
Examples of bioactive ligands used in the synthesis of metal complexes are in-
tercalators (which are able to insert between the DNA basepairs and induce
important modifications of the secondary structure of the polynucleotide) [151],
neuroactive molecules, which are amines such as γ-aminobutyric acid, typtamine,
serotonin, tyramine and butylamine, α-aminoacids and peptides [152], peptide
receptor [153], estradiol [154], nanotubes [148].
Various classes of ruthenium complexes exhibit photocleavaging properties and,
among these, the most investigated ones are the polypyridyl complexes, which
have high singlet oxygen quantum yields. In addition, their photoluminescent
properties and their ability to intercalate between the base pairs of DNA make
them suitable as DNA photocleavaging agents (λ > 440 nm) [155–157].
In the same way as polypyridyl complexes, many biscylometalated complexes
produce singlet oxygen and, recently, iridium complexes have been proposed as
photosensitizer in PDT [158,159].
Rhodium polypyridyl complexes exhibit good photocleavaging properties, as well.
In particular, it is found that they can intercalate between the nitrogenous base-
pairs or into the groove and cleave DNA. Interestingly, the ancillary intercalating
ligand plays a fundamental role in the recognition site [90]. Actually, variation
in the shape and functional groups of the ligands provide certain preference of
binding to the DNA secondary structure because of steric exclusion and noncova-
lent interactions. It follows that the development of octahedral systems able to
intercalate into the DNA and cleave the DNA in the region where the interaction
is placed is of remarkable interest [160]. In addition, dirhodium complexes can
form covalent adducts with nitrogenous bases under irradiation [161,162], a be-
haviour observed for ruthenium complexes, as well [163]. The reaction involves
the photorelease of a ligand, allowing the interaction with N7 of guanine.
1.5 The Metal Complexes in the Thesis
In Part II of the Thesis we treat different classes of metal complexes, with various
metal centers and ligands. Regarding the metal complexes, we used η6-arene
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and biscyclometalated complexes.
1.5.1 Arene Ruthenium(II) Complexes
Arene Ruthenium(II) complexes are an extensively studied class of compounds
for their high stability and their known cytotoxic activity (Figure 1.19).
Figure 1.19: The pseudo-octahedral structure of an arene Ru(II) complex. YZ is the
chelating group, X is the leaving group and n is the charge.
The reactivity of these compounds depends on various factors [99,164]:
• Nature of the arene (intercalative or nonintercalative group).
Arene is used to stabilize the ruthenium II oxidation state. In addition, it
provides an important contribution on the reactivity of the drug; actually,
the increase of the aromatic size of the arene group favours the interca-
lation inside the DNA, which greatly enhances the activity of the metal
complex [165]. Moreover, the arene ligand is the hydrophobic part of the
metal complex, and it favours the passage through the cell membrane. On
the other hand, the presence of polar functional groups on the arene rings
(such as amides, esthers and alcohols) lowers the drug efficiency [166];
• Leaving group (X): it generally is a halide group; it is substituted by
the more reactive water group in aqueous solution. The rate of hydrolysis
depends on the ligands nature (arene, chelating-group, leaving group) and
the release of the leaving group can allow the ruthenium to form covalent
binding with the DNA by displacement of the water molecule, in particular
with the N7 atom of the guanine [167,168];
• Chelating ligand (YZ): investigated groups are, for instance, NN, NO
and OO-chelating ligands. It is assessed that the chelating ligand influences
the binding to the nucleobase and its selectivity, as well (and it remarkably
rises the anticancer activity of the drug [100,164,168]). For example, the
ancillary ligand can form hydrogen bonds with the functional groups of
the guanine, promoting the covalent binding of the arene complex after the
release of the leaving group, In addition, the ancillary ligand can interact
via noncovalent binding to DNA due to its intrinsic properties [169];
• Charge (n): it influences the solubility of the drug and the partition
coefficient;
• Counterion: it changes the solubility of the drug and, in few cases, the
reactivity, as well.
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The large variety of arene, leaving, and chelating groups implies almost infinite
possibilities of Ru-arene compounds, achieving various thermodynamic and ki-
netic properties, which is a useful tool in the tuning of the pharmacokinetics of
the drug.
1.5.2 Biscyclometalated Iridium(III) and Rhodium(III) Com-
plexes
Good anticancer activity has been recently reported for Iridium and Rhodium
species [105], and a recent developed class containing such metal centers are
the biscyclometalated complexes. Biscyclometalated complexes are composed
by two CN cyclometalating ligands and an ancillary ligand (Figure 1.20; in the
present Thesis, we worked with NN ancillary ligands).
Figure 1.20: Biscyclometalated complex structure. CN is the cyclometalating ligand
and NN is the ancillary ligand.
This class of complexes has been applied in different fields for their promising pho-
tophysical properties [170]. Actually, Iridium(III) biscylometalated complexes
exhibit long lifetimes, large stokes shifts and high quantum yields. Cyclometa-
lating ligands are strong fields ligands which split the d orbitals of the metal
centers into high energy; it follows that the MC transition is not the lowest
electronic transition, but other excitation states are favoured. In particular,
for Iridium biscyclometalated complexes, the metal-to-ligand charge transfer
(MLCT) transition is the lowest one, even though ligand centered (LC) transi-
tion can exhibit a similar energy. It provokes a mixing of both states. On the
other hand, Rhodium complexes generally exhibit a LC lowest state.
The possibility to easily change the nature of the ligands, allows one to tune
the fluorescence of the complexes, obtaining almost infinite possible lumines-
cent species [171–173]. Concerning biological applications, biscyclometalated iri-
dium complexes have been proposed as labelling reagents of biological molecules
[174–177] and, in the last years, the cyclometalated complexes were suggested
as candidates for photodynamic therapy (PDT) [179–181].
On the other hand, Rhodium biscylometalated complexes are less studied be-
cause of their poor photophysical properties. Nevertheless, it is verified that
rhodium metal center generally exhibits higher cytotoxic activity than iridium
does, which makes it a good candidate for anticancer strategy [182,183].
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1.5.3 Ancillary Ligands
The chosen ancillary ligands bound to the metal complexes are the arylazole che-
lating ligands, which have been seen to exhibit interesting biological properties
and metal complexes coordinated to them have shown good properties. Actually,
the possibility to link the reactivity of a positive charged metal ion and the mode
of binding to nucleic acids of heteroaromatic planar ligand (e. g. groove binding,
intercalation) can increase the reactivity of the drug.
Benzoimidazole, benzoxazole, benzothiazole and species derived from them like
2-arylbenzazoles have been used as agents against Alzheimer disease [184] and in
other biomedical applications [185,186]. Even more interestingly, derivatives of
benzothiazole [187,188] or benzoimidazole [189] have proven to exhibit antitumor
activity. In addition different arene [190–192] and non-arene [193] ruthenium
compounds with ligands containing a core of benzoimidazole or benzothiazole
bonded to a 2-pyridine unit or other organic moieties have been reported to
exhibit antitumoral activity and other biological properties [194–197].
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All the experiments of characterization and reactivity in water have been per-
formed using bidistilled water by a Puranity TU+ equipment (VWR) and auto-
claving the water by means of a Typ Vapour Line 80-M (VWR). The experiments
were carried out always fixing the ionic strength and the pH, depending on the
type of involved system. Ionic strength was kept constant by means of differ-
ent salt: NaClO4 (Fluka, as monohydrate salt), NaCl (Panreac, Montplet &
Esteban) or KCl (Fluka). pH was fixed by means of sodium dimethylarsinate
(NaCac, also called cacodylate, Carlo Erba), having pKA = 6.2, or potassium
phosphate buffer (obtained by mixing of KH2PO4 and K2HPO4, pKA = 7.2).
2.1.1 Nucleic Acids
Different kinds of nucleic acids have been tested in the present Thesis:
• Synthethic RNA: poly-riboadenylic (poly(rA)) and poly-ribouridylic
(poly(rU)) acids were employed in the interaction with Al(III)/cacodylate
complex (Chapter 4). Poly(rA) and poly(rU) were purchased from Sigma
as lyophilized potassium salts. Standardization of the RNA stock so-
lutions was attained spectrophotometrically to ε257 = 10 100 M−1cm−1
for poly(rA) and ε260 = 8900 M−1cm−1 for poly(rU), at I=0.1 M (NaCl),
pH=7.0 and T=25.0 ◦C. It is worth to remind you that the polyriboadenylic
acid secondary structure changes with pH, as we discussed in Chapter 1:
poly(rA) converts itself into the [poly(rA)]2 double helix form at acidic pH,
while it remains as a single helix at neutral pH [1], with partially ordered
conformation. On the other hand, polyribourydilic acid has a random coil
conformation in both experimental conditions [2];
• Calf Thymus DNA: Liophylized Calf Thymus (CT) DNA sodium salt
was purchased from Sigma Aldrich. It was dissolved in bidistilled water
and sonicated in order to obtain a mean length of 1000 bp, confirmed
by electrophoretic assay in the presence of a molecular weight marker.
Standardization of stock solutions was performed spectrophotometrically
(ε260=13 200 M−1cm−1 in basepairs at I=0.1 M (NaCl), pH=7.0 (NaCac)
and T=25.0 ◦C);
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• Plasmid pUC18: pUC18 is a plasmid cloning vector present in E.Coli,
composed by 2686 bp. Plasmid was extracted by bacteria using a kit proto-
col (HP Plasmid Midi Kit, OMEGA Bio-Tek). The purity of the extracted
plasmid was checked by the Abs260Abs280 ratio, which assures the absence of
proteins. The secondary structure of the extracted plasmid was checked by
electrophoresis, confirming the predominance of the native Form I (Super-
coiled). CP is referred to the molar concentration of the nitrogenous bases.
pUC18 was used in the photocleavage study with Ruthenium, Iridium and
Rhodium complexes;
• Oligonucleotides: oligonucleotides are short sequences of defined length
and primary structure. In the Thesis we used different oligonucleotides:
the 5’-CAATCGGATCGAATTCGATCCGATTG-3’ 26-mer (7974 u m a ),
self associating to give a double strand structure (named 52B), the 5’-
[GAGGGTGGG]2GAAG-3’ Pu22 (7070 u m a ), forming an unimolecolar
G-Quadruplex moiety, mimicking the c-myc quadruplex conformation, and
5’-[AGGGTT]3AGGG-3’ Tel22 (6970 u m a ), which has an unimolecolar
G-Quadruplex structure as well, but displaying the conformation of the
telomere. All the nucleotides were purchased from Sigma-Aldrich. The
oligonucleotides stock solutions were prepared in KCl=0.09 M and potas-
sium phosphate buffer, obtaining I=0.1 M and pH=7.0. The stock solu-
tions were heated 10 ◦C above the melting temperature of the Quadru-
plex, being Tm=74.7, 76.3, 64.0 ◦C for 52B, Pu22 and Tel22, respectively.
Then, the solution was left to slowly return to 25.0 ◦C, in order to as-
sure that all the sequences adopt the most stable quadruplex confor-
mation. Standardization of the stock solutions came spectrophotometri-
cally, using ε260=414 000 M−1cm−1, 232 000 M−1cm−1, 228 500 M−1cm−1
for 52B, Pu22 and Tel22, respectively. In this case, the concentration CP
is referred to the molar concentration of the oligonucleotide. Titrations of
the oligonucleotides with iridium and rhodium complexes are reported in
Chapter 7.
2.1.2 Aluminium
Aluminium will be treated in Chapter 3 and 4. Aluminium ion source was
the octahydrate perchlorate salt form (Al(ClO4)3 · 8H2O) and was purchased
from Fluka. Aluminium stock solutions were prepared in doubly distilled water,
adding HClO4 to obtain pH=2.0, in order to avoid precipitation. Standardiza-
tion of aluminium was attained by EDTA titrations, using Eriochrome Black-T
as visual indicator. Briefly, the titration was carried out adding an EDTA excess
to an aluminium aliquot. The solution was boiled and acetate buffer was added
to achieve pH=6.0. After that, the solution was titrated with a standardized
Zn2+ solution.
2.1.3 Ruthenium, Iridium and Rhodium Complexes
All the studied complexes were synthesized in the Inorganic Chemistry Labora-
tory of the Facultad de Ciencias, Universidad de Burgos. [(p-cym)Ru(L-1)(NCS)]
(named [Ru-1], where p-cym is p-cymene andHL-1 = 2-(2’-hydroxyphenyl)ben-
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zothiazole) arene complex was studied in Chapter 5. Then, we tested the
[Ir(ppy)2(pyboz)]Cl ([Ir-1]Cl) and [Rh(ppy)2(pyboz)]Cl ([Rh-1]Cl) biscyclome-
talated complexes (Hppy = 2-phenylpyridine and pyboz = 2-(2’-pyridyl)benzox-
azole ligands) in Chapter 6. Finally, eight new synthesized complexes of general
formula [M(CN)2(NN)]Cl, being M = Ir, Rh, (CN) = ppy, piqi (2-phenylisoquino-
line) and (NN) = pybtz (2-(2’-pyridyl)benzothiazole), qibtz (2-(2’-quinolinyl)ben-
zothiazole), were discussed in Chapter 7 ([Ir-2]Cl-[Ir-5]Cl and [Rh-2]Cl-[Rh-5]-
Cl). As the syntheses, the purification and characterization of the complexes in
Chapter 7 are part of the present Thesis, they will be extensively discussed.
2.2 Methods
2.2.1 Synthesis Procedure
The synthesis of the organic ligands and the metal complexes was carried out
under a nitrogenous atmosphere (if oxygen is not required as reactant), using a
Schlenk line (also called vacuum gas manifold) apparatus, which consists of two
manifolds (Figure 2.1):
Figure 2.1: Scheme of a Schlenk line.
• the first manifold is connected to a vacuum pump, which is linked to a
trap to avoid the contamination of the pump with chemical solvents;
• the second manifold is a nitrogenous line, passing through an oil bubbler
to prove the gas flowing through the line;
• four ports are available to connect flasks or other chemical glassware. In
each line a tap is present, allowing to select vacuum or nitrogen. To obtain
an inert atmosphere in a Schlenk three cycles of vacuum-N2 are performed
and the reagents are inserted in the presence of a nitrogen flux.
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In addition, other procedures can be carried out using the Schlenk line:
• solvent evaporation: the solvent can be evaporated under vacuum con-
dition. The solvent passes through a cold trap inserted in a dewer and it
is freezed by means of liquid nitrogen. It avoids the liquid reaching the
pump.
• solvent filtering: the solvent can be filtered under pressure obtained by
a nitrogen flow. It is achieved blocking the gas flow and forcing it to pass
only to the Schlenk. A cannula transfer with a filter is put in the Schlenk
and the solvent passes from the cannula to a second flask because of the
nitrogen pressure.
Operations of separation and purification of the ligands were achieved using a
chromatographic column (Figure 2.2).
Figure 2.2: Scheme of the chromatographic procedure with a silica column gel.
Preliminary proofs of the elution of the crude product was carried out by means
of Thin Layer Chromatography (TLC) on silica gel. The retention time of a
molecule on the silica column depends on its polarity. The higher the polarity,
the higher the retention time. On the contrary, the lower the polarity, the higher
the affinity for the eluent phase, which means low retention times. The choice
of the eluent phase is crucial to obtain separation of all the subproducts present
in the crude sample. The different signals of the product and subproducts are
visualized on the TLC by their fluorescence with a UV lamp. When a suitable
elution phase is found, the dissolved product is passed through the column and
aliquots of 5 mL are collected and checked by TLC. Then the aliquots containing
only the product are put together and dried.
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2.2.2 UV-vis Spectrophotometry
Spectrophotometry is an analytical technique based on the Lambert Beer’s law
(Equation 2.1),
Abs = Log I0
I
= εbC (2.1)
where Abs is the absorption, I and I0 are the resulting light intensities passing
through the sample and the solvent, respectively, ε the molar extinction coeffi-
cient, b the path of the light through the sample and C is the molar concentration
of the molecule absorbing the radiation. The law is valid for diluted solution and
monochromatic light. If k molecules absorb radiation at a defined wavelength,
the total absorption will be the sum of the k contributions (Equation 2.2).




Thus, the absorption can be used to follow the progress of a reaction because
of its relationship with the concentration. Thermodynamic (spectrophotometric
titrations) and kinetic studies (variation of the absorbance with time) can be
performed with a spectrophotometer.
Regarding the spectrophotometric titrations, they can be carried out (i) adding
increasing aliquots of the titrant to a solution of the titrate at fixed pH, ionic
strength and temperature, or (ii) preparing i solutions at different titrant-titrate
ratios (batchwise titration).
On the other hand, kinetic curves were obtained by acquiring the absorption
value at a specific wavelength versus time.
The employed spectrophotometers in this Thesis are the double beam spectro-
photometer and the diode array spectrophotometer. The schemes of both in-
struments are reported below.
2.2.2.1 Double Beam Spectrophotometer
The scheme of a double beam spectrophotometer is reported in Figure 2.3.
Figure 2.3: Scheme of a double beam spectrophotometer.
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The instrument consists of a tungsten lamp (W) for the emission in the visible
region, and a xenon lamp (Xe) for the UV region. The light is divided into the
different wavelengths by means of a monochromator and the entire spectrum is
obtained by scanning the selected wavelength range. The radiation is splitted
by means of reflectant mirrors, sending part of the radiation to the reference,
which generally is the solvent of the reaction, and the other part to the sample.
Both beams are collided again to the same path and pass through a chopper,
sending them to the detector at different times. By comparing the intensity of
the signals, the detector expresses the difference by the absorption value. A scan
of the wavelengths is required to record the entire spectrum. The cells containing
the reference and the sample are made of quartz and have a 1 cm path length.
The system is maintained at 25.0 ◦C by means of a water thermostat.
2.2.2.2 Diode Array Spectrophotometer
Unlike the double beam system, the diode array spectrophotometer does not
measure the ratio of the intensity of the radiation, but rather it detects the
absolute intensity of the radiation. To achieve the same conditions of the double
beam spectrophotometer, an initial measurement of the blank is required, which
is subtracted from the sample. The scheme of the instrument is summarized
in Figure 2.4. The light strikes the cell containing the sample and then the
wavelengths are splitted by means of a monochromator, which sends the wave-
lengths to the diode array detector. The diode array detector collects all the
wavelengths at the same time. The advantage of such a kind of instrument is
the rate of acquisition of the spectra. However, the use of a single beam does
not allow a constant comparison of the signal of the sample and the reference,
with a lower stabilization of the baseline respect to the double beam system.
Figure 2.4: Scheme of a diode array spectrophotometer.
2.2.3 Spectrofluorimetry
The excitation of a molecule and the subsequent radiative process can be ex-
pressed by means of the Jablonsky Diagram, drawn in Figure 2.5 [3]. Actually,
when a photon having an energetic accessible wavelength strikes a molecule, the
photon will be absorbed and the molecule is promoted from the singlet ground
state S0 to the singlet excited state S1 (or S2). Vibrational relaxations dissipate
part of the acquired energy and the molecule switches from the excited vibra-
tional states to the fundamental vibrational state of S1. At this level, the system
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can evolve to:
Figure 2.5: Jablonski diagram.
• a non-radiative process: the energy is transferred to solvent molecules by
collisions;
• a radiative process: the system spontaneously emits a photon to return
to its singlet grounds state, always being νem < νex. The transition is
called fluorescence and it is a spin allowed transition. On the other hand,
an intersystem crossing of the excited states can occur, which provokes
a transition from the singlet excited state S1 to a triplet excited state
T1. In such a case an emission occurs as well, but the transition to S0 is
theoretically spin forbidden, impeding a fast decay. It follows that T1 is a
long lived excited state. Such a decay is defined as phosphorescence.
Fluorescence is used for different kinds of experiments, which can be sorted into
steady-state and lifetime measurements.
2.2.3.1 Fluorescence Steady-State
In steady-state measurements the intensity and the shape of the fluorescence
spectra are recorded. Expressing the fluorescence quantum yield (Φ) as the ratio
between the emitted and absorbed photons, a relationship between fluorescence




Since I and I0 are related to the absorption, it is possible to express fluorescence
as a function of Abs. In the case of diluted solution (Abs < 0.1) the formula is
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approximated by the Taylor series (Equation 2.4).
I
I0
= e−2.3εbC ⇒ I = I0(1− 2.3εbC) (2.4)
Inserting Eq. (2.4) into Eq. (2.3) we obtain the relation between the fluorescence
intensity and the concentration (Equation 2.5).
F = φC (2.5)
2.3ΦI0εb is named φ and it has the same function of ε for absorption. However,
note that the absorption is an universal value because ε is fixed at specific con-
ditions (solvent, pH and temperature). Differently, φ is not universal because it
depends on the amount of light reaching the sample; hence it greatly depends
on the instrumentation geometry. It means that fluorescence absolute value
obtained in different laboratories under the same experimental conditions can
be different.
Concerning the equipment, in a fluorimeter the radiation crosses a slit and a
monochromator and strikes the sample. As the light is emitted in all the direc-
tions by the fluorescent molecule, the detector is generally placed perpendicular
to the excitation light (right angle geometry), avoiding the interference of the
excitation source. The emission light goes through a second monochromator
and it is acquired by the detector. A block scheme of a fluorimeter is reported
in Figure 2.6.
Figure 2.6: Block scheme of a fluorimeter.
2.2.3.2 Fluorescence Lifetime
In lifetime measurements the exponential decay of the fluorescent signal is ac-
quired. For a monoexponential decay the fitting equation is given by Equation
(2.6),




where F0 is the fluorescence at t = 0 and τ the fluorescence lifetime. In the case






Regarding lifetime measurements, a pulsed nanoLED or a laser excite the sample
at a specific wavelength. Detection method used is the time-correlated single
photon counting (TCSPC). This method involves 4096 channels of detection, and
each one acquires photons at a defined ∆t after the pulse. The resulting graphic
is the counts (or its logarithmic value) of the photons reaching the detector
versus the channel number (which is converted into a time value, knowing the
relation between channel and ∆t). The mono-, bi- or multiexponential decays
are fitted and the goodness of the fitting is expressed by the χ2 value (1 is the
ideal value). Subtraction of the instrument response (PROMPT) is required to
correct the experimental curve, in particular for very short lifetimes.
Fluorescence decays were recorded in order to obtain the lifetimes of the metal
complexes. In addition, titrations of metal complex-nucleic acids systems can
be performed by means of this technique, as well.
2.2.3.3 Further Applications
Fluorimeter has been used also for:
• Fluorescence quantum yield: the fluorescence quantum yield ΦS is
calculated by comparing the area of the emission spectra of a complex
with a reference. A Ru(bpy)32+ solution was used as reference (ΦR=0.028
in air-equilibrated water at 25.0 ◦C) and the quantum yield is obtained by









where ni is the refractive index of the solvent. If the same solvent is used
and the prepared sample and the reference have the same absorption at
the excitation wavelength, the equation will be greatly simplified.
• Singlet oxygen quantum yield Φ1∆g : the phosphorescence of the sin-
glet oxygen can be detected at 1270 nm. The ratio of the spectrum area of
the studied complex and the phenalenone reference molecule is the singlet
oxygen quantum yield, being the quantum yield of the reference 1.0 [5].
Solutions having the same absorption at the excitation wavelength were
analysed. The singlet oxygen formation is observed in D2O, as the singlet
oxygen exhibits longer lifetime in the deuterated solvent.
2.2.4 Circular Dichroism
For a circularly polarized light the eletric field vector −→E has a circular trajectory
along the direction of the wave, −→E = Re−→E0eiΨ, where Ψ is the angle phase
(Figure 2.7) [6].
56 CHAPTER 2. MATERIALS AND METHODS
Figure 2.7: Electric field vector of the circularly polarized light.
For the circular radiation, two components are present, the left handed EL and
the right handed ER. When an optical active molecule absorbs the excitation
light, it will absorb only one of the components. It follows that the circularly po-
larized light is converted into an elliptical polarized light because of the intensity
decrease of one vector (Figure 2.8).
Figure 2.8: Formation of the elliptic polarized radiation from the cicularly polarized
radiation due to the different absorption of ER and EL; α is the rotation angle of the
light.
The elliciptity Θ can be calculated by the Equation (2.9).
tanΘ = ER − EL
ER + EL
(2.9)
In diluted solution tanΘ can be approximated toΘ by Taylor series. Furthermore,
the electric field can be expressed by the light intensity, and, consequently, it is































If ∆Abs«1 another approximation is possible
Θ = ∆Abs ln 104 (2.11)
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The value is converted into radiant using the 180π factor and the ellipticity is
passed to molar ellipticity using [Θ] = 100ΘbC . The resulting Equation (2.12) is
[Θ] = 100∆ε( ln 104 )(
180
π
) ∼= 3300∆ε = k′(εR − εL) (2.12)
Hence, a direct relationship between molar ellipticity and the variation of the
extinction coefficients of the right handed (εR) and left handed (εL) circularly
polarized light is found. The resulting spectra has the same properties of a
UV-vis absorption spectra with minima and maxima values. However, negative
values are possible for a circular dichroic spectra.
Circular dichroism can provide useful information in the study of biological sys-
tems and it is routinely applied for the study of proteins and polynucleotides.
The variation of the dichroic spectrum can be recorded in order to study the
interaction between small molecules with the nucleic acids. In fact, organic dyes
and metal complexes can provoke structural modification on DNA and RNA,
and it produces a modification of the stacking interactions. In particular, elec-
trostatic interactions provoke a small variation of the dichroic spectra, while the
interaction to nitrogenous bases or intercalation causes an important variation of
the dichroic signal. In addition, an achiral dye interacting with a macromolecule
can acquire an induced circular dichroism and a dichroic signal in the visible
region could be observed, as well.
The scheme of the instrument is summarized in Figure 2.9.
Figure 2.9: Scheme of the equipment for the circular dichroism acquisition.
2.2.5 Thermal Denaturation
Thermal denaturation involves structural modifications of a macromolecule be-
cause of the temperature. Concerning nucleic acids, they suffer notable variation
of their secondary structure by increasing the temperature. The most important
modification is the separation of two polynucleotidic chains to form two single
helices in DNA (also called melting process).
Two techniques have been employed for melting studies: UV absorption and
Differential Scanning Calorimetry (DSC).
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2.2.5.1 Thermal denaturation in Absorption
Double-helix denaturation produces a hyperchromic effect in absorption because
of the transition from the double- to single-stranded form. As the melting of
polynucleotide is a cooperative process, a sigmoidal track at a specific wavelength
versus the temperature can be observed (Figure 2.10).
Figure 2.10: Thermal denaturation of a double helix structure. The Tm is the temper-
ature corresponding to 50 % denaturation of the polynucleotide.
The curve is analysed by means of a sigmoid equation [7]. Alternatively, the dif-
ferential of the function can be used, where the peak corresponds to the melting
temperature Tm.
2.2.5.2 Differential Scanning Calorimetry
Differently from the melting study in absorption, Differential Scanning Calorime-
try (DSC) records the heat of a sample versus the temperature [8]. The apparatus
works providing a defined amount of heat to both sample and reference, which
is necessary to reach a defined temperature. Differences in the heat capacity
(also named Excess Heat Capacity ∆Csample−solventP ) of two samples of equal
volume, namely the solution containing the macromolecule (CsampleP ) and the
solvent (CsolventP ), is calculated [9].
The value of the CP as a function of temperature is calculated by Equation
(2.13), being mM the mass of the solute M, ν̄M the partial specific volume of M
and ν̄S the partial specific volume of the solvent:








When a transition occurs, such as the melting of the double-helix DNA to form
two single helices, a variation of the signal is recorded because the provided en-
ergy to the sample is spent also to break the hydrogen bonds of the double-helix.
It follows that the sample needs more energy to reach the same temperature as
the reference, because part of it is lost in the transition process. It results in
the ∆Csample−solventP value, and the resulting spectra is a peak corresponding
to the melting process of the double-stranded polynucleotide. Thus, DSC in-
strumentation allows the study of the conformational transitions of biological
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macromolecules. From the obtained graph it is possible to obtain different pa-
rameters, such as the melting temperature Tm, the enthalpy (∆H, Equation











where T1 and T2 are the initial and the final temperatures of the transition
(Figure 2.11).
Figure 2.11: Differential scanning calorimetry scheme and data results.
DSC technique is generally employed in bioinorganic chemistry for the study
of transition of macromolecules conformations, such as unfolding of the pro-
teins, lipid membrane transitions and nucleic acid melting. Organic dyes, metal
complexes and ionic metals interacting with a nucleic acid influence its thermal
stabilization. For instance, an external binding such as electrostatic interaction
and groove binding generally does not provoke significant variation of the Tm.
On the other hand, intercalation causes an important increase in the melting
temperature, for the reason that intercalators increase the stacking interaction
inside the DNA, and it stabilizes the double-helix.
2.2.6 Isothermal Titration Calorimetry
Isothermal Titration Calorimetry (or ITC) is a method based on the measure-
ment of released or acquired heat in a chemical reaction [10]. A reference, which
generally is water, and a solution containing the nucleic acid are thermostated
at 25.0 ◦C. When a reaction occurs in the sample cell, heat can be generated or
spent, varying the temperature of the cell. The system provides the necessary
energy to maintain the sample at 25.0 ◦C.
From the heat results at each titration point the equilibrium constant of the
reaction can be evaluated [9]. We can consider the titration of a molecule M
(the titrand), with a ligand L (the titrant). For each peak i of the titration it is
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possible to calculate the apparent heat change ∆qi,app, which is the integration
of the peak between i− 1 and i addition:
∆qi,app = qi−1 − qi (2.16)
The amount of heat depends on the amount of bound ligand ([L]bound), the cell
volume (Vcell) and the apparent enthalphy of reaction (∆Happ, Equation (2.17)).
∆qi,app = ∆[Li]boundVcell∆Happ (2.17)
Note that Vcell is always known and ∆Happ is fixed at a specific pressure and
temperature. However, ∆qi,app has various contributions, which are due to the
reaction itself (∆qi), the dilution effect (∆qdil) and other nonspecific effects
(∆qns). To obtain ∆qi a blank proof is required, performing the addition of L in
the solvent and recording the heat. Then the blank can be subtracted obtaining
∆qi = ∆qi,app −∆qdil −∆qns.
The heat will be maximum for the first titration points and it will decrease with
the diminishing of the bound ligand in the solution because of the saturation of
M. Equation (2.17) can be converted into Equation (2.18),
∆qi = nCMVcell∆HappR (2.18)
where n is the number of binding sites of M, CM is the analytical concentration
of M and R is a function defined by Equation (2.19),





) + nCLCM = 0 (2.19)
where Yi is the saturation degree at point i, being Yi = ∆[Li]boundCM , CL,i is the
analytical concentration of L at the ith point. The resolution of the equation
from the entire titration dataset by the NanoAnalyze program allows one
to calculation n, KA and ∆H.
A scheme of the equipment and an example of data treatment are provided in
Figure 2.12.
Figure 2.12: ITC equipment scheme and example of obtained data.
2.2. METHODS 61
2.2.7 Viscometry
Viscometry is a technique that allows to evaluate the viscosity of a fluid by
the measure of the elapsed time of a 1 mL sample volume to pass through
a capillary tube. This technique is useful in order to understand the nature
of the interaction between a small molecule and a polynucleotide. Actually,
the variation of the viscosity of a solution containing DNA is associated to
conformational variations of the system. For example, intercalation causes an
elongation of the polynucleotides, which provokes an increase of the viscosity
[11]. The viscometric equipment was an Ubbelhode’s microviscometer, whose
structure is shown in Figure 2.13. It was coupled with a thermostat at 25.0 ◦C
(precision 0.1 ◦C). The microviscometer needs a small amount of solution (3 mL).
The time is measured by means of a manual chronometer, with precision of
0.01 s.
Figure 2.13: Ubbelhode’s microviscometer.
The viscosity value is expressed as the cubic root of the viscosity ratio between
the bound (η) and the free polynucleotide (η0). This value is proportional to LL0 ,
which is the ratio between the length of the bound DNA (L) and the free DNA
(L0). The viscosity of the sample is obtained by equation (2.20), where t, t0 and




) 13 = ( t− tS
t0 − tS
) 13 (2.20)
2.2.8 Nuclear Magnetic Resonance
2.2.8.1 1H−NMR
Nuclear magnetic resonance is a spectroscopic technique based on the excitation
of the nuclear states of an atom in the presence of a magnetic field. The NMR
instrument measures the relaxation process of the nucleus to return to the
equilibrium condition after a radio frequency wavelength pulse.
Concerning the proton, in the absence of a magnetic field the mα = + 12 and
mβ = − 12 nuclear spin states are degenerate (the level population of both states
is equal); it follows that the magnetization vector −→M is null. However, when
we apply a static magnetic field −→B , the energy due to the interaction with the
magnetic moment µz will be given by Equation (2.21),
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EmI = gIµNB0mI (2.21)
with B0 the magnetic field along z-axis, µN the nuclear magneton, gI the nuclear
factor and mI the magnetic moment spin. Proton has I = 12 , which means two
possible mI values, m+ 12 and m− 12 . The energy difference is from Equation
(2.22).
∆E = E− 12 − E+ 12 = gIµNB0 (2.22)
Such an energy difference is very small, but it is enough to cause a difference in






where N+ 12 is the level population of the mI = +
1
2 state, N− 12 the level popu-
lation of the mI = − 12 state, νL the Larmor frequence of the transition and T
the temperature.
The energy difference makes the magnetization vector −→M different from zero
with the same direction as the −→B0 magnetic field. If a radiation having oscillating
magnetic field −→B1 and frequency νL is sent perpendicularly to the magnetization
vector, a precession of −→M is obtained and, if the radiation is pulsed, the vector
passes to the xy plane. After the pulse, a relaxation process of the spin to return
to the equilibrium condition can be followed along the y-axis and it is reported











This result could wrongly suggest that every proton suffers the same magnetic
field and, consequently, that every proton present in a molecule gives rise to
the same signal. However, each atom is influenced by a different chemical
environment, which generates a −→B 6= −→B0, differing from δB = −σB0, where σ
is the shielding constant. In effect, the magnetic field produces an electronic
orbital angular moment, generating a small δB opposing to −→B 0. Hence, each
proton suffers a different local magnetic field Bloc = B0(1−σ) and, consequently,
the atoms are excited by different Larmor frequencies (Equation (2.26)).
νloc = (1− σ)
γB0
2π (2.26)
A NMR signal consists of three different parameters:
• the chemical shift, δ, as to say the position of the signal in the chemical
shift scale (ppm unity), defined as
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σ = ν − ν0
ν0
106 (2.27)
where ν0 is the Larmor frequence of a reference, generally being tetrame-
thylsilane;
• the multiplicity M , which is the number of peaks of a proton signal, being
M = 2nI + 1 (2.28)
where n is the number of the scalar coupled atoms with the proton, and
I is its magnetic moment. The multiplicity of the signal is due to the
interaction of neighbouring nuclei (fine structure). The strength of the
interaction between the different nuclei is expressed by the scalar coupling
constant J (in Hertz);
• the area. It can be used for the quantification of the signal.
2.2.8.2 13C NMR
The NMR spectrum can be recorded for the carbon atom, as well. However,
unlike proton, the active nucleus of the carbon is 13C, which is 1 % of the total
carbon nuclei (for proton, 1H is 99.8 %). It means that the signal is very low
and accumulation of the signal is needed. In addition, decoupling of the signal
(expressed as 13C{1H}) is usually set up in order that each carbon has only one
peak, which allows an increase of the peak signal.
2.2.8.3 Bidimensional Techniques
Bidimensional NMRs show correlations between the nuclei of a molecule (or
between nuclei of different molecules, as well). Involved bidimensional techniques
in this Thesis are:
• COSY: COSY technique allows to obtain a 2D map which correlates scalar
coupled protons. Generally scalar three bond coupling is possible to detect,
whereas four bond coupling is sometimes observed for aromatic systems.
COSY is the first bidimensional technique which should be performed
in the characterization of a metal complex for the identification and the
assignements of the protons to a specific moiety of the metal complex (for
example, a specific ligand) ;
• NOESY: NOESY bidimensional spectrum correlates the spatially coupled
protons. Hence, in such a case the signal depends on the distance between
the nuclei. The information provided by NOESY is useful to understand
the tridimensional structure of the ligands and the distance between the
ligands of a metal complex.
• HSQC: HSQC is a heteronuclear bidimensional technique correlating the
protons and the carbons directly linked between themselves;
• HMBC: HMBC heteronuclear spectrum is a 2D map showing a signal
between protons and carbons two or three bond coupled.
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The contribution of all the cited bidimensional techniques makes possible the
assignments of all the protons and the carbons of a molecule.
2.2.9 Mass Spectrometry
Mass spectrometry is a technique which separates molecules differing from their
m
z ratio value, where m is the mass and z the charge (Figure 2.14).
Figure 2.14: Mass spectrometer scheme.
The separation method depends on the analyzer of the mass spectrometer.
Briefly, a mass spectrometer is composed by:
• an ion source, which induces ionization of the sample;
• an analyzer, which separates the ions by mz ;
• a detector, which generally is an electromultiplier.
Various ion sources are available, depending on the physical state and the pro-
perties of the sample. There are also different analyzers, which can be classified
depending on the method used to separate the mz fractions. The choice of the
analyzer affects the resolution, the sensitivity and the mz range.
In this Thesis two different mass spectrometers are employed. Both spectrome-
ters have an electrospray ionisation source (ESI), where a solution containing
the sample is passed through a capillary tube and a voltage is applied. When
the solution comes out from the capillary it converts into an aerosol. A nitrogen
flow is sent to the spray to reduce the droplet volume. When the volume is
sufficiently decreased, the repulsion of the charge inside the droplet causes its
explosion, further diminishing its size. The obtained small charged droplets are
sent to the analyzer. Used analyzers are:
• the Quadrupole, which is formed by a fixed magnetic field and an oscillating
field. The combination of the magnetic fields forces the ions to a specific
trajectory. In particular, at a specific magnetic field condition only the
ion having suitable mz value has a trajectory which permits to reach the
detector. The value of the oscillating magnetic field is switched in order
to scan all the mz range;
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• the Time of Flight (or TOF) analyzer separates the ions depending on the
arrival time to the detector. Actually, the ions acquire an energy E due
to the magnetic field, as shown in Equation (2.29).
E = 12mv
2 (2.29)







Since the ions pass through a d distance, molecules having different mass
arrive at different time, being t = 2mdE .
Finally, the electromultiplier detector converts the ion into electrons by the
impact on its surface, amplifying the signal. Signal amplification is attained for
the reason that each collision generates 2 electrons. It means that n collisions
form 2n electrons.
2.2.10 Irradiation Instrumentation
Irradiation study was carried out by means of an illuminator system coupled
with a double-beam spectrophotometer (Figure 2.15).
Figure 2.15: Scheme of the illuminator system.
It consists of an Ushio Xenon Short Arc Lamp and a monochromator. The
selected wavelength goes through an optic fiber and a cutoff filter and reaches
the sample. UV-vis spectra at different irradiation time can be recorded at a
specific irradiation wavelength.
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2.2.11 Photocleavage Study
Study of the cleavaging properties of the metal complexes was carried out by
interaction with pUC18 plasmid DNA [12]. Natural plasmid has a supercoiled
form (Form I). If the metal complex action cuts one of the strands, the open
circular form (Form II) is created. Moreover, if another cut occurs to the other
strand, the open circular form turns into the linear form (Form III, Figure 2.16).
Figure 2.16: Different structures of plasmid DNA.
Detection of the different forms is obtained by electrophoretic assay. Elec-
trophoresis is based on the application of an electric field. The samples are
inserted in an agarose gel immersed in TBE solvent and the application of a
potential causes the migration of positive charged species from the anode to
the cathode, the migration rate depending on the molecular charge and shape.
As the linear charge of the polynucleotides is the same, the migration depends
only on their secondary structure. In the presence of TBE buffer, the migration
order is (fastest) Form I > Form III > Form II (slowest). A scheme of the
electrophoretic system is provided in Figure 2.17.
Figure 2.17: Scheme of the electrophoretic system.
The detection of the separated species is achieved by addition of ethidium bro-
mide in the gel. This compound intercalates between the DNA basepairs and its
fluorescence switches on. Irradiation of the gel with a UV lamp (Fisher BioBlock
Scientific) allows to visualize the different plasmid forms and a photo is acquired.
Quantification is evaluated by the densimetric data of the lanes corresponding to
the different plasmid forms by means of the Image-J program [13]. ImageJ
program converts the lanes into peaks and their area can be quantified. The
cleavage values derives from Equation (2.31) [14], being DI , DII and DIII the
areas of the supercoiled, circular and linear forms, respectively. For DI a cor-
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rection factor of 1.4 is applied for the decreased ability of the dye to intercalate
inside the supercoiled form [15].
Cleavage = DII + 2DIII
DI +DII + 2DIII
(2.31)
For the cleavage assay, the solvent was the TBE buffer 1 % and the gel TBE
1 % containing 1 % of agarose. After irradiation, the samples were incubated
overnight at 37.0 ◦C in a KS 4000 I control incubator (IKA) and, then, 10 µL
of the solution (Plasmid concentration: 20 µM in bp) were mixed with 2 µL of
loading buffer (Bio-Rad, Glycerol 25 %) and loaded in the hole. The run was
performed at 80 V for 90 min.
An example of a lane and the data treatment is reported in Figure 2.18.
Figure 2.18: Example of the densimetric data of a lane by means of ImageJ program.
2.2.12 FRET Assay
Fluorescence Resonance Energy Transfer is a spectroscopic technique used to
obtain information about the structural conformation of a molecule. The FRET
effect involves energy transfer from a donor (D, or fluorophore) to an acceptor
(A, or quencher) by a non-radiative process, quenching the fluorescence of the
donor [16]. Energy transfer E depends on the distance of the molecules by the
following equation (Equation (2.32)).




being R the donor-acceptor distance and R0 the Forster radius, obtained by the
formula reported in Equation (2.33),
R60 = 8.8 · 10−28ΦDκ2n−4J(ν) (2.33)
with ΦD the fluorescence quantum yield of the donor, κ a parameter related to
the D-A orientation, n is the solvent refractive index and J(ν) is the equation of
the overlap between the emission of the donor and the absorption of the acceptor.
The technique has been successfully applied in the study of G-Quadruplex sta-
bilizers [17]. Actually, the synthesis of G-Quadruplex moieties with a donor (D)
and an acceptor (A) covalently linked to both terminals of the oligonucleotide
allows one to obtain information about the quadruplex folding. When the
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oligonucleotide exhibits quadruplex structure no fluorescence is present due to
the FRET mechanism. However, when denaturation of the four-stranded struc-
ture occurs, an increase of the fluorescence is visualized. The resulting graph
is a sigmoidal track in fluorescence due to the cooperative process of unfolding
(Figure 2.19).
Figure 2.19: G-Quadruplex FRET scheme.
FRET assays were performed employing a PCR equipment. Polymerase Chain
Reaction (PCR) instrumentation is typically used for the amplification of a DNA
sequence. The DNA chain is incubated together with the dNTP monomers, a
DNA polymerase enzyme and the primer, the latter being the complementary
sequence of the extreme of the chain which is going to be amplified. The method
is based on heating/cooling cycles. The heating causes the separation of the
DNA strands and the synthesis of the complementary strands by the enzyme;
the cooling returns the system to the native double-helix form. n cycles make
2n chains up (for examples 20 cycles → 220 ∼= 1000000 chains).
2.2.13 Other Techniques
2.2.13.1 Conductimetry
A Crison 522 conductimeter connected to a Crison 52 92 conductivity cell with
platinum electrodes was used. The conductimeter measures the electrolytic con-
ductimetry, as to say the capability of a solution to conduct electricity. Solutions
of the synthesized complexes at 1.0× 10−3 M in acetonitrile were prepared for
the measurements.
2.2.13.2 Microanalysis CHNS
Elemental analysis is performed by combustion of the sample in the presence of
oxygen. The products are CO2, H2O, N2 and SO2, which are trapped and quan-
tified. The measures were performed with a LECO CHNS-932 microanalyzer.
Results are the mean value of three samples of 1 mg weight.
2.2. METHODS 69
2.2.13.3 Infrared Spectroscopy
Infrared spectroscopy involves the excitation of the vibrational states of the
molecules. The resulting spectra is a sum of the peaks due to the different vibra-
tional modes of the molecular groups: stretching, bending, scissoring, rocking,
wagging and twisting. Functional groups have characteristic signal which can
be identified in the infrared spectrum (4000-400 cm−1). So, we can divide the
spectrum into different regions:
• 4000-2800 cm−1: X-H (X=heteroatom) and C-H stretching;
• 2300-2100 cm−1: triple bond stretching;
• 1800-1500 cm−1: double bond stretching and aromatic fingerprint;
• 1500-400 cm−1: fingerprint of the molecule: single bond stretching and
bending.
The instrument was a Jasco FT/IR-4200 system, equipped with an ATR acces-
sory, which is based on the reflectance of the solid.
2.2.13.4 X-Ray Diffraction
X-ray diffraction is a technique used for the resolution of a molecular structure
organized in a crystal. A beam is sent against the crystal and the atoms diffract
the ray into different but specific directions. The study of the diffraction of the
beam (intensity and angle of diffraction) allows to identify the structure of the
molecules forming the crystal, obtaining the bond lengths and the angles values.
Crystals of two synthesized complexes were obtained and characterized by means
of X-Ray diffraction technique. Crystalization was achieved solving the complex
powder in dichloromethane and adding a solution of MeOH and water saturated
with NH4PF6, in order to form two different phases. PF6– anion forms crystals
with iridium and rhodium complexes more efficiently respect to chloride anion,
because of its size. Crystals were analysed with a Bruker Smart Apex CCD
to obtain the geometric data of the unit cell and the length and angles of the
bonds inside the complex. The resolution of the crystals was performed by
Dr. Rodríguez Fernández-Pacheco from Universidad de Castilla La Mancha.
Detailed information are obtained analysing the results with Mercury 3.0
program.
2.2.13.5 MTT Assay
MTT assay quantifies the amount of live cells inside a sample. It is based on
the use of the MTT dye (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide), a molecule displaying yellow colour, which is reduced to formazan
inside the cell, a purple compound, by oxyreductase enzyme. Such a behaviour
can be exploited in the study of the cytotoxic activity of a metal complex [22].
The cells are seeded for 24 h in 96-well microplates in the presence of a growth
medium. Then, the medium is removed and a new medium containing the drug
is added, and the cells are incubated for a defined time. After that, the medium is
removed and sodium dodecylsulfate is added to solubilize the formazan crystals.
The formazan concentration is measured by absorption at λ = 590 nm, being
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this related to the amount of live cells. Triplicate cultures are performed for
each sample. Proofs at different concentrations allow to evaluate the IC50 value,
which is the metal complex concentration corresponding to 50 % of cell survival.
In addition, proofs were performed irradiating the sample for 20 min in the
presence of a UV lamp (maximum at 365 nm). From the irradiation proof the
photoindex value (PI) is calculated, which is the ratio between the IC50 value
in the dark (IC50DARK) and under irradiation (IC50IRR, Equation (2.34)).
The resulting number corresponds to the enhancement of the cytotoxic effect




All the MTT proofs in the present Thesis were performed by Dr. Busto of our
Physical Chemistry laboratory, except to part of the MTT assays in Chapter
5, performed by the group of Prof. Fernando Dominguez from Universidad de
Santiago de Compostela.
2.2.14 Determination of the Equilibrium Constant of the
Interaction Between a Metal Centre M and a Li-
gand L [18]
Considering a reaction between a metal centre M and a ligand L
M + L
KML−−−−→←−−−− ML (2.35)




where [M ], [L] and [ML] are the equilibrium concentration of the unbound metal
M, the unbound ligand L and the metal complex ML, respectively.
The analytical concentration of the metal (CM ) and the ligand (CL) are
CM = [M ] + [ML] (2.37)
CL = [L] + [ML] (2.38)
Inserting the (2.37) and (2.38) in the (2.36), (2.39) is obtained
KML =
[ML]
CMCL − (CM + CL)[ML] + [ML]2
(2.39)
If the ligand (L) and the complex (ML) both absorb, the absorption at a specific
wavelength will be
Abs = εL[L] + εML[ML] (2.40)
Inserting the (2.38) in the (2.40), the (2.41) is given
Abs− εLCL = (εML − εL)[ML] (2.41)
∆Abs and ∆ε are defined by (2.42) and (2.43), respectively,
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∆Abs = Abs− εLCL (2.42)

























Expressing x = (CM + CL) and y = (CMCL∆Abs +
∆Abs
∆ε2 ) a straight line is obtained,
having slope 1∆ε and intercept
1
KML∆ε
. Their ratio allows to determine the
equilibrium constant.
Note that ∆ε is present in the y formula, and it is initially unknown. To solve it,
an iteration of the value is required, using the ∆AbsCL at the end of the titration
as initial value.
From the same system it is possible to obtain a further equation for the deter-
mination of the equilibrium constant.





[M ](CL − ∆Abs∆ε )
(2.47)
and from (2.47), Eq. (2.48) is given
∆Abs
CL
= KML∆ε[M ]1 +KML[M ])
(2.48)
Expressing y = ∆AbsCL e x = [M ] a curve is obtained. KML comes from the
iteration of [M ] to convergence, using CM as initial value.
2.2.15 Scatchard Plot [19] and McGhee and von Hippel
Equation [20]
The reaction between a dye D and a polymer site S is considered
D + S
KSC−−−→←−−− DS (2.49)
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where [D], [S] and [DS] are the equilibrium concentrations of the free ligand, the
free site and the complex, respectively. Defining CP the analytical concentration
of the monomeric unit and B the inverse of the site size, the total concentration
of the free site is
[S]0 = BCP (2.51)
The Scatchard hypothesis assumes an ordered disposition of the ligand on the
polymer. So we can define the total concentration of the site [S]0 as
[S]0 = [S] + [DS] (2.52)




inserting the equation (2.53) in the (2.51) the equation (2.54) is obtained.
[S] = CP (B − r) (2.54)
Putting the Equations (2.53) and (2.54) in the (2.50) the Scatchard equation
results
r
[D] = KSCB −KSCr (2.55)
Considering y = r[D] and x = r a straight line is drawn with slope the equilibrium
constant −KSC and intercept KSCB. So, the Scatchard equation allows to
obtain the equilibrium constant and the site size of the reaction.
However, the Scatchard model does not consider deviations in the case of high
saturation degree, which provokes deviations from the linearity. The McGhee
and von Hippel equation corrects the Scatchard model inserting a correction
factor f(r) for [S]:
f(r) = (1− nr)
n








[1− (n− 1)r]n−1 (2.57)
putting y = r[D] and x = r we obtain a curve; the intercept on the y− axis is K
and the intercept on the x − axis is 1n . The relationship between the site size1





2.2.16 Determination of the Dimerization Constant [21]
Considering the reaction of a dye, D, to form the D2 dimer
2 D
Kagg−−−→←−−− D2 (2.59)




being [D2] and [D] the concentration at the equilibrium of the D2 dimer and
the D monomer, respectively.
The analytical concentration of the dye, CD is given by Equation (2.61)
CD = [D] + 2[D2] (2.61)
Considering that both dimer and monomer absorb at the working wavelength
the absorption is expressed as
Abs = εD[D] + εD2 [D2] (2.62)
where εD and εD2 are the molar extinction coefficient of the monomer and the
dimer, respectively.
Inserting the (2.61) in the (2.62) and, rearranging, we obtain the (2.63), being
∆ε = εD2 − 2εD
Abs− εDCD = ∆ε[D2] (2.63)





















= 2 + 1
Kagg[D]
(2.66)









Setting y = CDAbs−εDCD and x =
1
[D] a straight line results, with allows one to
determine Kagg. Note that the [D] is obtained by iteration of the latter equation,
using CD as starting value.
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2.2.17 Determination of the Time Constant Equation






the variation of [PD] with time is given by Equation (2.69)
d[PD]
dt
= k1[P ][D]− k−1[PD] (2.69)
where k1 and k−1 are the kinetic constants of the direct and the reverse reaction,
respectively, and [P ], [D] and [PD] the concentration of the free P, the free D
and the PD complex, respectively.
In a very short δt time the formula is converted into
dδPD
dt
= k1[D]δP + k1[P ]δD − k−1δPD (2.70)
Considering the anaytical concentration CD andCP of the dye and the monomeric
unit, respectively
CD = [D] + [PD] (2.71)
CP = [P ] + [PD] (2.72)
In a δt time we obtain
0 = δD + δPD ⇒ δD = −δPD (2.73)
0 = δP + δPD ⇒ δP = −δPD (2.74)
Inserting the (2.73) and (2.74) into the Equation (2.69) we obtain the (2.75)
dδPD
dt
= −k1[D]δPD − k1[P ]δPD − k−1δPD (2.75)





= k1([P ] + [D]) + k−1 (2.76)
If we work in an excess of P, [P ] + [D] ∼= [P ] and [P ] ∼= CP
1
τ
= k1CP + k−1 (2.77)
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In Part I of the Thesis, we focused our study on aluminium and its reactivity
with RNA.
In Chapter 3 we centered the study on the Al(III)/Cac system at different pH
values to infer the nature and strength of the interaction between Al(III) and the
ligand and to assess the possible use of cacodylate to provide Al(III) buffered
solutions for biochemical studies at neutral pH. First of all, we performed a
study on the speciation of the free metal and the free ligand by means of calcu-
lations and NMR analysis in order to observe the different free species involved
in the reaction. Then, the complex between aluminium and cacodylate was
characterized by means of mass spectrometry and NMR, which enables us to
suggest a structure for the formed complex. This study was integrated by DFT
calculations of the proposed structures, performed by Dr. Lozano from Univer-
sidad de Burgos. Moreover, UV-vis absorption titration allowed to calculate the
apparent constants at the different pHs and, by the derivation of a mathematical
model, the real equilibrium constants of the interaction.
Following the characterization of the aluminium/cacodylate complex, in Chap-
ter 4 we present a study of the interaction of Al/Cac with two synthetic RNAs,
namely, the poly-riboadenylic (poly(rA)) and the poly-ribouridylic (poly(rU))
acids, at pH 5.0 and 7.0. Neutral pH was chosen for mimicking biological
conditions, while pH=5.0 was selected to observe the effect of aluminIum on
[poly(rA)]2, the double-stranded form of poly(rA). Preliminary proofs of the
interaction of Al/Cac with AMP nucleotide were carried out by NMR. Then,
the study of the interaction with poly(rA) and poly(rU) was carried out with
different techniques, namely UV-vis absorption, circular dichroism, denaturation
study and viscometry. In addition, a deeper kinetic study of the binding and of
the strands aggregation process was performed using UV-vis absorption.
Chapter 3 and Chapter 4 are taken from published articles, Phys. Chem. Chem.









Aluminium ions are believed to play a role in a number of neurological and skele-
tal disorders in the human body. The wide variety of complex species that result
from hydrolysis of Al3+ ions render a difficult task the study of the biological pro-
cesses and molecular mechanisms that underlie these pathological disorders. In
addition, this ion displays a pronounced tendency to precipitate as a hydroxide,
so certain complexing agents should be envisaged to stabilize Al(III) solutions
in near physiological conditions. In this work, we show that the common buffer
cacodylic acid (dimethylarsinic acid, HCac) interacts with Al(III) to give stable
complexes, even at pH 7. After preliminary analyses of the speciation of the
metal ion and also of the ligand, a systematic study of the formation of different
Al/Cac complexes at different pH values has been conducted. UV-vis absorption
titrations, mass spectrometry, NMR measurements and DFT calculations were
performed to enlighten the details of the speciation and stoichiometry of Al/Cac
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complexes. The results altogether show that Al/Cac dimer complexes prevail,
but monomer and trimer forms are also present. Interestingly, it was found that
cacodylate promotes the formation of such relatively simple complexes, even
under conditions where the polymeric form, Al13O4(OH)247+, should predom-
inate. The results obtained can help to shed some light into the reactivity of
aluminium ions in biological environments.
3.1 Materials and Methods
3.1.1 Materials
The aluminium source was the Al(ClO4)3 · 8H2O solid salt supplied by Fluka.
Aluminium stock solutions were prepared by dissolving appropriate amounts of
the solid in HClO4 solutions, brought at pH=2.0 to avoid hydroxide precipitation.
The standardization of aluminium stock solutions was reported in Chapter 2
(Section 2.1.2). Stock solutions of sodium dimethylarsinate ((CH3)2AsOONa,
NaCac - Carlo Erba, purity 96 %) were prepared by dissolving weighed amounts
of the solid in water and titrated with NaOH. The ionic strength (I) of the
working solutions was kept constant at 0.1 M with sodium perchlorate (Merck) in
order to reproduce the ionic strength at physiological condition, while the desired
pH was attained by small additions of NaOH and HClO4. NaClO4 was chosen as
the ionic buffer for the reason that perchlorate is an inert anion [1], while other
species, such as chloride and phosphate, can form complexes with Al(III) [2]. All
of the reactants were analytical grade and were used without further purification.
Ultra-pure water from a Millipore MILLI-Q water purification system was used
to prepare the solutions and as a reaction medium.
3.1.2 Methods
pH measurements were performed with a Metrohm 713 (Herisau, Switzerland)
pH-meter equipped with a combined glass electrode. The uncertainty in the
calibration of the instrument was 0.05, and it was considered as the uncertainty
of the pH measurements. Spectrophotometric titrations were carried out with
a Shimadzu 2450-Spectrophotometer, equipped with jacketed cell holders (ther-
mostat precision 0.1 ◦C). All experiments were conducted at 25 ◦C. Titrations
of Al(III)/Cac system were performed in the batchwise mode at the desired pH
values and ionic strength 0.1 M (NaClO4). Different samples were prepared for
different metal-to-ligand ratios and left for 24 h to reach equilibration. For each
sample, the absorbance spectrum was recorded in the 190-300 nm range (path-
length cell 1 cm) and the binding parameters were evaluated averaging out the
results obtained at different selected wavelengths in the 205-193 nm range. Mass
spectra in double distilled water recorded for samples at CLCM = 1 (CM = 0.2 mM),
CL andCM being, respectively, the cacodylate and aluminium ion concentrations,
were obtained by means of a TOF Mass Spectrometer Bruker Maxis Impact,
with electrospray ionization (ESI). NMR samples were prepared by dissolving
in 0.5 mL of the respective oxygen-free deuterated solvent the proper amount
of Al3+ to 5 mM working solutions with the corresponding amount of sodium
cacodylate for each CLCM ratio studied. Unless otherwise stated, the spectra were
recorded at 25 ◦C on a Varian Unity Inova-400 (399.94 MHz for 1H; 104.21 MHz
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for 27Al). Typically, 1D 1H-NMR spectra were acquired with 32 scans into 32
k data points over 16 ppm spectral width; the spectra of 27Al-NMR were ac-
quired with 16 scans. 1H chemical shifts were referenced internally to TMS via
1,4-dioxane in D2O (δ = 3.75 ppm). Chemical shift values are reported in ppm.
All of the NMR data processing were carried out using MestReNova version
6.1.1. DFT calculations were carried out using B3LYP functional to optimize
some proposed structures for the aluminium-sodium cacodylate complex; this
procedure was used satisfactorily for DFT calculations of metals [3], and for
aluminium specifically [4–6], applying 6-31G(d) basis set to C, H and O atoms.
A double zeta function (LANL2DZ) was used for Al and As, including effective
core potential calculation (ECP) for core electrons, diminishing the computa-
tional calculation costs. Water was used as solvent. All calculations and data
analyses were performed with Gaussian 09 [7].
3.2 Results and Discussion
3.2.1 Evaluation of the pKA,1 and pKA,2 Acidity Constants
of Cacodylic Acid
Cacodylic acid is a diprotic acid; its diprotonated form is here denoted as H2Cac+.
This species undergoes acid dissociation according to Equations (3.1) and (3.2),
which are characterized by the acid dissociation constants KA,1 and KA,2 re-
spectively.
H2Cac+ + H2O
KA,1−−−→←−−− HCac + H3O+ (3.1)
HCac + H2O
KA,2−−−→←−−− Cac− + H3O+ (3.2)
The 1H-NMR spectra of cacodylate shows a singlet signal ascribable to the
methyl groups of NaCac. The location of these peaks very much depends on the
medium acidity for the higher acidity, the higher the chemical shift of the peaks
(Fig. 3.1A).
The pKA,1 and pKA,2 values have been determined by the chemical shift analysis
of the 1H-NMR singlets of sodium cacodylate at different values of the pH and
the acidity function H0 (Fig. 3.1B); the latter function was employed at the
highest acidity levels used, outside the boundary of the pH scale [8]. The two
dissociation constants of cacodylic acid were evaluated according to Equation
(3.3):
δ = δB − δBH+1 + 10−pH+pKA,i + δBH
+ (3.3)
where δB and δBH+ represent the chemical shift of the basic and acidic forms,
respectively, and δ that at an intermediate acid concentration, according to
species shown in Equations (3.1) and (3.2). To determine pKA,1, Equation (3.3)
was applied directly by adopting for δB the chemical shift at pH=4.0, whereas
that for δBH+ was taken as the highest value in Fig. 3.1 B. The continuous line
denotes the outcome of the two fittings. The pKA,1 and pKA,2 values obtained,
1.3± 0.2 and 6.2± 0.1 respectively, were in reasonable good agreement with the
literature values, pKA,1 = 1.1 [9, 10] and 2.6 [10], and pKA,2 = 6.2 [9, 11–13].
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Fig. 3.1C shows the speciation curves of cacodylic acid.
Figure 3.1: (A) 1H-NMR spectra at pH=0.5, 1.0, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0 and 8.0.
(B) δ versus pH (or H0) plot corresponding to pKA,1 and pKA,2. CL=5.00 × 10−3 M.
(C) Speciation of cacodylic acid (pKA,1 = 1.3, pKA,2 = 6.2). I=0.1 M (NaClO4),
T=25.0 ◦C.
As for the absorbance measurements, Fig. 3.S1 shows the spectra of cacodylic
acid at different pH values (I=0.1 M, NaClO4). The change in absorbance upon
titration within the 2-10 pH range (Fig. 3.S1, inset) has enabled us to evaluate
the second acid dissociation constant of cacodylic acid, the resulting value being:
pKA,2 = 6.0 ± 0.2. It is noteworthy to specify that the absorption spectra of
cacodylate lies in the limit of the instrumental range, and the measure suffers
from low signal to noise ratio. So, in order to ensure a reliable result, different
measures were performed and the KA,2 was calculated from each wavelength in
the 195-205 nm range, and the mean values obtained were within the experimen-
tal error. Below pH 3, the shift of the 193 nm band to lower wavelengths can be
ascribed to formation of the H2Cac+ species.
3.2.2 Speciation of Aluminium Forms
Fig. 3.2 shows the 27Al-NMR spectra in the 1.0–6.0 pH range (above pH 6.0 the
measurements could not be executed because aluminium precipitates). NMR
measurements show that the hexaaquoaluminium(III) ion, Al(OH)63+, prevails
between pH 1.0 and 4.0. The wide band in 27Al-NMR spectra observed be-
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tween pH 5.0 and 6.0 can be ascribed to the polycation species Al13O4(OH)247+
(also denoted as Al13−mer) [14]. Between pH 6.0 and 7.0, partial or full neu-
tralization of the polymer charge promotes aggregation of Al13−mer, which
tends to precipitate, and formation of more complex polymeric forms, such
as Al2O8Al28(OH)56(H2O)2618+ (also known as Al30−mers) is likely to oc-
cur [15,16].
Figure 3.2: 27Al-NMR spectra of Al(III) at different pH values. CM=5.00 × 10−3 M,
I=0.1 M (NaClO4) and T=25.0 ◦C. The pH-independent narrow peak at δ (roughly)
0 ppm, is ascribed to the monomeric species Al3+, whereas the broad band observed
at pH 5 and 6 is the Al13O4(OH)247+ polymer.
The NMR findings are corroborated by literature data. The molar fraction (β)
of the Al3+ hexahydrate ion and its hydrolytic forms can be calculated according
to Equation (3.4) [17]:







where I is the ionic strength of the medium, Qx,y is the equilibrium ratio
related to formation of the hydrolyzed Alx(OH)y
(3x–y)+ species (xAl+yH2O −−→
Alx(OH)y
(3x–y)+ + yH+) and Kx,y is the relevant thermodynamic equilibrium
constant, a and b being fitting parameters and mx is the overall aluminium
molality [17]. This calculation was performed at different pH values and metal
concentrations using the Octave program [18], yielding the distribution plots
shown in Fig. 3.3. This figure shows that the amount of dimer and trimer
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species is negligible and that the predominant species in the 4.5 to 8.0 pH range
is Al13O4(OH)247+ whereas Al(OH)4– is the prevailing species above pH 8.0.
Figure 3.3: Speciation of Al(III). CM=1.00 × 10−3 M, I=0.1 M and T=25.0 ◦C.
The results from Fig. 3.3 are compared in Fig. 3.S2 (A and B, Supporting
Information) with other results obtained for Al3+ concentrations of 1.0× 10−4
and 1.0× 10−5 M, showing that polymeric species are absent in dilute solutions.
Additionally, an increase in the aluminium concentration (CM ) causes a small
diminution of βAl and a sharp increase of the polymeric form Al13O4(OH)247+.
3.2.3 The Aluminium/Cacodylate System
3.2.3.1 Mass Spectrometry
The different number of peaks recorded at different pH reveals the complexity of
the distribution of the aluminum species (Fig. 3.S3 and 3.S4, Supporting Informa-
tion). We focused the attention on the most representative peaks in the spectrum
and determined four types of species: (i) free cacodylate, which is predominant
and in particular the [HCac+H]+ (mz =139) and [NaCac+H]+ (
m
z =161) adducts
and other peaks reported in literature [19,20], such as mz =277, 259, 299, 281, 437,
419 (corresponding to [H2Cac2 + H]+, [H2Cac2 + H−H2O]+, [H2Cac2 + Na]+,
[H2Cac2 + Na−H2O]+, [H3Cac3 + Na]+, [H3Cac3 + Na−H2O]+), respectively;
(ii) perchlorate and cacodylate salt clusters: [Na(NaClO4)x]+ (mz =145, 267,
389) and [Na(NaCac)x]+ (mz =183, 343, 503, 663); (iii) Al uncomplexed forms:
Al(OH)2(H2O)v+ (mz =79, 115, 133); Al2O(OH2)3+ (
m
z =121) and (iv) Al/Cac
complexes. By analogy with the formulation of aluminium(III) of aquo-chloro-
complexes, we adopt the general formula AlxOy(OH)zCacu(H2O)vn+ for the
aluminium/cacodylate complexes [21]. The distribution of the different forms
is shown in Fig. 3.4, whereas the respective formulas are summarized in the
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Supporting Information (Table 3.S1).
Figure 3.4: Distribution of the different forms of Al/Cac complexes at different pHs.
CL=CM=2.00 × 10−4 M and T=25.0 ◦C.
However, it should be pointed out here that assignment of the proper formula
is prone to certain ambiguity [22]. To a first place, the (OH)22– and O(OH2)2–
patterns, having the same value of the mz ratio, cannot be differentiated. There-
fore, Al2O(OH)Cac2(H2O)+ could be replaced by Al2(OH)3Cac2+. Moreover,
some peaks can be assigned to either a free or a bound aluminium species. For
instance, the peak at mz = 121 can be ascribed to the free species Al2O(OH)3+
and to the Al2O(OH)Cac(H2O)v2+ complex, and the peaks at 301 and 319 to
the 1:2 complex AlCac2(H2O)v+ or to the 3:1 Al3O(OH)Cac(H2O)v+ complex.
The theoretical (see below) and literature data will allow us to suggest the most
stable form [21–25].
At pH 4.0, 5.0 and 6.0 the most intense peaks are those associable to the dimeric
forms. On the other hand, monomeric species are mainly present not only at
pH 5, but also at pH 4. Trimeric forms display lower intensity signals and are
detected at pH 5.0, 6.0 and 7.0. In particular, the signal at pH 7.0 is lower
than those detected at pH 5.0 and 6.0, concurrent with the weakening of the
interaction of cacodylate at neutral pH, observed in the NMR experiments as
described below.
The high abundance of dimeric complexes contrasts with the β values, indicating
rather modest presence of dimers when cacodylate is absent (Fig. 3.3). To sup-
port this view, previous studies [21–25] on aluminium complexes with organic
ligands have shown that Al2O(OH)3+ yields a small peak, suggesting that the
dimeric aluminium free species are only poorly present in solution. Hence, it
can be surmised that, in addition to the 1:1 complex, the presence of cacody-
late induces the formation of ligand bound dimeric and (to a lesser extent) also
trimeric and tetrameric species. Furthermore, the fact that the peaks of these
species are present also at pH 5.0 and 6.0, where, in the absence of ligand, the
polymeric form Al13−mer is prevailing by far, suggests that the ligand induces
the disintegration of Al13−mer to give smaller entities.
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3.2.3.2 27Al-NMR and 1H-NMR Studies
Fig. 3.5A shows the 27Al-NMR spectra for Al/Cac in the pH 1–7 range. Be-
tween pH 1.0 and 2.0, only the signal corresponding to free Al3+ was observed
at 0 ppm. In addition to the signal at 0 ppm, at pH 3.0 and 4.0, two further
signals, at 2 and 4 ppm, were observed, the former remaining very modest at
the two pH values. The second displays a remarkable increase in intensity on
going from pH 3.0 to pH 4.0. At pH 5.0 and 6.0, a wide band is observed at
8 and 12 ppm, respectively. At pH 7.0, the centre of the band is shifted to 60 ppm.
Figure 3.5: 27Al-NMR spectra for (A) Al/NaCac system at pH = 1.0, 2.0, 3.0, 4.0, 5.0,
6.0 and 7.0, CM
CL
=1 (B) Al/NaCac system at CM :CL=1:1,1:2,1:3, CM=5.00 × 10−3 M,
pH=6.0, I=0.1 M (NaClO4) and T=25.0 ◦C.
Fig. 3.6 shows the 1H-NMR spectra of the Al/NaCac system recorded at dif-
ferent pH values and different times. The peak of the free ligand (circled), and
other peaks are displayed in the 4<pH<7 range, which are associated to the
bound cacodylate. The whole of the 27Al-NMR and 1H-NMR experiments have
contributed to interpret the behaviour of the aluminium/cacodylate system at
different pH values.
No Al/Cac complex is formed at pH 1.0 and 2.0. However little amounts of
complex are detected at pH 3.0 and the extent of binding becomes more and
more important as the pH is raised, in agreement with the general behaviour
displayed by complex formation reactions of metal ions with ligands protonated
at the reaction site.
Concerning the data at pH 4.0, comparison of the 27Al-NMR spectra of free
(Fig. 3.2) and bound (Fig. 3.5A) aluminium shows a remarkable increase of the
peak at 4 ppm, which can be associated to the dimeric aluminium/cacodilate
form [26, 27]. In the 1H-NMR spectrum (Fig. 3.6A), the singlet at 1.86 ppm
could be related to the AlCac2+ complex. Actually, the beta value of Al3+ at
pH 4.0 is 0.9, and a singlet peak agrees with the symmetrical form of Al3+ with
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the chelating ligand. In addition, it is supported by the fact that this peak is not
seen at pH 5.0 (Fig. 3.6C), where βAl = 0.004. The two peaks at 1.95 and 1.79,
having the same intensity, most likely correspond to a dimeric form, in which
the two methyl groups have different environment. Also other small peaks are
present, in particular in the 1.88-1.85 ppm range and at 1.82 ppm, which could
be related to other monomeric species, such as Al(OH)Cac+.
Figure 3.6: 1H-NMR kinetics of Al/NaCaC complex at t=10 min (A, B, C and D) and
t=1 day (E and F). CM=CL=5.00 × 10−3 M, I=0.1 M (NaClO4), pH=4.0, 5.0, 6.0, 7.0
and T=25 ◦C. Circled chemical shift stands for free cacodylate at every pH.
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The broad peak observed at pH 5.0 and 6.0 in the 27Al-NMR experiments (Fig.
3.5A) should be associated to the sum of dimeric, trimeric and other polymeric
species coming from the decomposition of the Al13 aggregate associated to the
broad peak at 60 ppm (Fig. 3.2). In addition, 27Al-NMR spectra recorded at
pH 6.0 for CLCM= 1, 2 and 3 show constriction of the broad peak, with signal
increase at 7.5 ppm (Fig. 3.5B). This behaviour agrees well with further disin-
tegration of the Al13−mer in the presence of an excess of cacodylate. As stated
above, the 1H-NMR experiments show that the peak at 1.86 ppm, present at
pH 4.0, disappears when the solution pH is raised (spectra at pH 5.0 and 6.0 in
Figs. 3.6C and 3.6D), while the peaks at 1.95 and 1.80ppm exhibit remarkable
intensity. Moreover, a very slow kinetic process is observed, followed by the
increase of two peaks at 2.01 and 1.92 ppm, of same intensity (Figs. 3.6E and
3.6F). Therefore, we can surmise that the interaction between aluminium and
cacodylate is the overlapping of two reactions. The first one is fast, possibly rep-
resenting the ligand binding to monomeric or dimeric aluminium species, and the
second represents the decomposition of the polymeric Al13−mer induced by the
interaction of cacodylate to give simpler species, in agreement with the observed
disaggregation of Al13 induced by ligands with oxygen-containing groups, such
as acetate, oxalate and lactate and, more conceivably, by protons [16,28–30]. In
this case, disaggregation seems to be strongly dependent on the pH and less on
the ligand.
Furrer et al. [28] state that the disaggregation of Al13−mer is driven by the
proton concentration. In other words, the only presence of cacodylate does not
allow by itself the disaggregation of the aluminium oligomers under the experi-
mental conditions ( CLCM = 1). However,
1H-NMR spectra (Fig. 3.S4, Supporting
Information) show that excess of ligand causes an increase in the peak intensity
associated to the complexed cacodylate. Thus, some competition between the
inner and outer coordination spheres can be guessed in excess of ligand, where
the first one can evolve to simpler forms by disruption of the polymer.
The results at pH 7.0 significantly differ from the trend observed at pH 5.0 and
6.0. A very broad, low intensity, peak centred at 60 ppm is obtained in 27Al-
NMR spectra (Fig. 3.5 A), and the 1H-NMR exhibits very small peaks of the
complexed forms (Fig. 3.6B), even at same resonance of the peaks at pH 5.0 and
6.0. However, at pH 7.0 no precipitation was observed in the Al/Cac solution,
whereas extended precipitation occurs for the free aluminium. Thus, we can
envisage occurrence of interaction, even though of different nature compared to
that at work at lower pH values.
Stumm [31] suggested that the interaction of an organic ligand with a solid
interface can be differentiated between inner (strong bonding) and outer (weak
bonding) coordination sphere. In a study of the acetate/aluminium system [32]
it has been proposed that the interaction of the acetate ion with Al2O3 in sus-
pension involves mainly the outer coordination sphere. We suggest that at pH 7
cacodylate can interact with Al(III) aggregates in the same way as acetate reacts
with aluminium oxide suspension. The resulting complex enables aluminium to
remain in solution. This is an interesting result because we have verified that
cacodylate renders aluminium soluble in near physiological conditions systems
(I=0.1 M, pH=7.0 and T=25.0 ◦C).
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3.2.4 Determination of Kapp of Aluminium/Cacodylate Com-
plexes
The apparent equilibrium constant,Kapp, for formation of the aluminium/cacody-
late (Al/Cac) complexes, was determined from batchwise spectrophotometric
titrations performed for different pH values. The apparent reaction is
Mf + Lf
Kapp−−−−→←−−−− MLT (3.5)
where Mf and Lf are, respectively, the non-complexed free metal and the ligand
forms, and MLT is the total complex. Most of the experimental data-pairs were
obtained with no excess of metal or ligand. The interaction between aluminium
species and cacodylate causes a hypochromic effect (Fig. 3.7A).
Figure 3.7: (A) Example of spectrophotometric titration of the Al/Cac system. Inset:
track at λ=195 nm. CL=1.0 × 10−3 M, I=0.1 M, pH=4.8 and T=25.0 ◦C. (B) Analysis
according to Equation (3.8) of the 4.3<pH<5.0 data.










where CL and CM are the analytical ligand and metal concentrations, respec-
tively, ∆A = A− εLCL and ∆ε = εML − εL, where εi is the absorptivity of the
ith species.
Different binding isotherms were obtained using absorbance values within 195-
205 nm (Fig. 3.7A), a range where aluminium ion displays no absorption,
whereas the different dimethylarsinic forms have different absorptivity, εi. As
for the the pKA measurements of the free cacodylate, the use of different tracks
allowed to assure the goodness of our results, in a range where the noise is
high. The equilibrium constants obtained (Table 3.1) are averaged values. At
pH=2, such evaluation was unfeasible because the change in absorbance was too
modest owing to the inhibition of the binding reaction caused by protons, and
in agreement with the NMR results.
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Table 3.1: Apparent equilibrium constant for binding of aluminium to cacodylate (Kapp)











The relationship between Kapp, and [H+] is expressed by Equation (3.7) (see
Appendix 3.B in Supporting Information)
Kapp
αβAl






















where αL is the molar fraction of the species Cac–, βAl is the molar fraction of
the species Al3+, KI , KII , KIII , KIV , KV , KV I , KV II and KV III are the true
equilibrium thermodynamic constants for binding of Cac to Al3+, Al(OH)2+,
Al(OH)2+, Al(OH)3, Al(OH)4–, Al2(OH)24+, Al3(OH)45+ and Al13O4(OH)247+,
respectively. On the other side, the β values (Fig. 3.3) support simplification of
Equation (3.7) to Equation (3.8). Actually, except for the Al3+ and Al13−mer,
all contributions are negligible under the experimental conditions employed, due
to the low mole fraction of the other species.
Kapp
αβAl






Moreover, since formation of the polymeric form is fully attained within a very
narrow pH range, two well defined pH ranges can be distinguished; in the
first (3.0<pH<4.3) the monomers Al3+ and AlOH2+ are active, while in the
second (4.7<pH<5.0) the Al13−mer is active. For pH>4.5, the contribution of
KI to Equation (3.8) is negligible (Fig. 3.7B). In this pH range, Log Kapp
αLβ13Al




versus CM plot (Fig. 3.S5B, Supporting Information) yielded
straight lines with slope equal to 32 and 12, respectively, reinforcing the presence
of Al13O4(OH)247+ as the reactive species. Analysis according to Equation (3.8)
of Kapp versus pH plots yielded KV III=(1.6± 0.4)× 106M−12 (Fig. 3.7B). This
datum can be used in the 3.0<pH<4.3 region to evaluate the true thermody-
namic constant KI=(4± 2)× 104M−1.
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Also, from the NMR data obtained we evaluated the apparent equilibrium con-
stant at CL = CM and different pH values (see Appendix 3.A, Supporting
Information). The Kapp values obtained at pH values 4 and 5 (Table 3.S1, Sup-
porting Information) concur well with the spectrophotometric values (Table 3.1).
However, the values obtained at pH 6 and 7 are smaller than expected, thus
disagreeing with the model proposed by means of UV measurements due to the
observed aggregation trend of the Al13 units.
27Al-NMR results show that the interaction between metal and ligand yield the
AlCac complex and not AlHCac or AlH2Cac, however no indication is provided
as to forming AlCac from Reactions (3.9) or (3.10) written below.
Al3+ + Cac−
KI−−→←−− AlCac2+ (3.9)
Due to the proton ambiguity, Reaction (3.9) cannot be thermodynamically
distinguished from the equivalent reaction (3.10), neither by thermodynamic
experiments (since the dependence of the conditional equilibrium constant on
[H+] would be the same) nor kinetically (since the formula of the activated





However some considerations, based on the kinetic behaviour of Al(III) species,
will allow us to establish the most probable pathway: being AlOH2+ about
104-fold more reactive than Al3+ aquo ion, as results from comparison of the
respective rates of water exchange [33], the first step of the Al(III) binding to
a chelating ligand should be about 103-fold faster in the case of AlOH2+ [34].
Hence, for pH>2 the formation of AlCac2+ will involve mainly Reaction (3.10).
The equilibrium constant of Reaction (3.10), here denoted as KI′ , is related to
KI by the relationship KI′ = KIKA,2/Q1,1. Its value is KI
′=(8± 4)× 103M−1.
Only for pH>5 the contribution of the deprotonated Cac– ion to the binding
reaction becomes important. This interpretation differs from that advanced in a
previous study were the formation of the 1:1 complex was rationalized assuming
that the main process is the reaction of the Al3+ ion with the deprotonated form
of the ligand, Cac– [35].
3.2.5 DFT Calculation
By means of the mass spectrometry and NMR data, we have hypothesized possi-
ble Al/Cac structures. It can reasonably be assumed that the ligand chelates the
metal, as demonstrated for other oxygenated ligands with aluminium [16,32,36].
The suggested structure of the monomer species is shown in Fig. 3.8A (note that
water molecules can be replaced by hydroxo groups, and more than one ligand
could be present). For the dimer species, the mass spectrometry and NMR
data gathered do not clarify the exact structure, so different geometries can be
considered. Based on earlier studies on different Al(III) complexes [22, 32], we
propose the following structures: two aluminium atoms linked by two oxygen
groups (Fig. 3.8B), the interaction of the aluminium complexes is obtained via
hydroxo groups (Fig. 3.8C), only one oxygen binds the aluminium complexes,
as in the third structure (Fig. 3.8D). Interestingly, a different M2L structure
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is proposed for the aluminium/acetate complex [32]. Since cacodylate exhibits
similar structure as the acetate, we proposed similar geometry associated to
the most intense signal in the mass spectrometry (mz = 121) and NMR spectra
(δ=1.95 and 1.80 ppm) (Fig. 3.8E). As a matter of fact, a syn-syn bridging
geometry is considered by the experimental results, where the two oxygens bind
to both aluminium atoms of the dimeric form. Hence, a double hydroxo- or oxo-
bridged geometry is present. For the trimeric and tetrameric species, other more
complex structures can be hypothesized with the same bridging geometry.
Figure 3.8: (A) 1:1 structure. (B) First 2:1 structure. (C) Second 2:1 structure, (D)
Third 2:1 structure (E) Fourth 2:1 structure: syn-syn bridging geometry.
To convincingly justify the hypotheses drawn on the dimeric complexes, we un-
dertook theoretical energy calculations of these complexes.
For the M2L dimeric system, four different structures were calculated (B, C
and two more E structures, with and without bridging oxygens, which will be
denoted as E(OH) and E(O), respectively. The two E structures consist of a 2:1
complex, where Cacodylate is bound to only one Al atom via a double O-bridge.
B and C structures resemble the E(O) and E(OH) structures, respectively, but
with OH bridging ligands between Al atoms, instead of O-bridge, and two more
hydroxo ligands.
The stability has been studied in terms of the overall energy (products energy).
The DFT optimization of these structures results in the stability sequence, from
most stable to less stable (Hartree units), as follows: (B) (-849.660435) > (C)
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(-849.651503)> (E(O)) (-849.590124) > (E(OH)) (-849.558751). Thus, the most
stable structure involves OH-bridging ligands between Al atoms with cacodylate
bound to both metal centres. The optimized structure of (E(OH) is plotted in
Fig. 3.9A.
Figure 3.9: (A) DFT optimization of structure E(OH) in water, using B3LYP functional
with 6-31G(d) basis set for C (grey), H (white) and O (red) atoms, and LANL2DZ for
Al (pink) and As (purple) atoms. (B) DFT optimization of 2:2 linear complex in water,
using B3LYP functional with 6-31G(d) basis set for C(grey), H(white) and O(red)
atoms, and LANL2DZ for Al (pink), As (purple) atoms and H-bonding interactions
(dashed lines).
A non-symmetrical conformation has been obtained (symmetry group C1) with
OH groups in the Al-Al plane pointing to cacodylate group. Surprisingly, methyl
groups bound to As, adopted eclipsed conformation. Full NBO (Natural Bond
Orbital) analysis has revealed that, as expected, the Al and As sites are mainly
positively charged. Oxygen atoms in the Al-O-As bonds are significantly more
negative than the others due to the charge donating nature of the metals. Thus,
the Oxygen site in the OH-bridges between Al atoms are, indeed, more negative
than those on the water molecules.
The characterization parameters (bond distance and angle) of the core of the
molecule (every atom surrounding Al and As atoms) are compiled in Table 3.S2,
Supporting Information. The two atom distances and angles containing Al are
similar, showing that the core lies in a symmetric environment and the abovemen-
tioned asymmetry is due to the slightly asymmetric conformation of the H2O, OH
and CH3 groups. In addition, DFT optimization and geometry analysis of two
2:2 complex (structures reported in Fig. 3.S7, Supporting Information), has been
carried out, whose presence was confirmed by mass spectrometry (mz = 361).
Since the calculations of a double syn-syn bridging geometry complex (Fig.
3.S7A) proved to be unstable in water, complex linear geometry (Fig. 3.S7B)
has been DFT optimized to a minimum energy state (E= -933.31Hartrees). In
the final conformation, one hydrogen atom from a water molecule is lost, and
transferred to one of the O-bridging ligand between Al atoms. Moreover, a
full water molecule is lost, remaining nearby the 2:2 complex via H-bonding
interaction (Fig. 3.9B). These rearrangements, result in a surprisingly differ-
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ent conformation for Al atoms, from the initial Al(octhedral)-Al(octahedral)
to Al(pyramidal)-Al(octahedral). The stabilization of the pyramidal configu-
ration can be explained by the H-bonding induced by the above mentioned
water molecule that falls off the molecule (Table 3.S3, Supporting Information),
showing that expected symmetry of the optimized structure is totally lost. The
distance and angle values of the Al-O bonds considerably differ from their theo-
retical mirror image bonds. The dihedral angles show different orientation of the
As-O-Al(pyramidal)-O and As-O-Al(octahedral) rings compared to the plane
containing Al(1), O(2) and Al(3); the Al(pyramidal) ring is primarily orientated
to the yz plane, whereas the Al(octahedral) containing ring, lies in the xz plane.
As described for the 2:1 complex, the NBO analysis displays electron donation
from metals to oxygen, an effect more intense for the O-bridging ligands between
Al atoms. The DFT calculations suggest that the 2:2 complex hypothesized by
MS data is an asymmetric system, where the four methyl groups are surrounded
by different chemical environments. It follows that they have different chemi-
cal shifts. The 1H-NMR at pH=6.0 (Fig. 3.6D) of the Al/Cac system show a
lot of peaks that, even if they cannot be specifically associated to each methyl
group, could agree with a Al2Cac2 asimmetric system. However the peaks are
little visible at pH=5.0, even if MS spectra prompts that Al2Cac2 is a relevant
product even at such a kind of pH. It could be explained by the fact that MS
measurements are not performed at I = 0.1 M, which can affect the process of
dimerization. Regarding 27Al-NMR, the broad peak does not allow to obtain
information on the presence of this specific complex. However, other studies
suggest the presence of penta-coordinated aluminum for oxygenated ligand and
mono- and dimeric aluminium [37,38].
3.3 Conclusion
Thermodynamic experiments of the interaction between Al(III) and dimethylar-
sinic acid suggest that the apparent binding affinity has a maximum in the 5-6
pH region, whereas at pH 4.0 and pH 7.0 the binding strength is low. Compar-
ison of the MS and NMR data suggests that the main species formed is a 2:1
complex. Thus, the most probable effect is that the 1:1 complex, which forms
first, has a high affinity for a second aluminium ion. In particular, the most
plausible structure is the dimeric syn-syn bridging geometry structure of the
cacodylate, interacting with the two aluminium centres (Fig. 3.8E). On the
other hand, the different behaviour observed at pH 7.0 respect to that at pH
4-6 is explained assuming the formation of an outer sphere coordination of the
ligand to the Al13 aggregates at neutral pH, thus avoiding precipitation. On the
other hand, at lower pH the polymeric form disintegrates into small molecules,
an effect promoted mainly by the proton and, to a lesser extent, by the ligand.
Elucidation of the Al/Cac complex, which does not allow aluminium to pre-
cipitate, in particular in those conditions named near physiological (I = 0.1 M,
pH=7.0 and 25.0 ◦C), can be very useful to obtain a system available to study
the biological processes and molecular mechanisms that underlie pathological
effects induced by aluminium ions.
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Supporting Information
Figure 3.S1: Absorbance spectra of dimethylarsinic acid recorded at different pH:
(•••) 1.0, (—) 3.0, (- - -), 7.0, (- • -) 11.0. CL=1.0 × 103 M, I=0.1 M (NaClO4)
and T=25.0 ◦C. Inset: absorbance variation with pH for the HCac/Cac– system at
λ=201 nm.
Figure 3.S2: (A) Molar fraction of Al3+ (βAl) versus pH at different analytical con-
centration of the metal, CM . (B) Molar fraction of the polymeric aluminium (βAl13)
versus pH at different CM . (a) CM=1.0 × 10−5 M, (b) CM=1.0 × 10−4 M and (c)
CM=1.0 × 10−3 M. I=0.1 M and T=25.0 ◦C.
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Figure 3.S3: Mass Spectra of Al/Cac solution at pH=4.0 (A) and 5.0 (B).
CM=2.0 × 10−4 M, CL=2.0 × 10−4 M, T=25.0 ◦C.
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Figure 3.S4: Mass Spectra of Al/Cac solution at pH=6.0 (A) and 7.0 (B).
CM=2.0 × 10−4 M, CL=2.0 × 10−4 M, T=25.0 ◦C.
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Figure 3.S5: NMR spectra of Al/Cac complexes at different CL
CM
. CM=5.0 × 10−3 M,
I=0.1 M (NaClO4), pH=7.0, T=25.0 ◦C.
Figure 3.S6: (A) Data treatment of Equation (3.8) as a function of pH at different CM
values; (B) data treatment of Equation (3.8) as a function of LogCM ; I=0.1 M and
T=25.0 ◦C.
Figure 3.S7: Structures for DFT analysis for the M2L2 dimeric system.
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Table 3.S1: Formula of Al/Cac complexes by the mass spectrometry data.
CM=CL=2.0 × 10−4 M; T=25.0 ◦C.
Complexes v m/z 1× 103 Intensity
pH4 pH5 pH6 pH7
Monomeric
AlCac(H2O)v2+ 1 91 5 3 1 0.5
AlOHCac(H2O)v+
0 181 1.5 4
1 199 2 8 - -
2 217 1 6
Dimeric
Al2O(OH)Cac(H2O)v2+
1 361 40 30 2 1
2 379 17 3 - -
Al2O(OH)Cac2(H2O)v+
0 361 50 13
1 379 - 7 1 -
2 397 2 1
AlOCac3(H2O)v+
0 481 6 3 0.75
1 499 - 1 0.5 -
2 517 0.5 0.3 -
Trimeric
Al3O(OH)3Cac(H2O)v3+ 1 107 1 1 1 1
Al3O3(OH)Cac2(H2O)v+
0 283 5
1 301 - 7 - -
2 319 2.5
Al3O2(OH)2Cac2(H2O)v+
0 421 - 13 5 1
1 439 - 1 1 -
Al3O(OH)3Cac3(H2O)v+
1 577 1.5 - -
2 595 - - 0.5 0.5
3 613 - - 0.5
4 631 - 0.5 -
Tetrameric Al4O2(OH)2Cac3(H2O)v+
1 603 - -
4 657 - - 1.5 -
6 693 3 3
7 711 - 0.5
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Table 3.S2: Selected parameters, distances (Å) and angles (°), for the 2:1 Al/Cac
complex.
Distances, Å Angles, °
Atoms Value Atoms Value
Al(1)-O(2) 1.92 O(2)-Al(1)-O(4) 74.28
Al(1)-O(4) 1.93 O(2)-Al(1)-O(5) 97.82
Al(1)-O(5) 1.90 O(2)-Al(3)-O(4) 74.28
Al(1)-Al(3) 3.00 O(2)-Al(3)-O(6) 96.14
Al(3)-O(2) 1.93 Al(1)-O(2)-Al(3) 102.65
Al(3)-O(4) 1.92 Al(1)-O(4)-Al(3) 102.79




Table 3.S3: Selected parameters, distances (Å), angles (°) and dihedral angles (°) for
the 2:2 Al/Cac complex.
Distances, Å Angles, ° Dihedral Angles, °
Atoms Value Atoms Value Atoms Value
Al(1)-O(2) 1.98 O(2)-Al(1)-O(4) 84.35 O(7)-Al(1)-O(2)-Al(3) 133.78
Al(1)-O(4) 1.75 O(2)-Al(1)-O(5) 89.26 Al(1)-O(2)-Al(3)-O(11) 164.80
Al(1)-O(5) 1.82 O(2)-Al(3)-O(4) 74.28
Al(1)-Al(3) 1.95 O(2)-Al(3)-O(6) 84.69
Al(3)-O(2) 1.94 Al(1)-O(2)-Al(3) 87.87
Al(3)-O(4) 1.78 Al(1)-O(4)-Al(3) 99.98
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3.A Determination of the Equilbrium Constant
by NMR
To evaluate the apparent equilibrium constant for complex formation (Kapp) from
the NMR data of Fig. 3.S5, quantitative analyses were conducted according to
Equation (3.A1), where InL is the normalized peak area of free cacodylate and







Table 3.S4: Apparent equilibrium constant for binding of aluminium to cacodylate






Figure 3.S8: Resume of the values of Kapp obtained from the UV titrations () and
the NMR spectra (•). I=0.1 M and T=25.0 ◦C.
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3.B Determination of Equation (3.8)
The apparent constant Kapp which represents the overall equilibria between the
aluminium forms and the cacodylic acid form can be expressed by Equation
(3.B.1), where [i], is the concentration at the equilibrium of the ith form
Kapp =
[Al3+]
[Al3+] + [AlOH2+] + [Al(OH)+2 ] + [Al(OH)3] + [Al(OH)−4 ]+
[Al3+]
+[Al2(OH)4+2 ] + [Al3(OH)5+4 ] + [Al13O4(OH)7+24 ]
(3.B.1)
Using the molar fraction of deprotonated cacodylate (αL) and Al3+ (βAl)
αL =
[Cac−]
[HCac] + [Cac−] (3.B.2)
βAl3+ =
[AlCac2+] + [Al(OH)Cac+] + [Al(OH)2Cac]+
[Al3+] + [AlOH2+] + [Al(OH)+2 ]+
+[Al(OH)3Cac−] + [Al(OH)4Cac2−] + [Al2(OH)2Cac3+]+
+[Al(OH)3] + [Al(OH)−4 ] + [Al2(OH)4+2 ]+
+[Al3(OH)4Cac4+] + [Al13O4(OH)24Cac6+]
+[Al3(OH)5+4 ] + [Al13O4(OH)7+24 ]
(3.B.3)
Equation (3.B1) turns into Equation (3.B.4) (Note that in Equation (3.B.2) the
species H2CaC+ has been disregarded since the concentration of this species is






















The equilibrium ratio Qx,y for aluminium hydrolysis, defined in [17] of the text
are introduced in Equation (3.B.4), to convert [Al3+] into the concentrations of
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The equilibrium constants of the different complexes can be expressed as Kx =
[ML]
























However, since the predominant species are Al3+ and Al13 in the experimental
conditions, the equation can be simplified, resulting the Equation (3.B.7), which
corresponds to Equation (3.8) of the text.
Kapp
αLβAl











The study carried out in Chapter 3 al-
lowed to keep aluminium ion by com-
plexation with cacodylate anion, even
at neutral pH, thus rendering feasible
the study with biological molecules.
Actually, over the last years, focused
interest in aluminium has been height-
ened by recent studies regarding its
health effects. The possible relation
with chronic diseases makes it conve-
nient to address more in depth the
reactivity of aluminium with biologi-
cally relevant molecules. The present
work investigates the interaction of aluminium ion with two synthetic RNAs,
poly(rA) and poly(rU), through a detailed thermodynamic and kinetic study.
The results obtained with spectrophotometry, circular dichroism, viscometry
and thermal stability measurements indicate that aluminium strongly interacts
with single and duplex RNA structures. The kinetic experiments point up that,
even though cacodylate was required to keep the metal in solution, actually it
inhibits the reaction of aluminium with RNA as it converts the metal into an
unreactive dimer species. Notably, further interaction occurred under excess of
aluminium/cacodylate complex, inducing aggregation of single-stranded RNAs.
An analysis of the kinetic data has shown that the modes of aggregation of the
two RNAs differ and such a difference can be ascribed to the diverse polynu-
cleotide secondary structures. The observed stabilization of multiple-stranded
systems by aluminium can be of interest for the use of this metal in the study
of non-canonical nucleic acid structures.
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4.1 Materials and Methods
4.1.1 Materials
The octahydrate perchlorate (Al(ClO4)3 · 8H2O, Fluka) was used as the alu-
minium(III) source. The stock solutions were prepared in doubly distilled water,
adding HClO4 acid up to pH=2.0 to avoid precipitation. The standardization
of aluminium stock solutions was reported in Chapter 2 (Section 2.1.2). Sodium
dimethylarsinate (NaCac, 96 %) was purchased from Carlo Erba and stock so-
lutions were prepared in doubly distilled water; its analytical concentration is
denoted as CL.
Working solutions of the aluminium/cacodylate complex (Al/Cac) were prepared
from stock solutions adding doubly distilled water, which was used as reaction
medium. The ionic strength was kept at 0.1 M with sodium perchlorate mono-
hydrate salt (Merck), while the desired pH was attained by adding calibrated
amounts of NaOH and HClO4.
Adenosine 5’-monophosphate monohydrate (AMP), poly-riboadenylic (poly(rA))
and poly-ribouridylic (poly(rU)) acids were purchased from Sigma as potas-
sium salts and the relevant stock solutions were prepared by dissolving suitable
amounts of the solid in water. Standardization of the RNA stock solutions was
attained spectrophotometrically to ε257 = 10 100 M−1cm−1 for poly(rA) and
ε260 = 8900 M−1cm−1 for poly(rU), at I = 0.1 M (NaCl), pH=7.0 (NaCac) and
T=25.0 ◦C. The analytical concentration of polynucleotides, CP , was expressed
as the concentration of the phosphate group for single-stranded forms and as
the concentration of base pairs for poly(rA) when it is present as double-helix
(pH=5). In fact, single stranded poly(rA) dimerizes, yielding [poly(rA)]2 in
relatively acidic aqueous media [1, 2].
4.1.2 Methods
The pH value was controlled by means of a Metrohm 713 (Herisau, Switzerland)
pH-meter (precision ±0.1), fitted out with a combined glass electrode. Nine
buffers in the 1.7-12.5 pH range were required for a proper calibration of the
pH-meter required. Scattering of the solutions was evaluated using a LS55
Luminescence Spectrometer (Perkin Elmer), selecting λex = λem = 250 nm and
recording the absolute value of the Rayleigh scattering peak. Light scattering
experiments were carried out at pH=5.0 and pH=7.0 after one day equilibration.
1H-NMR, 31P-NMR and 27Al-NMR spectra were acquired at 25 ◦C with a Varian
Unity Inova-400 (399.94 MHz for 1H, 161.9 MHz for 31P and 104.21 MHz for 27Al)
spectrometer. 1D 1H-NMR spectra were recorded with 32 scans into 32 k data
points over 16 ppm spectral width. 1H chemical shifts were referenced internally
to TMS using 1,4-dioxane in D2O (δ = 3.75 ppm). The NMR data were analysed
with the MestReNova version 6.1.1 program. Spectrophotometric titrations
and kinetic studies were carried out with a double-beam 2450-Spectrophotometer
(Shimadzu). Titrations were performed adding increasing amounts of Al/Cac
to a cuvette containing the polynucleotide. The kinetic study was performed
by adding calibrated amounts of Al/Cac to a cuvette containing the RNA, and
absorbance versus time curves were recorded. Kinetic experiments were carried
out by changing the concentration of the Al/Cac complex, cacodylate ligand
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and RNA. The initial rate method was used to estimate the reaction order with
respect to each reactant. Denaturation tests were performed with the Shimadzu
spectrophotometer, recording one spectral curve every 5 ◦C and waiting (20 min)
for signal stabilization. Solutions of different metal complex-to-RNA ratios
were analyzed to observe the possible destabilization/stabilization of the double
or multiple-stranded structures. Circular dichroic spectra were recorded with
a MOS 450 equipment (BioLogic, Science Instruments) coupled with a water
thermostat (25.0 ± 0.1◦C). The thermodynamic study was carried out using
different solutions at different metal complex-RNA ratios, once the solutions had
reached the equilibrium, in a 1 cm path-length cell. The spectra were recorded
at 0.5 nm s−1 scan rate in the 200-400 nm range. Kinetic data were obtained by
recording the time evolution of the dichroic signal at a defined wavelength. An
Ubbelhode microviscometer was used to study the dependence of the viscosity
of the system on the Al/Cac-RNA ratio. The temperature was kept at 25.0 ◦C
by a water thermostat.
4.2 Results
Firstly, we characterized the aluminium/cacodylate complex, its solubility and
stability at pH 5.0 and 7.0 and then we addressed the interaction of the complex
with the RNAs.
4.2.1 Properties of Aluminium/Cacodylate System at pH
5.0 and 7.0
In a previous study of the Al/Cac system, we found that for 1:1 Al:Cac ratio and
at pH=5.0, the Al2Cac dimeric form is the dominant species in solution, accom-
panied by minor amounts of the Al2Cac2 dimer, whereas at pH=7.0 formation
of remarkable amounts of a Al13 oligomer is observed [3]. In the present study,
further tests were carried out aimed to individuate optimal species distribution
and concentration.
At pH=5.0 no light scattering of aluminium/cacodylate solutions was detected
for all the investigated values of the cacodylate concentration, CL (Fig. 4.S1A,
Supporting Information); this finding indicates that neither precipitation nor
reactant aggregation occurred. At pH=7.0, however, light scattering was ob-
served (Fig. 4.S1B); the higher the cacodylate concentration, the lower the light
dispersion, until the scattering disappeared for CLCAl = 5.
The 1H-NMR study performed at pH=7.0 agrees with the light scattering mea-
surements. Actually, the signals of the aluminium/cacodylate complexes in-
creased with the concentration of cacodylate (Fig. 4.S2A, Supporting Informa-
tion). The largest peaks in the 1H-NMR spectra displayed the same chemical
shift as the ones found for the aluminium/cacodylate dimeric forms at pH=5.0 [3],
hence, we assumed that the main aluminium-containing species, at pH=7.0, in
the presence of an excess of cacodylate, are dimeric in nature. Therefore, it fol-
lows that an excess of cacodylate promotes disaggregation of the Al13 oligomer,
forming simpler species. Similar behaviour has been observed for other oxygen
functionalized ligands [4]. The extent of complex formation reached a plateau
at (roughly) CLCAl = 5.0, in agreement with the light scattering experiments (see
Fig. 4.S2B, Supporting Information).
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Based on the above results, the CLCAl = 5.0 ratio was kept for all experiments in
the presence of mono and polynucleotides to maintain the same experimental
conditions. This ratio was increased only for the kinetic experiments where
CL was varied. It is reasonable to assume that, under conditions of excess of
cacodylate, the concentration of Al2Cac2 (M2L2) will be higher compared to the
conditions of the previous work, where CLCAl = 1.0. Actually, the kinetic study
(described below) has provided evidence for the presence of remarkable amounts
of the above dimer. From now on, the analytical concentration of the Al/Cac
complex will be denoted as CAlCac.
4.2.2 Binding of Al/Cac to Riboadenosine Monophosphate
(AMP)
1H, 31P and 27Al-NMR spectra were recorded for the Al/Cac-AMP system (1:1)
at pH 5.0 and 7.0. At pH=5.0 the Al/Cac-AMP system partially precipitated,
whereas at pH=7.0 it remained in solution (Fig. 4.S3, Supporting Information).
Regarding 31P-NMR spectra, at pH=5.0 the peak of AMP shifted by addition
of Al/Cac (Fig. 4.S4A, Supporting Information), suggesting an interaction
with the phosphate group. At pH=7.0 no significant variation in chemical
shift was observed (Fig. 4.S4B); however, for both pH values, a decrease in
the phosphorous band width was noticeable. Little chemical shift variation
was observed for the 1H peaks of the adenine (Fig. 4.S4C,D). Moreover, the
small shift of the methylene groups adjacent to the phosphorous site (δ =
3.97 ppm at pH=7.0) could suggest interaction with the phosphate group (Fig.
4.S4D). The 27Al-NMR spectra showed a broad peak around 50 ppm for both
pH values, advancing a similar structure for the aluminium system (Fig. 4.S4E)
and significant shift of the peak respect to the 27Al-NMR spectra of Al/Cac
(δ = 7.5 ppm) [3] and a broad peak around 50 ppm for both pH values, suggesting
that the structure of the Al/Cac-AMP system is only scarcely affected by pH
(Fig. 4.S4E).
Kinetic experiments, carried out under excess of Al/Cac, showed a hypochromic
effect of the adenosine band, agreeing with an interaction of Al/Cac with AMP
(Fig. 4.S5, Supporting Information).
4.2.3 Binding of Al/Cac to Poly(rA) and Poly(rU)
4.2.3.1 UV Absorption Titrations
Sample spectra for increasing CAlCacCP ratios were recorded at pH=5.0 and 7.0,
under equilibrium conditions. The behaviour of the systems was complex and
the titration curves were biphasic.
Concerning the Al/Cac-[poly(rA)]2 system at pH=5.0, an initial small (but
well defined and reproducible) absorbance increase was observed, followed by a
decrease in the signal for higher Al/Cac levels, which can be related to formation
of a second adduct (Fig. 4.1A). On the other hand, the titration curve of the
Al/Cac-poly(rU) system exhibited only a decrease in absorbance (Fig. 4.1B).
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Figure 4.1: Spectrophotometric titrations at pH=5.0. (A) Al/Cac-[poly(rA)]2,
CP=3.8 × 10−5 M; inset: track at 252 nm. (B) Al/Cac-poly(rU), CP=4.8 × 10−5 M;
inset: track at 260 nm. I=0.1 M (NaClO4) and T=25.0 ◦C.
Concerning the Al/Cac-poly(rA) single stranded system at pH 7.0, the interac-
tion was even more complex. Actually, an initial hyperchromic effect was present
and, under excess of Al/Cac, baseline increase and change of the spectrum shape
were observed (Fig. 4.2A). The second effect is ascribed to light scattering and
most likely it reflects an aggregation of the strands. Fig. 4.S6 in Supporting In-
formation compares the tracks at the maximum of absorbance (257 and 260 nm
for poly(rA) and poly(rU), respectively) and at 320 nm, showing a decrease in
the absorbance maximum together with baseline enhancement.
On the other hand, the titration of poly(rU) with Al/Cac brought about signal




interpreted as due to aggregation (Fig. 4.2B).
Figure 4.2: Spectrophotometric titrations at pH=7.0. (A) Al/Cac-poly(rA),
CP=5.0 × 10−5 M; inset: track at 257 nm. (B) Al/Cac-poly(rU), CP=5.0 × 10−5 M;
inset: track at 260 nm, the scattering value was subtracted from the maximum absor-
bance. I=0.1 M (NaClO4), and T=25.0 ◦C.
4.2.3.2 Circular Dichroism
Al/Cac greatly affected the circular dichroism of poly(rA). At pH=5.0 the
dependence of [Θ] on CAlCac for the Al/Cac-[poly(rA)]2 system, exhibits three
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different trends (Fig. 4.3A, inset): (i) for CAlCacCP < 1.0 a small decrease in the
dichroic peak occurred. (ii) In the 1.0 < CAlCacCP < 10 range, the signal displays
a sharp fall, indicating precipitation of the Al/Cac-polynucleotide system. (iii)
For CAlCacCP > 10 the Al/Cac-polynucleotide system remains in solution. Note
that precipitation was observed at pH 5, also for the Al/Cac-AMP system (Fig.
4.S3, Supporting Information).
Figure 4.3: CD spectra at increasing CAlCac
CP
ratios. (A) Al/Cac-[poly(rA)]2 at pH=5.0;
inset: track at 264 nm. (B) Al/Cac-poly(rA) at pH=7.0; inset: track at 266 nm.
CP=5.0 × 10−5 M, I=0.1 M (NaClO4) and T=25.0 ◦C.
At pH=7.0, addition of Al/Cac to poly(rA) caused a significant decrease in the
CD signals (Fig. 4.3B). The further decrease of the band together with the shift
of the minimum (from 248 to 251 nm) and maximum (from 266 to 269 nm) in
Al/Cac excess should be ascribed to the aggregation effect observed in the UV
experiments (Fig. 4.2A), also in agreement with the CD kinetic experiments
described below.
The dichroic signal of poly(rU) is less intense because of its random coil structure
[5]; however, further lowering of the signal intensity was found to occur for
the Al/Cac-poly(rU) system under both pH conditions (Fig. 4.S7, Supporting
Information).
4.2.3.3 Thermal Stability
Thermal denaturation experiments provided valuable information about the ef-
fect caused on the polynucleotide stability by addition of Al/Cac.
At pH=5.0, the hyperchromic effect observed for the Al/Cac-[poly(rA)]2 system
for small CAlCacCP ratio (
CAlCac
CP
< 1) has been interpreted as due to conversion
of the double- to single-stranded poly(rA) (Fig. 4.4A). The presence of Al/Cac
caused a reduction in the slope of the melting curve. No melting temperature
values could be obtained because the absorbance did not reach a plateau.
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Figure 4.4: Denaturation of [poly(rA)]2 in defect (A) and excess (B) of Al/Cac.
CP=2.5 × 10−5 M, I=0.1 M (NaClO4) and pH=5.0.
By contrast, the presence of an excess of Al/Cac, results in hypochromic effect
(Fig. 4.4B) and increase of the melting temperature as the CAlCacCP ratio is
increased. The latter observation agrees with the analysis of the CD spectra,
which suggested the formation of a further adduct whose stability is enhanced
by increasing the CAlCacCP ratio. Temperature increase resulted in reduction of
the association extent.
Fig. 4.5 shows the denaturation of the Al/Cac-poly(rA) system at pH=7.0.
Figure 4.5: Denaturation of the aggregated forms of Al/Cac-poly(rA). (A) Examples
of melting curves. (B) Track of Tm at different CAlCacCP ratios. CP=3.4 × 10
−5 M,
I=0.1 M (NaClO4) and pH=7.0.
Since the absorbance value was the sum of the system absorption and the scatter-
ing of the solution caused by aggregation, the value of the latter was subtracted.
The result was a sigmoidal hypochromic trend, ascribable to breakage of the
aggregated form [6] (Fig. 4.5A for Al/Cac-poly(rA) and Fig. 4.S8A, Supporting
Information, for Al/Cac-poly(rU)). Rising the metal concentration, the melting
temperature increased up to a plateau (Fig. 4.5B for Al/Cac-poly(rA) and Fig.
4.S8B for Al/Cac-poly(rU)).
4.2.3.4 Viscometry
The viscosity values decreased for all the investigated systems upon increasing
the aluminium/cacodylate complex content (Fig. 4.6). Precipitation of double-
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stranded [poly(rA)]2 occurred at CAlCacCP = 1.0 ratio. The large viscosity variation
observed for poly(rA) and poly(rU) implies major structural changes.
Figure 4.6: Viscometric results for Al/Cac-RNA systems at different CAlCac
CP
.
CP=2.0 × 10−4 M, I=0.1 M (NaClO4) and T=25.0 ◦C.
4.2.3.5 Kinetics: Al/Cac-RNA Complex Formation.
The kinetic aspects of the reactions between Al/Cac and the RNAs were inves-
tigated by recording the variation of absorbance with time. Figure 4.7 shows
examples of the obtained kinetic curves.
Figure 4.7: Kinetics traces for the interaction between Al/Cac and RNA: (A)
[poly(rA)]2 at pH=5.0, track at 252 nm. (B) poly(rU) at pH=5.0, track at 260 nm.
(C) poly(rA) at pH=7.0, track at 257 nm. (D) poly(rU) at pH=7.0, track at 260 nm.
CP=3.4 × 10−5 M, CAlCac=4.1 × 10−4 M, I=0.1 M (NaClO4) and T=25.0 ◦C.
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A hyperchromic signal was visible for poly(rA) (Fig. 4.7A and 4.7C), whereas
for poly(rU) a hypochromic effect (Fig. 4.7B and 4.7D) was observed under both
pH conditions.
The reaction order with respect to each reactant was derived from the slope of
dilogarithmic plots of the initial rate vi versus molar concentration Ci of the
i-th reactant by means of Equation (4.1), k′ being a constant.
Logvi = nLogC + Logk′ (4.1)
The individual reaction orders are listed in Table 4.1 (see Supporting Information,
Figs. 4.S9-4.S12, for details). For the experiments at variable concentration of
aluminium, the concentration of cacodylate also had to be varied to maintain
CL
CAl
= 5.0. Thus, the sum of the individual reaction orders with respect to
metal-containing species and free cacodylate (nAlCac and nL), was obtained.
Being nL known, the value of nAlCac could be obtained straightforwardly.
Table 4.1: Reaction orders ni of the reactants for the reaction between Al/Cac and
RNA. I=0.1 M, and T=25.0 ◦C.
RNA nAlCac nL nP
[poly(rA)]2 pH=5.0 1.2 -1.2 0.9
poly(rU) pH=5.0 1.0 -2.0 1.0
poly(rA) pH=7.0 2.0 -2.0 1.0
poly(rU) pH=7.0 2.1 -2.1 1.0
M2L2 dissociation is reported in Reactions (4.2) and (4.3), where K2 and K1
are the apparent formation constants of the aluminium/cacodylate complex at
pH=5.0. Note that Reaction (4.3) involves the formation of two Al(III) ions
instead of M2 because free dimeric aluminium was negligible under the working
conditions [7]. On the other hand, the formation of M2L was observed in our
previous work [3].
M2L2
1/K2−−−−→←−−−− M2L + L (4.2)
M2L
1/K1−−−−→←−−−− 2 M + L (4.3)
Concerning Al/Cac-poly(rU) at pH=5.0, the reaction orders concur with a model
(Equation (4.4)) where two molecules of cacodylate are released upon interaction
of the metal complex with the monomeric unit of RNA (see mechanism in
Appendix 4.A, Supporting Information). In Equation (4.4), k1 is the forward
kinetic constant for the metal-RNA complex formation.
2 M + P k1−−→ products (4.4)
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Two monomeric aluminium ions, from Reaction (4.3), would interact with the
polymer, whereas the M2L and M2L2 species do not react directly. The kinetic
parameters of the reaction were evaluated from the intercept of the dilogarith-
mic plots. The values for k1 obtained from the initial rates of each graph
are in good agreement with each other (Table 4.S1, Supporting Information,
k1
2K1K2 =(7.6 ± 0.6) × 10
−5s−1 M2, Confidence 95 %), reinforcing the goodness
of our hypothesis. For the Al/Cac-poly(rA) and Al/Cac-poly(rU) systems at
pH=7.0 the partial reaction orders are quite similar, suggesting a similar ki-
netic mechanism. However, these are significantly different respect to the above
cited mechanism found for poly(rU) at pH=5.0. At pH=7.0 the reaction me-
chanism for both RNAs should involve two M2L complexes originated from
Reaction (4.2) (Appendix 4.B, Supporting Information); under these circum-
stances the reaction is expressed by Equation (4.6) and the rate law by Equation
(4.7) ( k24K′22





for Al/Cac-poly(rU), where K ′2 refers to Reaction (4.2) at pH=7.0 and k′2 to
poly(rU)).








To conclude, concerning [poly(rA)]2 at pH=5.0, the reaction mechanism is given
by Equation (4.8) and the relevant initial rate is expressed by Equation (4.9)
( k32K2 =(5.0 ± 0.5) × 10
−2s−1M, Appendix 4.C, Supporting Information). The
change of the order of reaction with respect to the ligand implies a change in
the reaction mechanism: here, instead of two free Al(III) ions, one molecule of









4.2.3.6 Kinetics: Aggregation Reaction
In addition to the effect discussed above, a further kinetic effect was displayed
at pH=7.0 by the investigated systems (Fig. 4.8). Actually, an increase in the
signal was detected, which is ascribable to the previously observed aggregation
effect (Fig. 4.2). Comparison of the kinetic curves recorded at the maximum of
absorption of the polynucleotides and at λ = 320 nm, where any RNA absorption
is absent, revealed hyperchromic effects in both kinetic curves (Fig. 4.8A).
Consequently, the second absorbance enhancement was related to aggregation of
the polynucleotides chains, which reflected in an increase of the light scattering
process.
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Figure 4.8: Kinetic traces of the reaction between Al/Cac and RNA and subsequent
aggregation process. (A) Comparison of the normalized kinetic curves at 257 (black
line) and 320 nm (red line) for Al/Cac-poly(rA); (B) Al/Cac-poly(rU), track at 260 nm.
CP=3.4 × 10−5 M, CAlCac=4.1 × 10−4 M, I=0.1 M (NaClO4), pH=7.0 and T=25.0 ◦C.
The same effect was clearly visible for the CD signals. In this case, the aggrega-
tion caused a signal decrease with time (Fig. 4.9).
Figure 4.9: Kinetics of the dichroic signal under Al/Cac excess. (A) Al/Cac-
poly(rA), track at 264 nm. (B) Al/Cac-poly(rU), track at 272 nm. CP=5.0 × 10−5 M,
CAlCac=7.5 × 10−4 M, I=0.1 M (NaClO4), pH=7.0 and T=25.0 ◦C.
The slow kinetic curves were acquired for different concentration of Al/Cac, free
ligand and RNA. Figure 4.10 shows some sets of kinetic curves concerning the
Al/Cac-poly(rA) system, recorded at 257 nm. From Figures 4.10A-C it was
possible to obtain a qualitative trend about the contribution of each reactant
to the aggregation effect. By increasing the amount of Al/Cac, the aggregation
was faster (Fig. 4.10A), whereas free cacodylate and RNA concentration slowed
down the reaction rate (Fig. 4.10B, C).
122 CHAPTER 4. AL/CAC-RNA STUDY
Figure 4.10: Kinetic curves at λ=257 nm of Al/Cac-poly(rA); (A) different CAlCac,
CP=3.4 × 10−5 M; (B) differentCL, CP=3.4 × 10−5 M (C) differentCP (normalized ab-
sorbance values), CAlCac=4.1 × 10−4 M. I=0.1 M (NaClO4), pH=7.0 and T=25.0 ◦C.
The aggregation kinetics were analysed using Equation (4.10) [8–10]:
Abs = A(1− eBt
m
) (4.10)
where A is the curve amplitude, B the time constant and m the parameter that
reflects the cooperativity of the aggregation process. From Equation (4.10) the
t 1
2
parameter could be calculated as t 1
2
= (ln2/B) 1m [11]. Note that the start of
the sigmoid curve (t0) was taken at the end of the first kinetic effect, subtracting
the t0 value from tread, being t = tread − t0 in Equation (4.10). The analysis
of the sigmoid curve was carried out at different concentrations of the metal
complex and polynucleotide and the results are reported in Table 4.S2 and 4.S3,
Supporting Information.
Concerning poly(rA), it was seen that the amplitude was enhanced by increasing
CAlCac and CP , whereas t 12 decreased with Al/Cac concentration (Fig. 4.10A)
but it increased with CP (Fig. 4.10C). At first sight, these results could suggest
(wrongly) that the addition of RNA reduces the reaction rate. However, an
increase in CP causes lowering of the CAlCacCP ratio, which affects the aggregation.
On the other hand, the parameterm seems to depend on the RNA concentration
(m increased with CP up to m = 4), but not on the Al/Cac concentration (Table
4.S2 ESI). Al/Cac-poly(rU) behaves similarly as the amplitude and t 1
2
trends
(Table 4.S3). However, the m value did not rise with CAlCac and CP , being
confined between 1.5 and 2.
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4.3 Discussion
The affinity of aluminium with AMP and ATP is reported in the literature to be
stronger compared to other metal ions [12]. Although interaction of aluminium
with adenine group has been reported, the interaction with phosphate group
seems to be preferred [13, 14]. The preliminary study of the Al/Cac-AMP by
1H and 31P-NMR would confirm that, under equimolar conditions (CAlCacCP = 1),
the interaction involves the phosphate group.
However, the study with single-stranded nucleic acids reveals alterations to the
secondary structure that can hardly be related only to interaction with the phos-
phate, which generally induces small modifications. Actually, the study of the
binding of Al/Cac to polynucleotides, using different techniques, has revealed
the occurrence of changes in the nature of the interaction depending on the
amount of aluminium present in the reaction medium.
Concerning single-stranded poly(rA) at pH=7.0, the initial hyperchromic effect
displayed by the absorbance measurements (Fig. 4.2A) and the strong decrease
in the dichroic maximum (Fig. 4.3B) suggest involvement of nitrogen containing
base to the coordination process. Actually, the results obtained here concur with
the transition from the ordered poly(rA) structure to a random coil one; the un-
winding of the single helix agrees with interaction of the metal with the adenine,
promoting unstacking of the bases [15]. In addition, unwinding of the partially
ordered poly(rA) structure leads to a viscosity decrease [16], as observed in the
presence of Al/Cac (Fig. 4.6). Hence, from the NMR data and the results ob-
tained from the various techniques employed, one can conclude that two different
coordination sites are available for the Al/Cac complex: the phosphate group
and the nitrogenous base. A dual mode of binding has been advanced for other
trivalent cations like Terbium(III) [17]. The results shown in Fig. 4.2 reveal
that, under excess of Al/Cac, strand aggregation occurs. Poly(rA) aggregation
induced by Mg2+ was spectrophotometrically detected also by Kankia [18], an
effect that causes the baseline to increase and a hypochromic effect, as well. The
observation that the same effect is induced by Al/Cac both in poly(rA) and
poly(rU) implies that the aggregation is not promoted by a particular base pair,
but rather it starts up when an adequate excess of metal (or metal complex) is
present at the appropriate concentration level (CAlCacCP about 4.0 for both sys-
tems). Moreover, the thermal experiments performed in the present study have
shown that relatively large levels of complex do stabilize the aggregate solutions
(Fig. 4.5 and Fig. 4.S8, Supporting Information).
It should be noted that aggregation effects are promoted by aluminium in several
proteins [19]. For instance, a deal of interest has been addressed to aggregation
of the β-amyloid proteins, which is observed in relation to Alzheimer’s disease,
for the in vitro formation of plaques [20]. Hence, our results point up that such
behaviour is not only exclusive to proteins, but also nucleic acids can undergo
aggregation in the presence of aluminium. Such a discovery can be of interest
to the effects of aluminium with other biologically relevant macromolecules.
On the other hand, at pH=5.0, the behaviour of [poly(rA)]2 is different. For
CAlCac
CP
< 1, the small variation in the circular dichroism (Fig. 4.3A) could sug-
gest an interaction with the phosphate group, in agreement with the NMR results
obtained for Al/Cac-AMP. The broadening of the sigmoid curve observed in ther-
mal denaturation concurs with the presence of unbound [poly(rA)]2 and bound
Al/Cac-[poly(rA)]2 systems, ensuing the overlapping of the sigmoidal tracks, to
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give a final broad curve (Fig. 4.4A). Broad sigmoid curves are observed for DNA
in the presence of aluminium, as well, and an analogue explanation has been
proposed [21]. Destabilization of the [poly(rA)]2 double-helix is verified for many
metal ions (even though a strong stabilization effect has recently been reported
due to ammonium ion [22]). As the double-helix is stabilized by hydrogen bonds
involving the phosphate and the base nitrogen, the interaction of the metal with
these coordination sites promotes the transition to single-stranded RNA [15].
The precipitation of the Al/Cac-[poly(rA)]2 system at higher aluminium con-
centration observed by viscometry (Fig. 4.6) and circular dichroism (Fig. 4.3A)
concurs with neutralization of the negative charge of phosphate group, which
reduces the solubility of the system. However, a further excess of aluminium
renders the system soluble again, probably because of electrostatic interaction on
the poly surface that promotes solubilization of the systems. The sigmoidal track
obtained in the thermal denaturation experiments (Fig. 4.4B) would suggest
association between the double-strands, forming a positively charged aggregated.
Heating of the solution causes breakage of such a linkage; the larger the alu-
minium concentration, the more stable becomes the strand association.
Concerning poly(rU), the high variation of viscosity shown in Fig. 4.6 is to be as-
cribed to formation of a more ordered and compact form, also in agreement with
the observed decrease in the system absorbance (Fig. 4.1B and 4.2B). Viscosity
decrease is reported for poly(rU) with temperature decrease and in the presence
of various salts, which are accounted to provoke folding of the single-strand to
form intramolecular double-helix [23,24]. A similar behaviour could be tought
for the Al/Cac-poly(rU) system, as well. Interestingly, the aggregation effect
occurs only at pH 7.0, suggesting that the mechanism of action of the Al/Cac
complex changes by changing the pH of the medium.
Regarding the kinetic study, the negative reaction order with respect to cacody-
late (nL = −2) at both pH 5.0 and 7.0 indicates that, under the experimental
conditions employed, the main species present in solution is the M2L2 dimer,
which does not react directly with the polynucleotides. However, the data anal-
yses indicate that the dimer dissociates partially to give simpler species able to
interact directly with the RNAs. At pH=5.0 the reacting species is Al3+ (and/or
AlOH2+), whereas at pH=7.0 the reacting species is M2L. This behaviour is
explained by the fact that at pH=5.0 the cacodylate anion is more than 90 %
protonated (pKA = 6.2 [3]) and, under these circumstances, the ligand dissocia-
tion from the metal coordination shell is favoured.
Concerning the Al/Cac-poly(rA) system at neutral pH, thermodynamic data
suggest interaction with phosphate and nitrogen containing bases, agreeing with
a kinetic model involving reaction of two M2L molecules. On the other hand,
the mechanism derived for the Al/Cac-[poly(rA)]2 system involves only one M2L
molecule. Note that adenine is partially protonated at pH=5.0 and it could in-
hibit the attack of a second molecule of M2L to the double strand. The features
of the Al/Cac-AMP 31P-NMR spectrum at pH=5.0 (Fig. 4.S4A, Supporting
Information) suggest that the interaction of Al/Cac with the phosphate of AMP
plays the main role in the binding process and this could apply to [poly(rA)]2
as well. A similar result has been reported also for Terbium, whose interaction
with the guanine moiety of poly(dG) is inhibited by protonation of N7 (pH ≤ 2,
I = 0.02 M) [17].
The kinetics of the aggregation process were analysed using the Avrami equation,
which has been successfully applied to polymeric systems [11]. The observed
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differences in the values of the reaction parameters show that differences are
present in the aggregation mechanism of the two RNAs. In particular, the dif-
ference in the m parameter means that, although the aluminium ion plays a
chief role in both RNAs, the mechanisms of the aggregation processes follow
different pathways, which depend on the structures of the two nucleic acids. Our
results agree with a picture where the more ordered poly(rA) is able to develop
an aggregation mechanism characterized by a higher degree of cooperativity and




Aluminium strongly binds to single-stranded poly(rA) and poly(rU) in acidic and
neutral pH, interacting with the phosphate and the base nitrogen groups, thus in-
ducing a notable alteration of the polynucleotides secondary structure. However,
the interaction with phosphate seems to prevail in the case of double-stranded
[poly(rA)]2. Kinetic studies indicate that cacodylate inhibits the interaction of
the metal with the RNAs since it converts the aluminium reactive forms into
the inert dimer Al2Cac2 form.
A RNA aggregation process is induced by appropriate amounts of Al/Cac com-
plex, the aggregation being more extended in the case of poly(rA). The kinetic
studies confirm that the ordered poly(rA) structure undergoes aggregation at
faster rate and with higher cooperativity degree than poly(rU), which displays a
random coil structure. The extent of aggregation can be tuned by calibrating the
level of added Al/Cac complex. Hence, the results of this investigation reveal
that the Al/Cac-poly(rA) and poly(rU) systems can be used as a model for
future studies, as they provide a useful tool for the study of the interaction of
biomolecules with those metals which, due to hydrolysis, polymerization or poor
solubility, could not be employed under physiological pH conditions. The ability
of aluminium to stabilize multiple nucleic acid strands could be of interest for
the study of non-conventional forms of polynucleotides. Lastly, since aluminium-
promoted protein aggregation have been indicated in many chronic diseases, the
finding that aluminum can promote aggregation also in nucleic acids can prompt
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Supporting Information
Figure 4.S1: Scattering of the aluminium/cacodylate solutions for increasing CL
CAl
ratios at (A) pH=5.0 and (B) pH=7.0. The dotted line is the solvent background.
CAl=2.5 × 10−3 M, I=0.1 M, λex=λem=250 nm and T=25.0 ◦C.




=5.0 at pH=7.0. (B) Normalized




is the area of the complex peaks and AL the area of the free ligand. AAlCacAL+AAlCac is the
relative area of the bound cacodylate. Multiplication of the relative area by CL yields
the absolute concentration of the bound cacodylate and, dividing by CAl, it yields the
ratio between the ligand and the metal in the complex when the extent of the complex
formation reaches the plateau. I=0.1 M (NaClO4) and T=25.0 ◦C.
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Figure 4.S3: Photo of the NMR solutions of the Al/Cac-AMP experiments.
CAlCac=5.0 × 10−3 M, CP=5.0 × 10−3 M and I=0.1 M (NaClO4).
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Figure 4.S4: NMR spectra of Al/Cac and AMP solutions. (A) 31P-NMR of AMP and
Al/Cac-AMP at pH=5.0. (B) 31P-NMR of AMP and Al/Cac-AMP at pH=7.0. (C) 1H-
NMR of AMP and Al/Cac-AMP at pH=5.0. (D) 1H-NMR of AMP and Al/Cac-AMP
at pH=7.0. (E) 27Al-NMR of Al/Cac-AMP at pH=7.0 and 5.0. CAlCac=5.0 × 10−3 M,
CP=5.0 × 10−3 M. I=0.1 M (NaClO4) and T=25.0 ◦C.
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Figure 4.S5: Kinetic curve of the Al/Cac-AMP system in excess of aluminium. (A)
Al/Cac-AMP at pH=5.0 (B) Al/Cac-AMP at pH=7.0. CP=3.0 × 10−5 M, CAlCacCP =10,
I=0.1 M (NaClO4) and T=25.0 ◦C.
Figure 4.S6: Comparison of the track at the absorbance maximum and 320 nm for
(A) Al/Cac-poly(rA) and (B) Al/Cac-poly(rU). Absorbance maximum (full square)
257 nm for poly(rA) and 260 nm for poly(rU); Scattering at 320 nm (open circle). The
scattering value was subtracted from the absorbance maximum. CP=5.0 × 10−5 M,
I=0.1 M (NaClO4), pH=7.0 and T=25.0 ◦C.
Figure 4.S7: Circular dichroism of poly(rU) for increasing concentration of Al/Cac,
at (A) pH=5.0 and (B) pH=7.0. CP=5.0 × 10−5 M, CAlCac=0-5.0 × 10−4 M I=0.1 M
(NaClO4) and T=25.0 ◦C.
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Figure 4.S8: Denaturation proofs of the aggregated forms of Al/Cac-poly(rU).
(A) Examples of melting curves. (B) Track of Tm for different CAlCacCP ratios.
CP=3.4 × 10−5 M, I=0.1 M (NaClO4) and pH=7.0.
Figure 4.S9: Dilogarithmic plots of initial rates versus (A) CAlCac, (B) CP and (C)
CL for Al/Cac-[poly(rA)]2 at pH=5.0. I=0.1 M (NaClO4) and T=25.0 ◦C.
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Figure 4.S10: Dilogarithmic plots of initial rates versus (A) CAlCac, (B) CP and (C)
CL for Al/Cac-poly(rU) at pH=5.0. I=0.1 M (NaClO4) and T=25.0 ◦C.
Figure 4.S11: Dilogarithmic plots of initial rates versus (A) CAlCac, (B) CP and (C)
CL for Al/Cac-poly(rA) at pH=7.0. I=0.1 M (NaClO4) and T=25.0 ◦C. The change
in the reaction orders at the lower Al/Cac concentration was due to formation of
noticeable amounts of M2L.
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Figure 4.S12: Dilogarithmic plots of initial rates versus (A) CAlCac, (B) CP and (C)
CL for Al/Cac-poly(rU) at pH=7.0. I=0.1 M (NaClO4) and T=25.0 ◦C. The change
in the reaction orders at the lower Al/Cac concentration was due to formation of
noticeable amounts of M2L.
Table 4.S1: Kinetic constants obtained from plots of the initial rate equations. I=0.1 M,
and T=25.0 ◦C.
Parameter [poly(rA)]2 poly(rU) poly(rA) poly(rU)










s−1 M s−1 M2 s−1 M2 s−1 M2
CL 3.0 7.8 3.4 1.2
CP 7.4 8.1 2.3 1.2
CAlCac 5.0 7.6 1.7 1.0
Mean Value 5 7.6 2.4 1.1
Conf. 95 % 2.5 0.6 1.0 0.1
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Table 4.S2: Avrami parameters obtained for Al/Cac-poly(rA) aggregation. I=0.1 M,
pH=7.0 and T=25.0 ◦C. A, is the amplitude, t 1
2
is the time corresponding to 50 % of
aggregation process, m is the cooperativity parameter. In brackets the uncertainty in
the last digit.
CP = 3.4× 10−5 M, fixed CAlCac = 4.1× 10−4 M, fixed
104CAlCac M 102A 10−2t 1
2
s m 105CP M 102A 10−2t 1
2
s m
2.7 4.8(1) 6.4(5) 4.1(1) 1.1 2.2(1) 1.6(3) 2.0(1)
4.1 5.0(1) 4.6(4) 4.4(1) 1.4 2.5(1) 1.1(2) 1.7(1)
5.4 5.3(3) 3.6(5) 4.2(1) 2.2 3.6(1) 2.7(3) 2.9(1)
6.9 5.5(1) 3.4(4) 4.3(1) 2.9 4.8(1) 3.1(3) 3.5(1)
8.2 5.8(1) 2.6(3) 4.1(1) 3.6 5.6(1) 4.8(2) 4.4(1)
9.6 5.8(1) 2.9(4) 4.0(1) 5.7 6.8(1) 8.6(2) 4.1(1)
7.2 7.8(1) 13(2) 3.8(1)
Table 4.S3: Avrami parameters obtained for Al/Cac-poly(rU) aggregation. I=0.1 M,
pH=7.0 and T=25.0 ◦C. A, is the amplitude, t 1
2
is the time corresponding to 50 % of
aggregation process, m is the cooperativity parameter. In brackets the uncertainty in
the last digit.
CP = 3.4× 10−5 M, fixed CAlCac = 4.1× 10−4 M, fixed
104CAlCac M 102A 10−2t 1
2
s m 105CP M 102A 10−2t 1
2
s m
2.7 5.8(1) 18(2) 2.0(1) 0.9 2.5(1) 6.7(8) 1.5(1)
4.1 7.8(1) 12(1) 1.8(1) 1.7 4.9(1) 5.6(7) 1.4(1)
5.4 8.0(3) 9(1) 1.8(1) 3.4 7.9(1) 9(1) 1.5(1)
6.9 7.4(1) 9(1) 1.8(1)
8.2 7.9(1) 8(1) 1.5(1)
9.6 6.2(1) 9(1) 2.1(1)
10.3 7.5(1) 9(1) 1.4(1)
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4.A Determination of the Initial Rate Equation
for the Al/Cac-Poly(rU) System at pH=5.0
For Al/Cac-poly(rU) at pH=5.0 the hypothesized model is
M2L2
1/K2−−−−→←−−−− M2L + L (4.A.1)
M2L
1/K1−−−−→←−−−− 2 M + L (4.A.2)
2 M + P k1−−→ products (4.A.3)
where M is the free metal, L the free ligand, P is the RNA monomeric unit,
M2L2 and M2L are the metal/ligand complexes. The apparent constants K1
and K2 of the metal/ligand complex at pH=5.0 are given by (4.A.4) and (4.A.5)
with [M ], [L], [M2L] and [M2L2] the molar concentration of the free metal, the
free ligand and the complexes at the equilibrium, respectively, whereas k1 is the








The initial rate of the reaction is given by Equation (4.A.6)
vi = k1[M ]2[P ] (4.A.6)
Analytical concentration of the RNA (CP ) and metal (CAlCac) are expressed by
equation (4.A.7) and (4.A.8)
CP = [P ] + [products] (4.A.7)
CAlCac = [M ] + 2[M2L2] + 2[M2L] + [products] (4.A.8)
In the initial stage of the reaction, the concentration of the products is negligible
with respect to the reactant concentrations. So, it can be excluded from (4.A.7)
and (4.A.8). The reaction order with respect L is nL = −2 which indicates that
large amounts of M2L2 are formed. Hence CAlCac ∼= 2[M2L2]. In addition, as
we work in excess of cacodylate, it follows that [L] ∼= CL.
From (4.A.4) and (4.A.5) one obtains (4.A.9)
[M ]2 = CAlCac2K1K2C2L
(4.A.9)
and, then, equation (4.A.10) for the initial reaction rate, provided that reaction
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4.B Determination of the Initial Rate Equation
for the Al/Cac-Poly(rA) and the Al/Cac-
Poly(rU) Systems at pH=7.0
For Al/Cac-poly(rU) and Al/Cac-poly(rA) at pH=7.0 the hypothesized model
is
M2L2
1/K′2−−−−→←−−−− M2L + L (4.B.1)
2 M2L + P
k2−−→ products (4.B.2)
where L is the free ligand, P is the RNA monomeric unit, M2L2 and M2L
are the metal/ligand complexes. The apparent equilibrium constant K ′2 of the
metal/ligand complex at pH=7.0 is given by (4.B.3) with [L], [M2L2] and [M2L]
the molar concentration of the free ligands and the complexes at the equilibrium,
respectively, whereas k2 and k′2 are the kinetic constants of the forward reaction





The initial rate of the reaction is:
vi = k2[M2L]2[P ] (4.B.4)
Analytical concentration of the RNA (CP ) and metal (CAlCac) are expressed by
Equations (4.B.5) and (4.B.6)
CP = [P ] + [products] (4.B.5)
CAlCac = 2[M2L2] + 2[M2L] + [products] (4.B.6)
For the reasons given in Appendix 4.A it turns out that for this system as well
CAlCac ∼= 2[M2L2] and [L] ∼= CL.
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4.C Determination of the Initial Rate Equation
for the Al/Cac-[Poly(rA)]2 System at pH=5.0
For Al/Cac-[poly(rA)]2 at pH=5.0 the proposed model is
M2L2
1/K2−−−−→←−−−− M2L + L (4.C.1)
M2L + P
k3−−→ products (4.C.2)
where L is the free ligand, P is the RNA monomeric unit, M2L and M2L2 are the
metal/ligand complexes. The apparent constant K2 of the metal/ligand complex
is given by (4.C.3), being [L], [M2L] and [M2L2] the molar concentration of the
free ligand and of the metal/ligand complexes at the equilibrium, respectively,





The initial rate of the slow reaction is:
vi = k3[M2L][P ] (4.C.4)
Analytical concentration of the RNA (CP ) and metal (CAlCac) are expressed by
Equation (4.C.5) and (4.C.6)
CP = [P ] + [products] (4.C.5)
CAlCac = 2[M2L2] + 2[M2L] + [products] (4.C.6)
For the reasons given in Appendix 4.A it results that CAlCac ∼= 2[M2L2] and




















The second part of the Thesis has been centered on the study of the interaction
between metal complexes of Ruthenium, Iridium and Rhodium with different
conformations of DNA. In particular, a deep study of the photoreactivity of the
selected classes of metal complexes has been carried out, in order to observe the
optimal properties of a metal drug for the Photodynamic Therapy. The metal
complexes taken into account are the η6-arene and biscyclometalated complexes.
The examined arene complex was the [(p−cymene)Ru(L−1)(SCN)] with HL-1
= 2-(2’-hydroxyphenyl)benzothiazole. The work is inserted in the study of a
new family of arene ruthenium complexes developed in collaboration with the
Inorganic Chemistry Laboratory of the Universidad de Burgos. This complex
was chosen because of its interesting cytotoxic activity, which results higher
respect to the free HL-1 ligand. Initially, the physico-chemical properties of
HL-1 and the ruthenium complex were studied, together with the pKA values
and the aquation process by means of UV-vis spectrophotometry and fluorimetry.
Then, the interaction of the ligand and the complex with different types of DNA
was analysed by different techniques (fluorimetry, circular dichroism, viscome-
try, DSC). In addition, the product derived from the irradiation of the metal
complex was analysed using UV-vis absorption, NMR and mass spectrometry
and the photoreactivity was evaluated in the presence of plasmid pUC18 DNA.
Then, in Chapter 6 and 7 our interest was focused on to bicyclometalated com-
plexes of iridium (Ir) and rhodium (Rh).
In Chapter 6 we proposed two newly synthesized cyclometalated complexes,
which differ from the metal centre, Ir(III) and Rh(III), with CN = 2-phenylpyridy-
nate and NN = 2-(2’pyridyl)benzoxazole, [Ir-1]Cl and [Rh-1]Cl, prepared by
Dr. Martinez Alonso of the Inorganic Chemistry group. Interaction in dark
condition with CT-DNA was studied by means of UV-vis absorption titrations,
ITC, fluorescence steady-state, fluorescence decays, DSC and viscometry. Pho-
tocleavage of plasmid pUC18 in the presence of the complexes was conducted
under different conditions in order to elucidate the mechanism of action of the
irradiated drugs. Finally MTT proofs with SW480 cell lines were performed by
Dr. Busto, in the dark and under irradiation, to prove the obtained results from
the photocleavage study.
From the results obtained in Chapter 6 we decided to synthesize eight new bis-
cyclometalated complexes, which are the topic of Chapter 7. In this case we
changed not only the nature of the metal centre (again Iridium and Rhodium),
but also the CN (2-phenylpyridyine and 2-phenylisoquinoline) and the NN an-
cillary ligands (2-(2’-pyridyl)benzothiazole and 2-(2’-quinolinyl)benzothiazole).
The resulting complexes ([Ir-2]Cl, [Ir-3]Cl, [Ir-4]Cl and [Ir-5]Cl Ir complexes
and [Rh-2]Cl, [Rh-4]Cl and [Rh-5]Cl Rh complexes) were fully characterized
by NMR, mass spectrometry, IR and elemental microanalysis in order to assure
the structure and the purity of the products. UV-vis absorption and lumines-
cence properties were also studied. Then, two different studies were carried out:
the photoreactivity and the interaction towards G-Quadruplex DNA. Part of
this work was developed in collaboration with Dr. Ilse Manet from the Isti-
tuto per la Sintesi Organic e la Fotoreattività, of the National Research Center
of Bologna, Italy. Concerning the photoreactivity, photocleavage of DNA was
checked at different irradiation wavelengths, from the ultraviolet to visible region.
Again, MTT proofs of the irradiated and non-irradiated species with SW480
cancer cell line were performed by Dr. Busto. On the other side, the study of
the interaction with G-Quadruplex and duplex oligonucleotides was conducted
144
using various techniques (UV-vis absorption titrations, UV and visible circular
dichroism, fluorescence steady-state and fluorescence decay). These proofs were
integrated by stabilisation proofs of different G4 structures in the presence of




Two-Step Binding to DNA
and Photoreactivity
The interaction with DNA of a ruthenium arene complex was tested, namely
the [(p−cym)Ru(L−1)(SCN)] complex. This complex suffers aquation in buffer
solution (I=6.5 mM and pH=7.0). First of all, interaction towards dGMP was
found, which was accounted to a covalent binding to the guanine moiety. Ir-
reversible interaction with guanine was observed in the presence of DNA, as
well. Interestingly, a further interaction was hinted for DNA by the kinetic study
and confirmed by fluorimetric titrations. Actually, a light-switch behaviour was
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displayed and proofs with different DNA sequences showed that the highest fluo-
rescence enhancement was observed in the presence of poly(dAdT)2, suggesting
a weak binding on the minor groove. Proofs with the HL-1 ligand showed a
similar fluorescence enhancement. Consequently, a dual mode of binding of the
arene complex with DNA has been advanced: a covalent binding to the guanine,
which is governed by the leaving group (H2O) and a minor groove binding, ruled
by the ancillary chelating ligand.
Furthermore, photoirradiation of the ruthenium complex provoked the release
of the η6-arene ligand, and a certain photocleavage activity with plasmid DNA
was diplayed, which seems to follow an oxygen-independent pathway.
5.1 Materials and Methods
5.1.1 Materials
Lyophilized Calf Thymus (CT) DNA sodium salt was purchased from Sigma
Aldrich and prepared according to Chapter 2 (Section 2.1.2). The poly(deoxyade-
nylic-deoxythymidylic) (p(dAdT)2), and the poly(deoxyguanylic-deoxycytidylic)
(p(dGdC)2) acid sodium salts were purchased from Sigma and the concentrations
were checked by UV-vis spectra, using ε = 13 400 cm−1M−1 in base pairs (bp) at
λirr = 260 nm for p(dAdT)2 and ε = 16 600 cm−1M−1 in bp at λ = 254 nm for
p(dGdC)2, I = 0.1 M (NaCl), pH=7.0 and T=25.0 ◦C [1]. Plasmid pUC18 (2686
bp) for the photocleavage study was extracted from bacteria and purified by
means of a HP Plasmid Midi Kit (OMEGA Bio-tek, VWR). The concentration
of the polynucleotides is expressed in molarity of the nitrogenous bases and
denoted as CP . 2’-Deoxyguanosine-5’-Monophosphate (dGMP), was purchased
from Sigma Aldrich (purity of 99 %) and used without further purification.
[(p−cym)Ru(L−1)SCN] (where HL-1=2-(2’-hydroxyphenyl)benzothiazole), de-
fined as [Ru-1], was prepared by Dr. Martinez-Alonso of Inorganic Chemistry
group, and it was previously characterized. The structure of the complex is
reported in Figure 5.1.
Figure 5.1: Molecular structure of [Ru-1].
All the experiments between [Ru-1] and mono- and polynucleotides were carried
out in double distilled water, at a fixed ionic strength (I) and pH. Work solutions
had I=6.5 mM (NaClO4) and pH=7.0.
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5.1.2 Methods
Desired pH of work solutions was reached adding small aliquots of concentrated
solution of HClO4 and NaOH, using a Metrohm 16 DMS Titrin pH meter, with a
glass electrode containing a solution of KCl 3 M. UV-vis absorption spectra were
recorded by means of a Hewlett Packard 8453 A spectrophotometer (Agilent
Technologies), with diode-array detector and coupled with a computer-assisted
temperature-control system. Kinetic absorption studies of the interaction be-
tween [Ru-1] with dGMP and CT-DNA were performed recording the spectra
at a defined time lapse and a kinetic curve was treated at a specific wavelength.
Circular dichroic spectra were recorded with a MOS-450 Bio-Logic dichrograph
(Claix, France), at different CDCP or
CL
CP
(CP = 5.0× 10−5 M), where CL, CD and
CP are the analytical concentration of the ligand L, the complex and the polynu-
cleotide, respectively. The spectra were recorded from 200 to 600 nm, with an
acquisition rate of 0.5 nm s−1. The elapsed time of 1 mL of DNA solution passing
through a capillar was measured in a microviscometer Ubbelhode. The measure-
ment of the viscosity allows to determine the elongation of the DNA through
Eq. (2.20) (Chapter 2, Section 2.2.7). The temperature was kept at 25.0 ◦C
by means of an external water thermostat. Thermal denaturation study was
carried out by means of a Nano-DSC (TA Instruments). The working solutions
(solutions at different CDCP , CP = 4.0× 10
−4 M) were degassed before injection
in the equipment. The system was pressurized at 3 atm and the solutions were
heated from 20 to 110 ◦C at 1 ◦C min−1 scan rate. NMR samples were prepared
under a N2 atmosphere by dissolving the suitable amount of compound in 0.5 mL
of the respective oxygen-free deuterated solvent, and the spectra were recorded
at 298 K on a Varian Unity Inova-400 (399.94 MHz for 1H; 161.9 MHz for 31P).
Typically, 1D 1H-NMR spectra were acquired with 32 scans into 32 K data points
over a spectral width of 16 ppm. 1H chemical shifts were internally referenced to
tetramethylsilane via 1,4-dioxane in D2O (δ=3.75 ppm). Chemical shift values
are reported in ppm and coupling constants (J) in hertz. All NMR data pro-
cessing was carried out using MestReNova v10.0.2-15465. FAB mass
spectra (position of the peaks in Da) were recorded with an Autospec spectro-
meter. Study of photo-dissociation was carried out by means of the illuminator
explained in Chapter 2 (Section 2.2.10), in which was described also the cleavage
assay (Section 2.2.11).
5.2 Results and Discussion
5.2.1 Physico-Chemical Properties
5.2.1.1 HL-1 Luminescence
A comparison between the physico-chemical properties and the reactivity of
HL-1 and [Ru-1] was conducted to observe the role played by the ligand in the
reactivity of the metal complex.
HL-1 ligand was poorly soluble in the buffer solution (micromolar concentrations
in I=6.5 mM, NaClO4, pH=7.0 in 2 % DMSO:H2O (v:v)). Its photo-properties
have been largely studied in scientific literature [2, 3]. The UV-vis spectrum
displays two maxima at 288 and 327 nm, and a band at 460 nm is visible in the
emission spectra, corresponding to the solvated tautomer enol-imine form [4].
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Hence, HL-1 displays a large Stokes shift of the emission peak (∆λ=135 nm,
Figure 5.2).
Figure 5.2: Absorption and emission spectra of HL-1. CL=2.5 µM, 2 % DMSO,
I=6.5 mM (NaClO4), pH=7.0 (NaCac), λex=325 nm and T=25.0 ◦C.
Interestingly, variation with time of the absorption and fluorescence spectra was
observed, for concentrations above CL>3 µM, CL being the molar concentration
of HL-1. A kinetic process was recorded both in absorbance and fluorescence
modes (Figure 5.3). The well-defined isosbestic points at 272 and 343 nm in the
spectral curves denote two species in equilibrium (Figure 5.3A). Figure 5.3B
shows the change with time undergone by the fluorescence spectra. The band
at 460 nm gradually vanishes, producing a shoulder, while a new band emerges
at 508 nm.
Figure 5.3: Kinetics of HL-1 in buffer solution. (A) Absorbance versus time for the
experiment at 0.2 % DMSO; inset: track at 385 nm for different DMSO contents. (B)
Fluorescence versus time example; inset: track at 460 nm for different DMSO contents.
CL=10 µM, I=6.5 mM (NaClO4), pH=7.0 (NaCac), λex=325 nm and T=25.0 ◦C. (C)
Tautomeric equilibrium for HL-1.
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According to literature [4], the fluorescence spectrum of the keto-enamine tau-
tomer shows a strong emission band at ≈535 nm and a weak shoulder at 456 nm.
This finding demonstrates that the illustrated process in Figure 5.3 corresponds
to the enol-imine to keto-enamine transformation by ESIPT (Excited State In-
tramolecular Proton Transfer) effect. It follows that a dual emission occurs from
mixtures, with the keto-enamine form emitting at longer wavelength. The contri-
bution of the isomers primarily depends on the solvent. Actually, the tracks at
385 nm in the UV-vis absorption spectra (Figure 5.3A, inset) and at 460 nm in
the emission spectra (Figure 5.3B, inset) reveal that the reaction rate diminishes
when the DMSO content increases, and becomes very slow above 10 % DMSO.
The rate constants obtained from fitting of a monoexponential function to the
kinetic tracks recorded are shown in Table 5.1.
Table 5.1: Rate constants of the observed kinetics for HL-1 at different DMSO con-
centration. CL=10 µM, I=6.5 mM, pH=7.0 and T=25.0 ◦C.




Therefore, it is conceivable that under the conditions utilized the enol-imine
form of the ligand is present in the early stages, evolving afterwards to the
keto-enamine taumer form. As we always used freshly prepared solutions of
the ligand and under suitable DMSO concentration (2-5 % depending on the
technique employed) it can be assumed that, under the working conditions, the
ligand was preferentially in the enol form.
On the other hand, for very low DMSO concentration (0.2 %), the monoexpo-
nential function could not fit properly the kinetic trace, suggesting aggregation,
as many dyes are prone to aggregation in water [5,6]. Actually, aggregation has
been observed previously for high HL-1 concentration (20 µM, 2 % DMSO [4])
and for similar molecules, as 2-(2’-hydroxyphenyl)benzoxazole [7].
5.2.1.2 Aquation of [Ru-1]
Regarding the low-fluorescent complex [Ru-1], this is soluble in DMSO and,
for CD≤50 µM, at neutral pH buffer, as well; in the presence of CT-DNA, the
solubility increased, rendering viable the study at higher concentrations.
Exchange kinetics of SCN– with dimethylsulfoxide was not observed. However,
the recorded UV-vis spectra in aqueous solution at neutral pH as a function of
time (Figure 5.4) shows SCN– release and substitution by a H2O molecule, ac-
cording to Reaction 5.1, forming the [(p−cym)Ru(L−1)(OH2)]+ species, which,
from now on, will be denoted as aquo-[Ru-1].
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Figure 5.4: Kinetic of aquation of [Ru-1] complex. Inset: track at λ=290 nm fitted by
a monoexponential curve (red line). CD=18 µM, 2 % DMSO, I=6.5 mM, pH=7.0 and
T=25.0 ◦C.
Fitting of the monoexponential function to the recorded data-pairs leads to
the rate constant k=4.0× 10−4 s−1. This value resembles aquation processes of
many chlorido ruthenium complexes [8].
(p−cym)Ru(L1)(SCN) + H2O
k−−→ (p−cym)Ru(L1)(OH2)+ + SCN− (5.1)
Since aqua-complexes are generally more reactive species than their chlorido
precursors [9], the experiments were carried out after finishing the aquation
process of [Ru-1].
5.2.1.3 Acid Base Behaviour
Regarding pH, fluorescence enhancement of HL-1 was visualized for increasing
pH values (Figure 5.5A).
Figure 5.5: (A) Fluorescence spectra of HL-1 for different pHs. Inset: track at
λem=460 nm. CL=2.5 µM, λex=380 nm. (B) Normalized absorbance of the neutral
HL-1 (dashed line) and the deprotonated L-1 species (red line). 2 % DMSO, I=6.5 mM
and T=25.0 ◦C.
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In addition, notable variations of the absorption spectra were recorded for
basic pH, as well (Figure 5.5B). The pKA values obtained by means of the
Henderson-Hasselbach equation [10], 9.4±0.1, refers to deprotonation of the phe-
nol group (Reaction (5.2)). This value concurs with pKA obtained for other (hy-
droxyphenyl)benzothiazoles (for example, for 2-(3’-hydroxyphenyl)benzothiazole,
pKA=9.5 and, for 2-(4’-hydroxyphenyl)benzothiazole, pKA=8.8 [11]).
HL1 + OH−
KA−−→←−− L1− + H2O (5.2)
Related to aquo-[Ru-1], the spectra recorded for increasing pH values show
changes and two isosbestic points at 290 and 330 nm (Figure 5.6).
Figure 5.6: UV-vis absorption spectra of the aquo-[Ru-1] complex for different pH
values. CD=10 µM, 2 % DMSO, I=6.5 mM and T=25.0 ◦C.
Such spectral variations are ascribable to formation of the hydroxo-compound
[(p−cym)Ru(L−1)(OH)], according to Reaction 5.3.
[(p−cym)Ru(L1)(H2O)]+ + OH−
K′A−−→←−− [(p−cym)Ru(L1)(OH)] + H2O (5.3)
From the track at 303 nm (Figure 5.6, inset) we obtain pK ′A=9.2±0.1 indicating
that at neutral pH the complex is present in the aqua form. Similar KA values
have been reported for the formation of some ruthenium hydroxo-compounds [8].
Note that, even though the pKA values for HL-1 and the complex are similar,
the acid-base equilibria are definitively related to different functional groups, the
hydroxo group and the water leaving group for HL-1 and [Ru-1], respectively,
because of the different structure of the compounds. For high pH values, a slow
kinetic effect (data not shown) was observed for aquo-[Ru-1] and, as the new
peaks formed are the same as those of the ligand anion form, we assumed that
highly basic conditions can disrupt the binding between the metal and the L-1
ancillary ligand.
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5.2.2 Interaction of aquo-[Ru-1] with dGMP
Prior to the study of the interaction of DNA with aquo-[Ru-1], kinetic proofs by
means of absorption measurements were performed in the presence of deoxyadeno-
sine-5’-monophosphate (dAMP) and deoxyguanosine-5’-monophosphate (dGMP)
in excess of nucleotides. No signal variation was detected for aquo-[Ru-1]
with dAMP, whereas for the aquo-[Ru-1]/dGMP system a slow kinetic was
perceptible. The reaction caused hypochromism at 383 nm and a hyperchromic
effect at 340 nm of the aquo-[Ru-1] absorption spectra, with an isosbestic point
at 353 nm (Figure 5.7A).
Figure 5.7: (A) Example of kinetic spectra for the interaction between the aquo-[Ru-1]
complex and dGMP system, CD=14 µM, CPCD=50; inset: track at λ=340 nm and fitting
(red line) by monoexponential function. (B) Fitting of the rate constants by the
1
τ
= k1CP equation (red line). 2 % DMSO, I=6.5 mM, pH=7.0 and T=25.0 ◦C.
Interactions of metal complexes with the phosphate group are generally fast,
whereas covalent binding to the nitrogenous bases are slower. Actually, various
ruthenium arene complexes have been reported to bind guanine through the N7
by substitution of their leaving group [12,13].
The time constants ( 1τ ) increased linearly with the increase in the dGMP con-
centration (CP ) (Figure 5.7B). In addition, the plotting shows close to zero
intercept, indicating that an irreversible reaction between aquo-[Ru-1] and
dGMP to give a [Ru-1]/dGMP complex is at work (Equation 5.4). The slope
value provides the reaction rate constant k1=0.20± 0.01 M−1s−1.
aquo−[Ru−1] + dGMP k1−−→ [Ru−1]dGMP + H2O (5.4)
This type of interaction was also studied by means of 1H-NMR and 31P{1H}-
NMR spectroscopy. New sets of peaks emerged in the presence of 9-MeG (data
not shown) and dGMP. In particular, for the [Ru-1]/dGMP system, a new set
of proton peaks was detected after three days (Figure 5.8), suggesting a slow
reaction between the complex and dGMP. In addition, a small signal in the
31P{1H}-NMR spectrum appeared for [Ru-1]/dGMP (Figure 5.9).
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Figure 5.8: 1H-NMR: evolution of the aromatic region of [Ru-1] with dGMP in
DMSO−d6/D2O (5:2) at 25 ◦C. • [Ru-1], • free dGMP and N[Ru-1]/dGMP product.
(a) Spectrum in DMSO−d6, (b) after addition of D2O at t=0 and after addition of
dGMP at (c) t=5 min, (d) 20 min, (e) 55 min, (f) 72 h and (g) 1 week.
Figure 5.9: 31P{1H}-NMR spectra for the reaction between dGMP and [Ru-1] complex
recorded after one week. • free dGMP, N [Ru-1]/dGMP majority product and 
[Ru-1]/dGMP minority product.
Hence, we can hypothesize the presence of a minor species in which the ruthenium
is bound to the phosphate group. Moreover, a second more intense peak is
attributed to the major Ru-N species. This signal undergoes no significant shift
in the 31P{H}-NMR spectrum, and exhibits intense peaks in the 1H-NMR.
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5.2.3 Interaction of HL-1 and aquo-[Ru-1] with CT-DNA
First of all, the interaction between the HL-1 ligand and CT-DNA was studied.
Fluorescence titrations of polynucleotides with HL-1 were performed; note that,
under the working conditions (low HL-1 concentration, DMSO 2 % and freshly
prepared solutions), the species present in solution is the enol-imine tautomer,
as demonstrates by the emission spectra of the ligand (Figure 5.2B).
The presence of CT-DNA and poly(dG−dC)2 caused a strong red shift in the
emission of HL-1 (∆λem=55 nm) and in the presence of poly(dA−dT)2 a sud-
den fluorescence enhancement was also observed (Fig. 5.10A). Figure 5.10B
shows that fluorescence enhancement is much higher in the presence of the
poly(dA−dT)2 sequence than in the presence of poly(dG−dC)2 or CT-DNA.
Figure 5.10: (A) Comparison of the fluorescence spectra of the titration of HL-1
with different polynucleotides at CP
CL
=10. (B) Titration track at λem=500 nm for the
HL-1/p(dAdT)2, HL-1/CT−DNA and HL-1/p(dGdC)2 systems; the fluorescence in-
tensity F is normalized for the value at λem=500 nm of the free ligand, F0. CL=2.5 µM,
CP=0-180 µM, 2 % DMSO, I=6.5 mM (NaClO4), pH=7.0 (NaCac), λex=355 nm and
T=25.0 ◦C.
This result points up that HL-1 displays selectivity towards AT base pairs,
concurring with binding on the minor groove [14,15].
Results provided by fluorimetric titrations are endorsed by further employed
techniques. Actually, the HL-1/CT-DNA system exhibited slight decrease of
circular dichroism (Figure 5.11A) and viscosity (Figure 5.11C). In addition,
HL-1 did not alter the melting temperature of the DNA double-stranded confor-
mation (Figure 5.11D). All these results agree with a non-intercalative binding.
Most minor groove binders (netropsin, distamycin, Hoechst 33258, berenil, 40,6-
diamidino-2-phenylindole, and SN-6999) are prone to interact with AT-rich se-
quences, bringing about only a slight distortion of the double helix [16]. Indeed,
first of all the GC grooves are sterically hindered by the H bond between the
NH2 functional group at C2 of the guanine and the carbonyl group at C2 of the
cytosine. Therefore, the electrostatic potential is larger in the AT sequences
than in the GC-rich regions. Both characteristics render poly(dA−dT)2 suitable
for the external interaction with groove binders [17].
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Figure 5.11: Thermodynamic study of the interaction betweenHL-1 and aquo-[Ru-1]
with CT-DNA. (A) Circular dichroism of HL-1/CT-DNA system, CL
CP
=0-0.65 (arrow
sense) and (B) circular dichroism of aquo-[Ru-1]/CT-DNA system, CD
CP
=0-1.2 (arrow
sense); CP=50 µM, 4 % DMSO and T=25.0 ◦C. (C) Viscometry; CP=200 µM, 5 %
DMSO and T=25.0 ◦C. (D) Tm versus CDCP experiments; CP=400 µM, 5 % DMSO.
Square: aquo-[Ru-1]/CT-DNA, Circle: HL-1/CT-DNA. I=6.5 × 10−3 M, and
pH=7.0.
Concerning the aquo-[Ru-1] system, variation of the absorption spectra with
time was observed also in the presence of CT-DNA (Figure 5.12).
Figure 5.12: (A) Example of kinetics of the aquo-[Ru-1]/CT-DNA system.
CD=14 µM, CPCD=45; inset: track at 340 nm. (B) Fitting of the rate constants by
Equation (5.6). I=6.5 mM (NaClO4), pH=7.0 (NaCac), T=25.0 ◦C.
Figure 5.12A shows the kinetic spectral curves for the aquo-[Ru-1]/CT-DNA
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system (with an isosbestic point at 359 nm) and the inset shows the absorbance-
time track at 340 nm. The spectral changes are similar to those observed for
the aquo-[Ru-1]/dGMP system (Figure 5.7A), hence, similar interaction with
the guanine moiety can be assumed. In this case, however, the increase of the
rate constant versus CP (CP being the CT-DNA concentration, Figure 5.12B) is
nonlinear as the one observed with dGMP (Figure 5.7B). This kinetic behavior
agrees with a pre-association mechanism of the metal complex to the nucleic
acid via a noncovalent binding, which modulates the kinetic rate of the covalent
binding to the guanine [18]. Therefore, we can assume: (i) the aquo-[Ru-1]
species reacts quickly with CT-DNA to form the PD complex, K1 being the
equilibrium constant of this step, and (ii) the PD complex converts to PD* in a
second unimolecular, irreversible step, k2 being the rate-determining constant
(Reaction (5.5)).
On this basis, Equation (5.6) was fitted to the 1τ versus CP data-pairs (see
Appendix 5.A, Supporting Information). Table 5.2 collects the values obtained













Table 5.2: Thermodynamic and kinetic parameters obtained by fitting of the kinetic
curves from the reactions of aquo-[Ru-1] with dGMP and CT−DNA.
k1, M−1s−1 10−3K1, M−1 105k2, s−1
dGMP 0.20± 0.01
CT-DNA 4± 1 5.8± 0.5
The fluorimetric titration of aquo-[Ru-1] with CT-DNA (Fig. 5.13) caused a
similar fluorescence light-switch and shifted the maximum emission to a wave-
length longer than that observed for the HL-1/CT-DNA system (Fig. 5.10).
The signal did not reach a plateau, and rose for increasing DNA concentration.
Note that, since the covalent binding is a very slow process, we can assume that
this interaction does not affect the fluorimetric titration. Actually, the time
elapsed to perform the titration (about one hour) ensured that, under such con-
ditions, formation of the covalent binding is minority (for example, considering
the end of the titration proof, at CP = 120 µM, the total amount of covalent
binding will be some 10 %). The increase in the emission (or light-switch) in
the presence of DNA is verified for other ruthenium complexes [19, 20]. Light
switch is usually considered a proof for intercalation; however, it is verified that
other interactions, such as groove binding, can induce light switch as well, as
seen for [(bpy)2Ru(tpphz)Ru(bpy)2]4+ [21] and Ru(phen)2(Hcdpq)(ClO4)2 [22].
Performed experiments with p(dAdT)2 and p(dGdC)2 exhibit preference for AT
base-pairs, as observed for the HL-1 ligand. It was not possible to obtain an
equilibrium constant from the fluorimetric titrations because the plateau was
not reached.
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Figure 5.13: (A) Fluorescence titration of aquo-[Ru-1] by addition of increas-
ing amount of CT-DNA. (B) Titration track at λem = 500 nm for the
aquo-[Ru-1]/p(dAdT)2, aquo-[Ru-1]/CT−DNA and aquo[Ru-1]/p(dGdC)2; the
fluorescence intensity F is normalized for the value at λem=500 nm of the free complex,
F0. CD=2.5 µM, CP=0-150 µM, 2 % DMSO, I=6.5 mM, pH=7.0, λex=355 nm and
T=25.0 ◦C.
Weak groove binding is verified for other ruthenium arene complexes [23]. In the
same way, few modifications were observed by circular dichroism, viscometry and
melting temperature, agreeing with minor groove binding hypothesis (Figures
5.11B to D).
The results indicate that the fast interaction observed for aquo-[Ru-1] is gover-
ned by the ancillary ligand. Although the highest light switch effect is observed
for the p(dAdT)2, as for HL-1, certain preference is observed for CT-DNA re-
spect to p(dGdC)2 polymer. Since aquo-[Ru-1] is singly charged while the
ligand is neutral, change in the nature of binding can occur, influencing the
interaction and, consequently, the binding preference.
In conclusion, a dual mode of binding of aquo-[Ru-1] towards CT-DNA was
observed: covalent binding to guanine moiety and the minor groove binding,
with preference towards AT base pairs. Covalent binding is governed by the
leaving group (the water molecule), while the interaction to the groove is go-
verned by the ancillary chelating ligand (HL-1). Recently, our group reported
a stable bifunctional interaction (covalent and partially intercalated) between
the [(p−cymene)Ru(κ2−NN−2−pydaT)]2+ fragment and CT-DNA, where both
interactions are present concurrently [24]. In the case of aquo-[Ru-1], however,
the obtained results did not clear about the possibility of a bifunctional group or
a two-step mode of binding. The geometrical structure of the compound and the
nature of the interactions would exclude a bifunctional interaction, but, rather,
the groove binding would promote the association of the metal complex to the
nucleic acid and, then, the covalent interaction to guanine occurs, resulting in a
two-step mechanism. However, the nature of the sequences of nitrogenous base-
pairs inside the DNA could influence one of the ways of interaction, obtaining a
different mode of action along the polynucleotidic chain.
5.2.4 Photoreactivity and Plasmid Photocleavage
Irradiation of deoxygenated solutions of aquo-[Ru-1] showed important changes
in its absorption spectra, suggesting alterations in its structure. Furthermore,
158 CHAPTER 5. RU ARENE COMPLEX
the kinetic rate is faster in DMSO (Fig. 5.14A) respect to buffer solution (Fig.
5.14B), under the same experimental conditions.
Figure 5.14: UV-vis absorption kinetic of photorelease of p-cymene from [Ru-1] in (A)
DMSO (Inset: track at 412 nm fitted by a monoexponential curve, 1
τ
=5.7 × 10−4 s−1)
and (B) buffer solution (2 % DMSO), I=6.5 mM (NaClO4) and pH=7.0 (NaCac) (Inset:
track at 383 nm). CD=20 µM, λirr=325 nm, and T=25.0 ◦C.
Thus, the stability of [Ru-1] in DMSO−d6 was studied by 1H-NMR for 3 months
under exposure to ambient light and N2 atmosphere at room temperature. No
significant change was observed after 24 h. However, after 3 months signals for
free p-cymene and a new set of peaks for a new species, denoted as [Ru-1*], were
detected along with the resonances of [Ru-1], which reveals a slow decomposition
process that involves arene loss. Moreover, irradiation of a [Ru-1] sample in
DMSO−d6 with an arc lamp source set at λirr = 325 nm speeds up the process,
in such a way that degradation was completed after 29 h (Figure 5.15).
Figure 5.15: 1H-NMR spectra of an irradiated solution of [Ru-1] in DMSO−d6. •
[Ru-1] complex; • [Ru-1*] complex;  free p-cymene.
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Again, resonances for free p-cymene (labeled with black squares in Figure 5.15),
and a new Ru(II) complex bearing L-1 ([Ru-1*], orange circles) were recorded
by 1H-NMR in the final mixture.
The molecular structure of [Ru-1*] (Figure 5.16) was elucidated by FAB-MS ex-
periments. In particular, the resulting peaks indicate that p-cymene was replaced
by three DMSO molecules: 470 [Ru-1*−2DMSO−d6]+, 496 [Ru-1*−NCS −
DMSO−d6]+, 554 [Ru-1*−DMSO−d6]+, 580 [Ru-1*−NCS]+, 638 ([Ru-1*]+)
Da (See spectra in Figure 5.S1-5.S3, Supporting Information). Release of
p-cymene from ruthenium arene complexes has been reported in other stud-
ies [25,26].
Figure 5.16: Proposed photoreaction found in DMSO involving the release of the
p-cymene ligand.
Photoreactivity of the aquo-[Ru-1] ruthenium complex was evaluated by clea-
vage of plasmid pUC18 DNA (Figure 5.17).
Figure 5.17: (A) Irradiated aquo-[Ru-1]/pUC18 samples. Lane 1: Molecu-
lar weight marker. Lane 2: Irradiated control (C I), tirr=250 min. Lanes 3-8:
aquo-[Ru-1]/pUC18 (I), tirr=0 (D), 50, 100, 150, 200, 250 min. Lane 9: Dark Con-
trol (CD). CD=20 µM, CP=20 µM, [NaClO4]=4.0 mM, [NaCac]=2.5 mM, pH=7.0 and
λirr=325 nm. Incubation at T=37 ◦C, overnight. (B) Quantification of the cleavage
by Equation (2.31).
The photocleavage was quantified by the conversion of the plasmidic native su-
percoiled form (Form I) to the circular form (Form II), by means of Equation
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(2.31) (See Chapter 2, Section 2.2.11). The separation of the different forms was
achieved by means of electrophoresis (Figure 5.17A), adding ethidium bromide
as probe of the different nucleic acid forms. Figure 5.17B shows certain degree of
cleavage of plasmid DNA, and it increased with enhancement of the irradiation
time.
Photocleavage proofs in the presence of scavengers of oxygenated radicals and
singlet oxygen would confirm the oxygen-independent pathway of reaction. Actu-
ally, no decrease of the cleavage was found in the samples containing L-Histidine
(for 1O2), DMSO (for OH·) and Superoxide dismutase (SOD, for O2–·) (Figure
5.S4, Supporting Information). An analogue independence from oxygen of the
photocleavage of plasmid DNA has been reported by Magennis et al. in the
presence of a ruthenium complex which releases the arene under nitrogen atmo-
sphere, as well [27].
5.2.5 Cytotoxic activity
MTT assays were performed by the group of Prof. Dominguez of the University
of Santiago de Compostela and Dr. Busto from our group in the University of
Burgos.
The difference in the type of the complexes formed with DNA, groove binding for
HL-1 ligand and bifunctional covalent-groove binding for aquo-[Ru-1], could
justify the difference in cytotoxicity towards A2780 cell culture. Actually, the
IC50 values (Table 5.3) indicate that, whereas the ligand is not cytotoxic, the
complex shows strong cytotoxicity, 26 µM. In other words, the metal plays a key
role regarding the biological behaviour due to its ability to bind covalently with
the guanine N7 site.
Table 5.3: IC50 (µM) of the metal complexes in different cancer cell lines.
Compound A2780 (96h) A549 (24h)
HL-1 > 100 -
[Ru-1] 26± 1 65
[Ru-1*] - 37
Cisplatin 0.54± 0.01 25
In addition, the IC50 value of [Ru-1*] in the A549 cancer cell line resulted
2-fold lower respect to the value obtained for [Ru-1] (Table 5.3), demonstrating
that the obtained product from photo-irradiation of [Ru-1] is more cytotoxic.
5.3 Conclusions
The aquo-[Ru-1] complex displays a dual mode of binding towards DNA, show-
ing a covalent binding to the guanine and a weak binding on the minor groove
of the helix, switching on its fluorescence. A two-step mechanism of action
has been advanced for aquo-[Ru-1], with a fast pre-association, the groove
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binding and, then, the irreversible binding to the guanine. Proof with the 2-(2’-
hydroxyphenyl)benzothiazole ligand clearly indicates that the ancillary ligand
plays the main role in the interaction with the groove, whereas the interaction
with the guanine depends on the release of the leaving group. The two-step
mode of binding could be accountable to the higher cytotoxic activity of the
drug respect to the cytotoxic activity of the free HL-1 ligand. The possibility
to tune the properties of the complex modifying the arylbenzazoles or adding
new ancillary ligands that can promote further interactions could be of interest
for new syntheses. In addition, photo-induced arene loss and photocleavage of
the plasmid DNA caused by ruthenium arene complex add interest towards such
class of complexes for the PDT strategy.
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Figure 5.S1: FAB-MS of [Ru-1*]. Theoretical and experimental spectrum of the
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Figure 5.S2: FAB-MS of [Ru-1*]. Theoretical and experimental spec-
trum of the observed fragments. m/z=496 ([Ru-1*−NCS−DMSO−d6]+), 554
([Ru-1*−DMSO−d6]+).
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Figure 5.S3: FAB-MS of [Ru-1*]. Theoretical and experimental spectrum of the
observed fragments. m/z=470 ([Ru-1*−2DMSO−d6]+).
Figure 5.S4: (A) Electrophoresis of the irradiated aquo[Ru-1]/pUC18 system in
presence of scavengers. Lane 1: Molecular weight marker. Lane 2: Dark con-
trol. Lane 3: aquo[Ru-1]/pUC18 in the dark. Lane 4: Irradiated control. Lane
5: Irradiated aquo[Ru-1]/pUC18. Lane 6: Irradiated aquo[Ru-1]/pUC18 + [L-
His]=1.2 mM. Lane 8: Irradiated aquo[Ru-1]/pUC18 + [DMSO]=200 mM. Lane
9: Irradiated aquo[Ru-1]/pUC18+ [SOD]=1000 Uml−1. Lane 9: Dark control.
CD=20 µM, CP=20 µM; [NaClO4]=4.0 × 10−3 M; [NaCac]=2.5 × 10−3 M, pH=7.0. Ir-
radiation: λirr=325 nm and tirr=140 min. Incubation at T=37 ◦C, overnight. (B)
Quantification of the cleavage in the presence of scavengers.
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5.A Determination of Equation (5.6)






where K1 is the equilibrium of the fast preliminary reaction defined in Equation





The variation of [PD∗] with time is given by Equation (5.A.3)
d[PD]
dt
= k2[PD]− k−2[PD∗] (5.A.3)
where k1 and k−1 are the kinetic constants of the direct and the inverse reaction
of formation of the second adduct, respectively, being [PD∗] its concentration.
In a very short δt time the formula is converted into
dδPD∗
dt
= k2δPD − k−2δPD∗ (5.A.4)
The anaytical concentration CD of the dye D and CP of the P unit, are given
by Eqs. (5.A.5) and (5.A.6)
CD = [D] + [PD] + [PD∗] (5.A.5)
CP = [P ] + [PD] + [PD∗] (5.A.6)
Considering that we worked in an excess of P, it follows that CP ≈ [P ] and,




+ [PD] + [PD∗] (5.A.7)
In a δt time the Equation (5.A.8) is given
0 = δPD
K1CP
+ δPD + δPD∗ ⇒ δPD = − K1CP1 +K1CP
δPD∗ (5.A.8)






δPD∗ − k−2δPD∗ (5.A.9)
Expressing − dδPD∗δPD∗dt =
1



















The interaction of the ruthenium arene complex towards DNA summarized in
Chapter 5 showed an interesting dual binding mode. However, low photocleavage
of plasmid DNA was found, and only at high irradiation energy (325 nm).
For this reason we took into account a new class of metal complexes: the bis-
cyclometalated ones. Here in Chapter 6, we treat two new biscyclometalated
systems, differing only by the metal center, the [Ir(ppy)2(pyboz)]Cl ([Ir-1]Cl)
and the [Rh(ppy)2(pyboz)]Cl ([Rh-1]Cl) complexes. Our study was focused on
the reactivity differences of such compounds in the absence of irradiation and
photoirradiated. Proofs in the dark regarded the interaction with CT-DNA,
whereas photocleavage was evaluated in the presence of plasmid pUC18.
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In the absence of a source of irradiation, the interaction of the iridium and the
rhodium complexes with CT-DNA was quite similar. Interestingly, the iridium
complex displayed increase of the fluorescence, whereas emission decrease was
visualized for [Rh-1]Cl, ascribable to the different nature of the electronic states
of the metal complexes.
Moreover, irradiation of the rhodium complex at 365 nm provoked an extensive
cleavage of DNA; on the other side, the iridium complex exhibited very low
photoactivity. Studies in the presence of scavengers demonstrated that singlet
oxygen is involved in the mechanism of reaction, confirmed also by singlet oxygen
detection experiments. In addition, a minority effect provoked the photodissocia-
tion of the ancillary ligand and the resulting product was seen to bind covalently
to 9-MeG through an oxygen-independent pathway. MTT proofs showed an
increase of cytotoxicity for the rhodium complex under irradiation, in agreement
with the photocleavage study.
Such work reveals the importance of the metal center in the biscyclometalated
complexes. Further study on the contribution of the ligands in the reactivity
of such a class of compounds towards nucleic acids and their photoreactivity is
treated in Chapter 7.
6.1 Materials and Methods
6.1.1 Materials
The examined iridium and rhodium complexes are the [Ir(ppy)2(pyboz)]Cl and
the [Rh(ppy)2(pyboz)]Cl complexes, named as [Ir-1]Cl and [Rh-1]Cl, respec-
tively, whose structures are drawn in Figure 6.1.
Figure 6.1: Molecular structure of [Ir-1]Cl and [Rh-1]Cl.
The complexes have been synthesized by Dr. Martinez-Alonso from Inorganic
Chemistry Laboratory of the Universidad de Burgos and they have been previ-
ously fully characterized. Stock solutions of [Ir-1]Cl and [Rh-1]Cl were prepared
in water, which resulted stable over weeks by checking the absorption spectra.
Calf Thymus DNA sodium salt was purchased from Sigma Aldrich and prepared
according to Chapter 2. Working solution were prepared in [NaCl]=4.0 mM and
[NaCac]=2.5 mM buffer (I=6.5 mM and pH=7.0). Ionic strength was attained
by concentrated solutions of NaCl, whereas suitable pH was reached by addition
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of concentrated solutions of NaOH and HCl.
6.1.2 Methods
UV-vis absorption titrations were carried out with an Evolution 300 UV-VIS
double beam spectrophotometer (Thermo Scientific), adding increasing concen-
tration of CT-DNA to the reference and to the sample, in order to subtract the
contribution of the DNA to the spectra. Fluorescence steady-state and lifetime
measurements were performed in a FLS980 (Edinburgh Instruments) fluorimeter.
Lifetime study was performed using a laser as excitation source (λexc = 375 nm),
preparing solutions at different CDCP and recording the decay, CD and CP being
the analytical concentration of the complex and the DNA in basepairs, respec-
tively. Analysis of the lifetime data was performed by Global Analysis with
FStat program, selecting the numbers of lifetime involved in the interaction.
Circular dichroic spectra were recorded with a MOS-450 (Bio-Logic Science In-
struments), equipped with a Xenon Arc Lamp. It is coupled with a Julabo
F30 thermostat (precision of 0.1 ◦C). The experiments were carried out adding
the metal complex to a solution of CT-DNA and recording the spectra in the
200-600 nm, scan rate 0.5 nm s−1. DSC experiments were performed for different
CD
CP
(CP = 3.0× 10−4 M), using a NanoDSC (TA Instrument) and scanning the
sample from 20 to 100 ◦C at 3 atm (scan rate 1 ◦C min−1). Isothermal Titration
Calorimetry technique was employed using a NanoITC, degassing the solution
with a TA Degassing Station (2× 15 min). A solution of CT-DNA was inserted
in the sample cell and the metal complex was added to the cell by means of a
syringe under stirring (25 additions of 2 µL, waiting 5 min after each addition).
Analysis of the titration was obtained by the NanoAnalyze program. Vis-
cometry measurements were performed with a Ubbelhode Microviscometer for
different CDCP ratios and analysed by Equation (2.20) (Chapter 2, Section 2.2.7).
NMR samples were prepared under a N2 atmosphere in the respective oxygen-
free deuterated solvent, and the spectra were recorded at 298 K on a Varian
Unity Inova-400 (399.94 MHz for 1H). 1D 1H-NMR spectra were acquired with
32 scans into 32 K data points over a spectral width of 16 ppm and the chemi-
cal shifts were internally referenced to tetramethylsilane via 1,4-dioxane in D2O
(δ=3.75 ppm). All NMR data processing was carried out using MestReNova
v10.0.2-15465. Mass spectrometry samples were analysed by an Agilent In-
strument, equipped with a TOF mass analyzer. Photoirradiation and cleavage
study were performed according to Chapter 2, Sections 2.10 and 2.11.
6.2 Results and Discussion
6.2.1 Metal Complex Properties
Various absorption peaks result from the biscycometalated complex spectra,
which can be related to different transitions [1]: bands with high extinction mo-
lar coefficient (>30 000 M−1cm−1) are ascribable to spin-allowed ligand centered
transitions (1LC), whereas above 350 nm, the lower peaks are associated to spin
forbidden LC and spin allowed MLCT transitions. Then, above 400 nm, very
low absorption is perceptible for iridium complex, which is related to the spin
forbidden MLCT transition.
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The luminescence properties are listed in Table 6.1. Fluorescence of the com-
plexes are quite different: iridium complex has a broad and unstructured emission
peak and exhibits large stoke shift; on the other hand, rhodium complex has
a structured peak and emits at shorter wavelengths than iridium does. Both
complexes exhibit low quantum yield fluorescence in air equilibrated water, calcu-
lated by comparison with the Ru(bpy)32+ quantum yield (Φ = 0.028 in water) [2].
Interestingly, the rhodium species has a long lifetime in comparison with the
iridium one.
Table 6.1: Emission parameters in water. Φ is the fluorescence quantum yield and τ
is the lifetime (in brackets the fractional intensity for each τ).
Complex λmaxex , nm λmaxem , nm Φ τ , ns
[Ir-1]Cl 310 625 0.0013 10.3 (0.90), 217 (0.10)
[Rh-1]Cl 303 542 0.0021 540
The analysis of the luminescent properties of rhodium and iridium complexes
is quite present in literature and important differences are reported [3, 4]. In
addition, large efforts were carried out in the study of the excited states of
iridium and rhodium cyclometalated complexes [5–10]. For biscyclometalated
complexes, structured peaks as the one observed for the rhodium complex are
associated to 3LC transitions, whereas unstructured peaks are generally due to
3MLCT. Actually, a recent paper [11] reports TD-DFT calculation for the new
synthesized [Ir-1]PF6 complex, which demonstrates that the lowest T1 triplet
excited state has a mixing 3MLCT-3LLCT nature.
The absorption spectra of the compounds did not change by varying the pH of
the solutions in the pH=2-11 range, in agreement with the absence of acid/base
behaviour. However, a decomposition process occurred for basic conditions
(pH>12, Figure 6.2). In addition, no dimerization or aggregation effect was
detected by absorption under the experimental conditions (Figure 6.S1).
Figure 6.2: UV-vis absorption spectra at different pH values. (A) [Ir-1]Cl, inset:
track at 313 nm. (B) [Rh-1]Cl, inset: track at 303 nm. CD=20 µM I=6.5 mM (NaCl),
T=25.0 ◦C.
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6.2.2 Interaction with CT-DNA
6.2.2.1 UV-vis Absorption Titration
Preliminary tests by means of spectrophotometry proved that no slow interaction
is present for the complexes in the presence of CT-DNA and dGMP monomeric
unit (data not shown). Consequently, we assumed a fast interaction between
the metal complexes and DNA.
UV-vis titrations with CT-DNA caused hypochromism of the bands for both
metal complexes, reported in Figure 6.3 (8 % for [Ir-1]Cl and 11 % for [Rh-1]Cl).
Figure 6.3: (A) [Ir-1]Cl/CT-DNA UV-vis titration. Inset: track at 310 nm. (B)
[Rh-1]Cl/CT-DNA UV-vis titration. Inset: track at 310 nm. CD=20 µM, I=6.5 mM
(NaCl), pH=7.0 (NaCac), T=25.0 ◦C.
Data treatment by means of Equation (2.46) and Scatchard Plot (Equation (2.55),
Figure 6.S2, [12]) allows to determine a constant (K) and a dimension site (n,
using the McGhee and von Hippel correction, Equation (2.58) [13]). The obtained
values are very similar: for the [Ir-1]Cl/CT-DNA system, K=(5± 1)× 105M−1
and n=1.1 ± 1; for the [Rh-1]Cl/CT-DNA system, K=(6 ± 1) × 105M−1 and
n=1.2± 0.1. This result suggests the same kind of interaction to DNA for both
compounds.
6.2.2.2 ITC
The titrations of CT-DNA with increasing amounts of the metal complexes re-
veal two effects for both systems by isothermal titration calorimetry (Figure 6.4),
differently from the absorption titrations, where only one effect was observed
(Figure 6.3). As the blank proofs did not show any effect, the observed tracks
were related to the direct interaction of the CT-DNA with the metal complexes.
The data were plotted by means of the multiple site model provided by the
NanoAnalyze program.
Consequently, we can hypothesize two different modes of binding, whose con-
tributions to the overall interaction of the metal to DNA depend on the CDCP
ratio.
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Figure 6.4: Isothermal Titration Calorimetry. (A) [Ir-1]Cl/CT-DNA titration;
C0P=5.0 × 10−4 M. (B) [Ir-1]Cl/CT-DNA proposed model; straight line: theoretical
data; dots: experimental data. (C) [Rh-1]Cl/CT-DNA titration; C0P=5.0 × 10−4 M.
(D) [Rh-1]Cl/CT-DNA proposed model; straight line: theoretical data; dots: experi-
mental data. I=6.5 mM (NaCl), pH=7.0 (NaCac), T=25.0 ◦C
In literature, a biphasic behaviour, in particular an exothermic process followed
by an endothermic reaction, has been observed in the interaction of some oc-
tahedral metal complexes with CT-DNA [14, 15], and it is ascribed to a dual
mode of binding of the complex, due to a canted and a central intercalation of
the ancillary ligand, respectively. The thermodynamic values obtained by the
[Ir-1]Cl/CT-DNA and [Rh-1]Cl/CT-DNA titrations are listed in Table 6.2.
Table 6.2: Thermodynamic values obtained from the plotting of the ITC titrations of
the [Ir-1]Cl/CT-DNA and [Rh-1]Cl/CT-DNA systems. K is the equilibrium constant
and ∆H the enthalpy of the reaction. Confidence interval 95 %.
Parameters [Ir-1]Cl/CT-DNA [Rh-1]Cl/CT-DNA
K1, M−1 (9± 6)× 105 (9± 6)× 105
K2, M−1 (3± 1)× 105 (4± 2)× 105
∆H1, kJ mol−1 1.3± 0.7 1.8± 0.3
∆H2, kJ mol−1 −4.0± 0.7 −4.0± 0.3
The obtained values are quite similar, as we observed by means of the absorp-
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tion titrations; it means that the metal center does not influence the reversible
interaction with DNA. The result makes sense for the reason that iridium and
rhodium exhibit the same oxidation number and the electronic density of the
molecule most likely is the same.
6.2.2.3 Fluorimetric Titration
Titrations were performed in fluorimetry, as well (Figure 6.5).
Figure 6.5: Fluorimetric titration of the metal complex with CT-DNA. (A)
[Ir-1]Cl/CT-DNA, λex=335 nm; inset at λem=650 nm. (B) [Rh-1]Cl/CT-DNA,
λex=340 nm; inset at λem=538 nm. CD=5.0 µM, I=6.5 mM (NaCl), pH=7.0 (NaCac)
T=25.0 ◦C.
Initially, a decrease of the fluorescence was observed for both systems, which can
be ascribable to the initial hypochromism seen in the absorption (Figure 6.3).
However, for [Ir-1]Cl/CT-DNA a linear increase of the fluorescence was detected,
which did not reach the plateaux, together with a blue shift of the signal from
640 nm to 602 nm. This effect was reported for other metal complexes [16, 17]
in the presence of CT-DNA. It is likely due to the fact that the aqueous
environment quenches the emission of the fluorophore, whereas the addition of a
polynucleotide allows the metal complex to be shielded from the water molecules,
which yields to a fluorescence switch-on [18]. For [Rh-1]Cl it was possible to
obtain the equilibrium constant from the fluorescence decrease (Figure 6.S3),
and the obtained value is K=(4± 1)× 105M−1, concurring well with the ones
obtained by UV-vis absorption and calorimetry titrations.
The effect of CT-DNA on the fluorescence lifetime of the biscyclometalated
systems was also monitored. Notably, for [Ir-1]Cl a relevant increase of the
fluorescence lifetime was observed (Figure 6.6A). In particular, the decrease of
the τ1 = 10.1 ns contribution and the appearance of a new lifetime, τ3 = 235 ns
(Figure 6.6C), was noticed, increasing the average lifetime of the species (Figure
6.6B). The average lifetime reached a plateau at CDCP = 1, in agreement with the
size site observed by the absorbance titration (Figure 6.S2).
On the other side, low variation of the rhodium lifetime was recorded by addition
of DNA (Figure 6.7A).
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Figure 6.6: Fluorescence lifetime study of the [Ir-1]Cl/CT-DNA system for different
CP
CD
ratios. (A) Fluorescence decays. (B) Average lifetimes. (C) Relative amplitudes
of the lifetimes. I=6.5 mM (NaCl), pH=7.0 (NaCac), λex=375 nm, λem=610 nm and
T=25.0 ◦C.
Figure 6.7: Fluorescence lifetime study of the [Rh-1]Cl/CT-DNA system for different
CP
CD
ratios. (A) Fluorescence decays. (B) Average lifetimes. (C) Relative amplitudes
of the lifetimes. I=6.5 mM (NaCl), pH=7.0 (NaCac), λex=375 nm, λem=542 nm and
T=25.0 ◦C.
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In fact, another lifetime appears, but it has a low relative amplitude (Figure
6.7C) and does not remarkably influence the average lifetime (Figure 6.7B).
To sum up: on the one hand, calorimetric and UV-vis absorption titrations
suggest an analogue interaction of [Ir-1]Cl and [Rh-1]Cl to CT-DNA. On the
other hand, both steady-state and lifetime fluorimetric titrations reveal impor-
tant differences. Diversity in the excited state of rhodium and iridium complexes
can explain such behaviour. It is important to recall here that rhodium biscyclo-
metalated complexes have 3LC as lowest excited state and iridium complexes a
3LC/3MLCT mixing state. Hence, we have a molecule, the [Ir-1]Cl, whose fluo-
rescence is highly sensitive to external variation; differently, [Rh-1]Cl excited
state is only little modified by the environment [19].
As we have previously pointed out, an increase in the fluorescence intensity
and lifetime means that the molecule is shielded from the quenching because
of the interaction with DNA. This evidence hints an insertion of the molecule
inside the DNA structure. Consequently, the most reasonably interaction is
the intercalation of the ancillary ligand, which is observed for many octahedral
compounds with aromatic ligands. However, the low aromatic extension of
2-(2’-pyridyl)benzoxazole probably does not allow a full intercalation of the
ligand. In agreement to this, the found equilibrium constants by the dif-
ferent techniques are lower in comparison with the values obtained for other
octahedral complexes whose ancillary ligands intercalate inside the basepairs,
considering also that we worked at low ionic strength (I = 6.5 mM). For in-
stance, 1.3× 106, 1.1× 106 and 1× 106 M−1 equilibrium constant values have
been observed for ∆−[Ru(bpy)2(dppz)]2+, ∆−[Ru(phen)2(dppz)]2+ [15] and
[Ru(tpy)(py)(dppz)]2+ (dppz=dipyrido[3,2-a:2’,3’-c]phenazine) [14] at I=0.15 M.
6.2.2.4 Circular dichroism
Addition of metal complex to a DNA solution provoked the decrease of the
dichroic maxima of CT-DNA, as it can be observed in Figure 6.8.
Figure 6.8: Dichroic spectra of CT-DNA for different CD
CP
ratios. (A) [Ir-1]Cl and
(B) [Rh-1]Cl. CP=5.0 × 10−5 M, CDCP =0-1.0, I=6.5 mM (NaCl), pH=7.0 (NaCac),
T=25.0 ◦C.
In addition, small peaks seem to appear above 300 nm, which could be account-
able to a weak induced dichroism proportioned by the nucleic acid to the metal
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complexes, once they interacted with the polynucleotide.
6.2.2.5 Viscometry
A remarkable decrease of ( ηη0 )
1
3 was visualized for increasing value of the metal
complexes (Figure 6.9). This effect excludes classical intercalation. However, par-
tial intercalation, which kinks the secondary structure of the nucleic acid, could
explain a decrease of the chain elongation and, consequently, the viscometric
data [20].
Figure 6.9: Viscometric data for the [Ir-1]Cl/CT-DNA and [Rh-1]Cl/CT-DNA sys-
tems for different CD
CP
ratios. CP=2.0 × 10−4 M, I=6.5 mM and T=25.0 ◦C.
6.2.2.6 DSC
Figure 6.10 reports a slight increase of the melting temperature for increasing
CD
CP
values, so a little stabilization of the double-helix structure is provided by
the presence of the metal complexes.
Figure 6.10: Melting temperature of CT-DNA for increasing CD
CP
for the [Ir-1]Cl/CT-
DNA and [Rh-1]Cl/CT-DNA systems. CP=3.0 × 10−4 M, I=6.5 mM and pH=7.0.
The resulting melting temperature enhancement (∆T=2.5-3 ◦C) is not so high
as to be associable to a full intercalation of the system, but, rather, to a partial
intercalation, in agreement with the previous results.
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6.2.3 Photoreactivity
6.2.3.1 Irradiation Study
First of all, proofs of irradiation of a complex solution were carried out and the
effect of light was checked by absorbance and NMR (Figure 6.11 and 6.12).
Figure 6.11: Irradiation of [Ir-1]Cl in deoxygenated solutions. (A) UV-vis absorption
spectra for different irradiation times (tirr=0-200 min); CD=30 µM, I=6.5 mM (NaCl),
pH=7.0. (B) 1H-NMR in D2O, CD=3.7 mM. λirr=365 nm and T=25.0 ◦C.
Figure 6.12: Irradiation of [Rh-1]Cl in deoxygenated solutions. (A) UV-vis absorption
spectra for different irradiation times (tirr=0-300 min); CD=30 µM, I=6.5 mM (NaCl),
pH=7.0. (B) 1H-NMR in D2O,  new formed peaks; CD=3.7 mM. (C) Irradiation in
CDCl3−d:  free pyboz; • shifted Rh(ppy)2 signals; CD=5.0 mM. λirr=365 nm and
T=25.0 ◦C.
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No significant variation of the iridium complex absorption spectra was obtained
at 365 nm (Figure 6.11A). Differently, the rhodium complex spectra changed
after irradiation in the UV region (Figure 6.12A).
The NMR analysis confirms that new signals appeared for [Rh-1]Cl, whereas
[Ir-1]Cl did not change upon irradiation (Figure 6.11B and 6.12B). Note that
no peak variation was observed for [Rh-1]Cl left in the dark after 24 h (Figure
6.S4). The irradiation of [Rh-1]Cl in chloroform demonstrated that the ancillary
ligand is released upon irradiation by comparison with the spectra of the free
ligand [21]. As all the proofs were performed under deoxygenated conditions,
the photorelease of the ligand is oxygen independent.
6.2.3.2 Photocleavage of plasmid DNA
Photocleavage proofs with pUC18 at 365 nm revealed a low photocleavaging
activity by the iridium complexes (Figure 6.13), which increased only at high
irradiation time (tirr). On the other hand, high photocleavage of plasmid DNA
was achieved in the presence of [Rh-1]Cl. Photocleavage increased with the
rhodium concentration (Figure 6.S5) and significant amount of linear form ap-
peared at higher irradiation time.
Figure 6.13: (A) Top: [Ir-1]Cl/pUC18 photocleavage at 365 nm. Lane 1: Molecular
weight marker. Lane 2-6: Irradiated samples at tirr=0, 50, 100, 150, 200 min. Lane 7:
Dark Control. Lane 8: Irradiated control, tirr=200 min. Bottom: [Rh-1]Cl/pUC18
photocleavage at 365 nm. Lane 1: Molecular weight marker. Lane 2: Irradiated control,
tirr=250 min. Lane 3-8: Irradiated samples at tirr=0, 50, 100, 150, 200, 250 min. (B)
Quantification of the cleavage by Eq. (2.31), Chapter 2. CP=20 µM, CD=20 µM,
[NaCl]=4.0 mM, [NaCac]=2.5 mM, pH=7.0. Incubation: Tinc=37.0 ◦C, overnight.
In order to get some information about the reaction mechanism, proofs were
carried out in the presence of scavengers of oxygenated radicals. Cleavage of
the [Rh-1]Cl/pUC18 system at λirr = 365 nm significantly decreased in the
presence of NaN3 and L−His, scavengers of singlet oxygen, and, to a lesser
extent, in the presence of superoxide dismutase, scavenger of superoxide anion
(Figure 6.14). Cleavage did not change in the presence of DMSO, scavenger of
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the hydroxyl radical.
Figure 6.14: (A) Electrophoresis of [Rh-1]Cl/pUC18 in the presence of scavengers.
Lane 1: Molecular weight marker. Lane 2: Dark Control. Lane 3: Sample left in
the dark. Lane 4: Irradiated control. Lane 5: Irradiated sample. Lane 6: Irradiated
sample + [L−His]=1.2 mM. Lane 7: Irradiated sample + [NaN3]=10 mM. Lane 8: Irra-
diated sample + [DMSO]=200 mM. Lane 9: Irradiated sample + [SOD]=1000 UmL−1.
CD=20 µM, CP=20 µM, [NaCl]=4.0 mM, [NaCac]=2.5 mM, pH=7.0, tirr=100 min,
λirr=365 nm. Incubation: Tinc=37 ◦C, overnight. (B) Quantification of the cleavage
(mean value of three independent experiments). (C) Phosphorescence of the singlet
oxygen produced by a solution of [Rh-1]Cl in D2O, irradiated at λirr = 325 nm.
Consequently, a conceivable mechanism of action would involve the excitation of
the rhodium complex, which transfers its energy to oxygen by collisions. Hence,
oxygen is excited from the triplet ground state to the singlet excited state, which
provokes DNA cleavage. Singlet oxygen was also observed by its phosphorescence
at 1270 nm by irradiation of a [Rh-1]Cl solution with a HeCd laser at 325 nm in
D2O (Figure 6.14C). Comparison with singlet oxygen production by phenalenone
under the same experimental conditions gave us the singlet oxygen quantum
yield value, which is Φ1∆g = 0.10 for the rhodium complex [22].
To confirm the result, proofs with deoxygenated samples, obtained by bubbling
argon for 15 min, were performed. An important lowering of the cleavage was
detected in comparison with the air-equilibrated samples (Figure 6.15). It follows
that the main pathway of photoreaction of the rhodium complex is oxygen-
dependent (Type II Mechanism).
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Figure 6.15: (A) Electrophoresis of [Rh-1]Cl/pUC18 with deoxygenated samples. Lane
1: Molecular weight marker. Lanes 2-6: Irradiated samples at tirr=0, 50, 100, 150,
200 min in air. Lanes 7-11: Irradiated deoxygenated samples at tirr=0, 50, 100, 150,
200 min. Lane 12: Deoxygenated dark control. Lane 13: Deoxygenated irradiated
control (tirr=200 min). CD=20 µM, CP = 20 µM, [NaCl]=4.0 mM, [NaCac]=2.5 mM,
pH=7.0, λirr=365 nm. (B) Quantification of the cleavage.
6.2.3.3 Photoadduction to Guanine
From the collected results, we have verified that irradiation of [Rh-1]Cl is the
cause of (i) singlet oxygen production and (ii) release of the ancillary ligand, be-
ing this an oxygen-independent mechanism. So, excitation of the metal complex
seems to have three different pathways: emission, non-radiative energy transfer
to triplet oxygen and slow photodissociation. The photoproduct, which reason-
ably is the Rh(ppy)2+ because of the observed release of the ancillary ligand in
1H-NMR (Figure 6.12C), could be accountable of part of the photoreactivity.
To verify it, solutions of [Rh-1]Cl in the presence of 9-methylguanine (9-MeG)
were prepared and irradiated at 365 nm for different irradiation times. Then,
the solutions were analysed by means of a high-resolution mass spectrometry
to detect the exact formula of the photoproducts. Little decomposition was
observed for the complex, even though two new peaks can be related to the
formation of adducts between the rhodium complex and 9-MeG. The signal
at 576 m/z (Figure 6.16) is due to the release of the ancillary ligand and the
formation of the covalent binding with the guanine moiety, reasonably to N7
position.
Figure 6.16: Experimental peaks of the Rh(ppy)2/9-MeG adduct and theoretical value
(squared).
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Reported studies in literature with dirhodium complexes containing photola-
bile ligands prove that they can form covalent binding with DNA via oxygen-
independent mechanism [23,24]. Unlike the previous studies found in scientific
literature, which use a monodentate photolabile ligand, the release of the che-
lating ancillary ligand from the [Rh-1]Cl system makes two coordination sites
available, which could increase the affinity strength of the metal complex to
guanine. Moreover, the release of the benzoxazole in solution could further
increase the cytotoxicity, as it is seen that many benzoxazole compounds display
anticancer activity by its own [25,26].
The list of the relevant observed peaks by mass spectrometry is reported in Table
6.3.
Table 6.3: Intensity of the observed peaks for irradiated [Rh-1]Cl/9-MeG solutions.
m/z Formula t=0 t=3h t=6h
166 [9MeG+H]+ 1.3× 105 1.2× 105 1.0× 105
607 [Rh(ppy)2(pyboz)]+ 7× 105 6× 105 5× 105
411 [Rh(ppy)2]+ 1× 105 9× 104 7× 104
788 [Rh(ppy)2(pyboz) + 9MeG + O]+ / 5× 103 1.2× 104
576 [Rh(ppy)2 + 9MeG]+ 1× 102 8× 102 1.0× 103
Thus, a further mechanism of photoreaction seems to be present for the rhodium
complex, even though it is minority respect to the oxygen-dependent pathway.
As we have previously reported, the photorelease has been observed under ni-
trogenous atmosphere; it means that the photoadduction to the guanine moiety
is an oxygen-independent mechanism.
More than that, another peak was found to increase with the irradiation time,
which is the peak at 788 m/z, corresponding to [Rh(ppy)2(pyboz)+9MeG+O]+.
In this case no release of the ligand occurs but a 9-MeG species is coordinated to
the complex, which has a new oxygen atom. Such species could be accountable
to the 8-oxoguanine form, which coordinates to the rhodium. 8-oxoguanine is
generally formed by the interaction of singlet oxygen with the guanine moiety,
which provokes the oxidation at C8 position. On the other hand, the ancillary
ligand would be coordinated to only a nitrogenous atom.
6.2.4 Cytotoxic Activity in the Dark and under Irradia-
tion
MTT proofs were performed by Dr. Busto from our Physical-Chemical Group,
testing [Ir-1]Cl and [Rh-1]Cl with the SW480 human colon cancer cell line, in
the dark and upon irradiation (20 min at 365 nm). No variation of the cytotoxic
activity was observed for the iridium complex. On the other hand, a five-
fold increase of the cytotoxic activity of [Rh(ppy)2(pyboz)]Cl was found upon
irradiation (Photoindex value PI = 5, Figure 6.17), in agreement with the
cleavage study.
186 CHAPTER 6. IR AND RH BISCYCLOMETALATED COMPLEXES 1
Figure 6.17: Percentage of SW480 cell viability for different concentrations of [Rh-1]Cl,
in the dark and irradiating at 365 nm for 20 min. Incubation time: 24 h.
The obtained IC50 are collected in Table 6.4.
Table 6.4: Cytotoxic activity of the metal complexes in the dark (IC50DARK) and
upon irradiation (IC50IRR) for 20 min at 365 nm (20 mWcm−1) and Photoindex value
(PI). 1 × 104 cells, incubation time: 24 h.
Compound IC50DARK, µM IC50IRR, µM PI
[Ir-1]Cl 0.3± 0.1 0.4± 0.1 1
[Rh-1]Cl 1.6± 0.7 0.3± 0.1 5
The cytotoxic activity results very high in the dark, as well. Even though the
results show that the complexes has not the optimal features for the PDT, they
can be useful for future synthesis of biscyclometalated complexes. In addition,
further proofs could be performed with different cell lines, in order to observe
variations of the cytotoxicity in dark conditions.
6.3 Conclusion
Two biscyclometalated complexes having iridium and rhodium as metal centers
exhibit a very similar interaction towards CT-DNA in dark conditions. The
results obtained from the different techniques suggest a partial intercalation of
the complex inside the basepairs. However, interesting differences are observed
exciting the complexes. First of all, the [Ir-1]Cl iridium complex switches on
its fluorescence in the presence of the polynucleotide, together with a notable
increase of the lifetime, whereas the [Rh-1]Cl rhodium complex did not. On
the other hand, the rhodium complex exhibits good cleavaging activity un-
der irradiation at 365 nm, whereas iridium poorly breaks plasmid DNA. The
mechanism of action mainly involves singlet oxygen production, although an
oxygen-independent pathway cannot be discarded, as the formation of a new
reactive species provoked by the release of the ancillary ligand was observed,
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even in deoxygenated conditions. Our work could be useful for the synthesis of
new complexes having similar skeleton structure, but improving singlet oxygen
production and interaction with nucleic acids by addition of new ligands.
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Supporting Information
Figure 6.S1: Normalized spectra at different CD. (A) [Ir-1]Cl/CT-DNA. Inset: track
at 360 nm. [Rh-1]Cl/CT-DNA. Inset: track at 360 nm. I=6.5 mM (NaCl), pH=7.0
(NaCac), T=25.0 ◦C.
193
194 CHAPTER 6. SUPPORTING INFORMATION
Figure 6.S2: Data treatment of the Uv-Vis Titration. [Ir-1]Cl/CT-DNA (A) Data
Treatment by Equation (2.48); (B) Scatchard Plot (Equation (2.55)). [Rh-1]Cl/CT-
DNA (A) Data Treatment by Equation (2.48); (B) Scatchard Plot (Equation (2.55)).
CD=20 µM, I=6.5 mM (NaCl), pH=7.0 (NaCac), T=25.0 ◦C.
Figure 6.S3: Data treatment of the fluorescence titration for the [Rh-1]Cl/CT-DNA
system. CD=5.0 µM, I=6.5 mM (NaCl), pH=7.0 (NaCac), T=25.0 ◦C.
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Figure 6.S4: 1H-NMR spectra of [Rh-1]Cl left in the dark in D2O. CD=5.0 mM and
T=25.0 ◦C
Figure 6.S5: (A) Photocleavage of the [Rh-1]Cl/pUC18 system at different metal
concentration. Lane 1-6: Irradiated system at CD=0, 5, 10, 20, 30, 40 µM. Lane
7: Dark control. (B) Quantification of the cleavage. CP=20 µM, [NaCl]=4.0 mM,









In Chapter 6 we observed that the Rh biscyclometalated [Rh-1]Cl complex ex-
hibits good photocleavaging activity upon irradiation in the UV region, whereas
the [Ir-1]Cl Ir complex, having the same CN and NN ligands, does not.
However, the main disadvantage of Rh complexes is their high absorption energy,
an unfavorable condition for PDT. Differently, cyclometalated Ir complexes ex-
hibit lower absorption energy because of the presence of a peak in the 400-500 nm
region, which could allow photoactivation in a less-damaging and better tissue
penetrating wavelength region.
Hence, further investigation was addressed to observe the effect of the ligands on
the photoreactivity of cyclometalated complexes of Ir and Rh. Seven new biscy-
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clometalated complexes have been synthesized and fully characterized, varying
the NN and the CN ligands and the metal center.
Photoreactivity was tested with plasmid pUC18 DNA irradiating in the ultravio-
let and visible region. Then, MTT assays on SW480 cancer cells were performed
in the dark and upon irradiation. High photocleavage yields were observed for
the Rh complexes, but only the Ir complexes could reach longer wavelength of
photoactivation (λirr = 500 nm). The increase of the aromatic size of the ligands
resulted in an extension of the absorption in the visible region and, consequently,
their photoactivity was tested in this wavelength region.
In addition, focus was given to the interaction with oligonucleotides. In particu-
lar, we tested the interaction towards various G-Quadruplex (G4) structures, in
order to detect possible binding selectivity, depending on the ligand type. Titra-
tions were carried out with the Ir complexes and three different oligonucleotides:
double-stranded DNA of self-complementary 26-mer (52B), G4 c-myc (Pu22)
and human telomere (Tel22) sequences in potassium salt excess. The affinity of
the complex towards DNA was evaluated by means of Uv-vis absorption, circular
dichroism in the UV visible region, steady-state and time-resolved fluorescence.
The obtained equilibrium constants hinted at selectivity of the complex towards
the quadruplex moieties, in particular for c-myc proto-oncogene quadruplex.
FRET assays showed stabilization of such structures, with the highest effect
observed upon increase of the aromatic extension of the ligand.
7.1 Materials and Methods
7.1.1 Materials
IrCl3 ·xH2O and RhCl3 ·xH2O have been purchased from Johnson Matthey. Or-
ganic compounds phenylpyridyne, phenylboronic acid and 1-bromoisoquinoline
were from ACROS, while 2-pyridylcarbaldheyde 2-quinolinylcarbaldheyde and
2-aminothiophenol were from Sigma-Aldrich and used without further purifica-
tion. Seven new complexes have been prepared, namely the [Ir-2]Cl, [Ir-3]Cl,
[Ir-4]Cl and [Ir-5]Cl Ir complexes and the [Rh-2]Cl, [Rh-4]Cl and [Rh-5]Cl
Rh complexes. The synthesis procedure is presented in Section 7.2.1 and the
characterization data are listed in Section 7.4. Stock solutions of the complexes
were prepared in bidistilled water, whereas working solutions in two different
buffer media: (i) I=6.5 mM (NaCl) and pH = 7.0 (NaCac); this buffer was
used in the study of the photoreactivity, and (ii) I=0.1 M (KCl) and potassium
phosphate buffer at pH=7.0 for the titrations with oligonucleotides. Stock so-
lutions of oligonucleotides were prepared in KCl buffer (I = 0.1 M, pH = 7.0),
heating the solution above the melting temperature of the quadruplex or duplex
structures, and waiting overnight the solution to return to room temperature.
The solutions were spectrophotometrically standardized.
7.1.2 Methods
All synthetic manipulations were carried out under an atmosphere of dry, O-free
N2 using standard Schlenk techniques, as explained in Chapter 2, Section 2.1.
The solvents were distilled from the appropriate drying agents and degassed
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before use. Elemental analyses were performed with a LECO CHNS-932 micro-
analyzer. IR spectra were recorded on a Nicolet Impact 410 (within the frequency
range 4000-400 cm−1), and in a Jasco FT/IR-4200 spectrophotometers.
NMR samples were prepared under a N2 atmosphere by dissolving the suitable
amount of compound in 0.5 mL of the respective oxygen-free deuterated solvent,
and the spectra were recorded at 298 K on a Varian Unity Inova-400 (399.94 MHz
for 1H and 100.6 MHz for 13C). Typically, 1D 1H-NMR spectra were acquired
with 32 scans into 32 K data points over a spectral width of 16 ppm. 1H and
13C chemical shifts were internally referenced to tetramethylsilane via the resid-
ual 1H and 13C signals of the corresponding solvents, according to the values
reported by Fulmer et al. [1]. 2D NMR spectra such as 1H-1H gCOSY, 1H-1H
NOESY, 1H-13C gHSQC, and 1H-13C gHMBC were recorded using standard
pulse sequences. The probe temperature (±1 K) was controlled by a standard
unit calibrated with methanol as a reference. All NMR data processing was
carried out using MestReNova v10.0.2-15465.
Singlet oxygen emission was detected by means of an Edinburgh Fluorimeter
equipped with a Hamamatsu RC5509-72 detector, using a CW HeCd Laser as
light source (λex = 325 nm). To ensure that no interfering light arrived at the
detector, two filters were inserted in the emission path, namely the 850 nm and
the 1000 nm cut-off filters. Photoirradiation and cleavage study was performed
according to Chapter 2, Sections 2.10 and 2.11.
Titrations of the metal complex with oligonucleotides were performed preparing
solutions of constant metal complex concentration (CD) and increasing DNA con-
centration (CP ), analysing the mixtures with different techniques. Absorption
spectra were recorded with a Perkin Elmer Lambda 650 spectrophotometer in
the 200-800 nm range. UV and visible circular dichroism spectra were recorded
by means of a Jasco J-715. For the oligonucleotide region (220-305 nm), 1 cm
and 2 mm path length quartz cuvettes were used, whereas for the visible region
(310-500 nm), a 2 cm path length quartz cuvette was used. For all the dichroic
spectra, 4 accumulations of the signal were averaged out. Corrected steady-state
fluorescence spectra were acquired in 1 cm quartz cuvettes with an Edinburgh
F980 fluorimeter using right angle geometry. Fluorescence decays were mea-
sured in air-equilibrated solutions for excitation at 331 nm and 465 nm (Horiba
led) and 407 nm (Hamamatsu pulsed laser with 1 MHz repetition rate) using a
time-correlated single-photon counting system (TCSPC) (IBH Consultants Ltd.,
Glasgow, UK) with a resolution of 55 ps and 1.755 ns per channel. Photons were
detected in right angle configuration with a cut-off filter. Fluorescence decay
profiles were analysed with a least-squares method, using multiexponential de-
cay functions (Equation 7.1) and deconvolution of the instrumental response
function. The software package was provided by IBH Consultants Ltd.






The relative amplitude fi, also known as the fractional intensity, and the average











Multiwavelength global analysis of the titrations was performed by ReactLab
program, choosing a 1:1 or a 2:1 metal complex:oligonucleotide model.
Stabilization study of G-Quadruplex was performed in a 7500 Real Time PCR
System (Applied Biosystems), setting λex = 492 nm and λem = 516 nm. For
our study, 0.2 µM oligonucleotide covalently linked to a donor (fluorescein) and
an acceptor (TAMRA, a rhodamine) was heated in the presence of an excess of
metal complex (10 µM), with a temperature ramp rate of 1 ◦C min−1 (I = 0.11 M
([LiCl] = 90 mM, [KCl] = 10 mM, [LiCac] = 10 mM), pH = 7.2).
7.2 Results and Discussion
7.2.1 Synthesis Procedure
The synthesis of the complexes was carried out under the supervision of Prof.
Espino of the Inorganic Chemistry Lab. (Universidad de Burgos). Eight
different complexes of general formula [M(CN)2(NN)]Cl have been planned,
the [Ir-2]Cl, [Ir-3]Cl, [Ir-4]Cl and [Ir-5]Cl Ir complexes and the [Rh-2]Cl,
[Rh-3]Cl, [Rh-4]Cl and [Rh-5]Cl Rh complexes (Figure 7.1).
Figure 7.1: The eight planned biscyclometalated complexes and their ligands.
NN ancillary ligands: pybtz = 2-(2’-pyridyl)benzothiazole, qibtz = 2-(2’-
quinolinyl)benzothiazole. HCN proligands: ppy = 2-phenylpyridine, piqi = 2-
phenyilisoquinoline.
The scheme of the synthesis is reported in Figure 7.2.
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Figure 7.2: Scheme of the biscyclometalated complexes synthesis.
The new-synthesized Ir and Rh compounds differ by the aromatic size of the CN
and NN ligands. On the one hand, aromaticity enhancement of both CN and NN
ligands should favour the π-stacking interaction towards nucleic acids, increasing
the affinity between the reactants [2]. In addition, aromatic extension should
shift the absorption spectra to longer wavelengths, allowing more achievable
wavelengths for PDT. For an analogue reason, we changed the oxygen (present
in the NN benzoxazole ligand, in Chapter 6) for the S heteroatom, which theo-
retically stabilizes the LUMO, obtaining low absorption energy [3].
First of all, an important consideration concerns the structural conformation
of the complexes. Actually, a biscyclometalated metal complex contains 2 CN
ligands and a NN ancillary ligand and this theoretically implies the presence
of cis-trans isomerism. Three isomers are possible: the trans-N,N cis-C,C, the
trans-C,C cis-N,N and the cis-N,N cis-C,C (Figure 7.3).
Figure 7.3: Possible cis- trans- isomers of biscycometalated compounds.
However, as the M-C bonds display strong trans effect, the trans-C,C conforma-
tion is impeded because of the high electronic density which would be provided
to the same d orbital of the metal center. So, the most thermodinamically stable
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isomer results to be the trans-N,N cis-C,C one, where M-C groups can supply
electronic density to the NN ancillary ligand by the trans effect.
The complexes depicted were prepared following the classical two-steps proce-
dure reported by Nonoyama [4]. In the first step, RhCl3 · xH2O or IrCl3 · xH2O
were reacted with the proligands HCN to produce the respective chlorido-bridged
dimeric Rh and Ir complexes [M(µ−Cl)(CN)2]2 (M = Rh or Ir).
The spatial disposition of the ligands along the dimer complex can be different
(Figure 7.4).
Figure 7.4: Diastereoisomeric forms of the dimeric complexes.
Four different forms can be obtained, which are (∆,∆), (Λ,Λ), (Λ,∆) and (∆,Λ)
complexes. For steric reasons the (∆,Λ) and (Λ,∆) meso forms are disadvantaged
due to the fact that the hydrogens of the CN ligands are sterically hindered,
namely the H in C6 and C10 of ppy and piqi ligands, respectively. Hence, the
most favourable forms are the (∆,∆) and (Λ,Λ) racemate forms [5].
Afterwards, the appropriate ancillary ligand, NN, was reacted with the desired
Rh(III) or Ir(III) starting material to obtain the chloride salts of new derivatives
with general formula [M(CN)2(NN)]Cl (M = Ir, Rj; NN = pybtz, qibtz; CN
= ppy, piqi) through a bridge splitting reaction. The ancillary ligands were
prepared by reaction of the 2-aminothiophenol and 2-pyridylcarboxaldehyde or
2-quinolinylcarboxaldehyde in the presence of oxygen [6]. The reaction evolves
to a first imine intermediate, then cyclization of the chain occurs followed
by a further oxydation which brings to 2-pyridylbenzothiazole (pybtz) and 2-
quinolinylbenzothiazole (qibtz). Purification is needed for the separation of
subproducts, using a silica gel column (eluent AcOEt:Hexane).
The reaction between the dimer and the ancillary ligand yields two molecules of
monomeric compound (Figure 7.5).
Figure 7.5: Enantiomeric ∆ and Λ forms of a [M(CN)2(NN)]+ complex.
The complexes were isolated as racemic mixtures (∆ and Λ) of yellow to red
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solids with good yield and purity according to analytical and spectroscopic data.
Moreover, they are soluble in common organic solvents, such as EtOH, CH3CN
and CH2Cl2 and slightly soluble in water and methanol.
The synthesis work led to seven complexes from the eight planned compounds.
We did not obtain [Rh-3]Cl with acceptable purity degree, so it was not further
characterized.
7.2.2 Characterization
All the characterization data are reported in Section 7.4.
We cleared the structures up by means of various techniques. First of all, high-
resolution mass spectrometry allows the identification of the exact formula of
the compound, checking the experimental molecular weight and the isotopic
distribution with the theoretical one. Then, bidimensional NMRs were employed
to obtain structural information of the complex. With the COSY technique we
assembled the protons of each aromatic group. Note that the CN ligands are
surrounded by different chemical environments; this means that the protons are
not equivalent and two sets of signals can be detected. With the NOESY we
were able to visualize the geometric distribution of the ligands around the metal.
For example, the NOESY spectra for [Rh-4]Cl complex is reported in Figure
7.6.
Figure 7.6: Example of assignment of the spatially correlated peaks by the NOESY
bidimensional spectra.
For biscyclometalated complexes it is possible to individuate two triangular
interactions between the protons of the ancillary ligand and the protons of the
CN ligands. For example, the triangular interactions in the [Rh-4]Cl structure
can be found for the 16-10’-b and for the 16’-10-m protons. In addition, for the
2-phenylisoquinoline CN ligand we can observe two signals between 4-13 and
7-9 atoms which allows to distinguish the signals of the aromatic groups from
each CN ligand. From these data we drew the structure up.
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7.2.2.1 Crystal Structure by X-ray Diffraction
Single crystals of [Ir-5]PF6 · CH2Cl2 and [Rh-2]PF6 · CH3OH suitable for X-
ray diffraction analysis were obtained by slow diffusion of a saturated NH4PF6
solution in methanol into a solution of [Ir-5]Cl and [Rh-2]Cl in dichloromethane.
For [Rh-2]Cl, two drops of H2O were also added. The acquired data are reported
in Table 7.S1, Supporting Information. Both [Ir-5]PF6·CH2Cl2 and [Rh-2]PF6·
CH3OH crystallize in the monoclinic space group P21/n. The corresponding
unit cells show two pairs of the enantiomers (∆) and (Λ) resulting from helical
chirality inherent to trischelate octahedral metal complexes, along with four
PF6– counterions, four CH2Cl2 and four CH3OH molecules for [Ir-5] and [Rh-
2], respectively. For the [Ir-5] structure, both PF6– counterion and the ancillary
ligand display positional disorder (see Figure 7.S1, Supporting Information). The
Ir center displays a slightly distorted octahedral coordination geometry with the
expected cis-C,C and trans-N,N mutual disposition for the piqi ligands, whereas
for the Rh center such a distortion is less evident. The ORTEP diagrams for
(∆)-[Ir-5]+ and (∆)-[Rh-2]+ are depicted in Figure 7.7.
Figure 7.7: ORTEP diagram for (A) (∆)-[Ir-5]+ and (B) (∆)-[Rh-2]+ forming the
asymmetric unit of racemic [Ir-5]PF6 ·CH2Cl2 and [Rh-2]PF6 ·CH3OH, respectively.
Thermal ellipsoids are shown at the 30 % probability level. The counterion (PF6–) and
solvent molecules (CH2Cl2 and CH3OH) have been omitted for the sake of clarity
Selected bond lengths and angles with estimated standard deviations (in brackets)
are gathered in Table 7.1 and Table 7.2.
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Table 7.1: Selected parameters, distances (Å) and angles (°) for the X-Ray structure
of [Ir-5] complex. Standard deviations in brackets.
Distances Angles
Atoms Value Atoms Value
Ir(1)-C(27) 1.997(5) C(27)-Ir(1)-C(42) 82.62(17)
Ir(1)-C(42) 2.005(4) C(27)-Ir(1)-N(4) 94.13(17)
Ir(1)-N(4) 2.059(4) C(42)-Ir(1)-N(4) 79.44(16)
Ir(1)-N(3) 2.052(4) C(27)-Ir(1)-N(3) 79.71(17)
Ir(1)-N(1) 2.221(3) C(42)-Ir(1)-N(3) 96.01(16)










Table 7.2: Selected parameters, distances (Å) and angles (°) for the X-Ray structure
of [Rh-2] complex. Standard deviations in brackets.
Distances Angles
Atoms Value Atoms Value
Rh(1)-C(23) 1.994(4) C(23)-Rh(1)-C(30) 87.89(14)
Rh(1)-C(30) 1.995(4) C(23)-Rh(1)-N(3) 81.48(14)
Rh(1)-N(3) 2.032(3) C(30)-Rh(1)-N(3) 92.75(14)
Rh(1)-N(4) 2.042(3) C(23)-Rh(1)-N(4) 93.55(14)
Rh(1)-N(1) 2.180(3) C(30)-Rh(1)-N(4) 81.26(14)










Intermolecular distances were measured by Mercury 3.0 program. Con-
cerning the [Ir-5] structure, the Ir−Cpiqi and Ir−Npiqi bond distances lie in
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the expected ranges for phenylpyridanate type ligands, that is, very close to
2Å [7, 8]. The bond lengths for the ancillary ligand are significantly longer
due to the strong trans influence attributed to the C atoms of the CN ligands,
Ir(1)-N(1) = 2.221(3)Å and Ir(1)-N(2) = 2.232(2)Å [9,10]. The bite angle for
the NN ligand, N(1)-Ir(1)-N(2) = 74.91(11)°, is comparable to those previously
reported for five-membered N-Ir-N iridacycles in analogous derivatives, whereas
the C-Ir-N bite angles for the CN ligands, C(27)-Ir(1)-N(3) and C(42)-Ir(1)-
N(4), are also standard (79.71° and 79.44° respectively) [11]. The 3D crystal
packing is hold down by intermolecular hydrogen bonds, (C(51)-H(51A)—F(3),
C(37)-H(37)—F(4) and C(5)-H(5)—F(4)), anion-π (PF6– and quinoline ring)
and CH-π (C(30)-H(30)—isoquinolinyl) contacts and offset π − π stacking in-
teractions between isoquinolinyl and benzothiazolyl units (see Tables 7.S2-7.S5,
Supporting Information).
Regarding the [Rh-2] crystal structure, similar lengths of the bonds between
the metal and the ligands were found (Rh−Cppy Rh−Nppy close to 2Å, whereas
Rh(1)-N(1) = 2.180(3)Å and Rh(1)-N(2) = 2.196(2)Å). The same considera-
tion can be advanced for the angles (for the ancillary ligand N(1)-Rh(1)-N(2) =
76.23(12)°, and for the CN ligands C(23)-Rh(1)-N(3) = 81.48(12)° and C(30)-
Rh(1)-N(4) = 81.26(14)°). Differently from the iridium structure, no relevant
π-π stacking and CH-π interaction have been found, probably because the lower
aromatic extension, which does not provide strong intermolecular interactions
between the metal complexes. However, intermolecular hydrogen bonds (C(15)-
H(15)—F(2), C(16)-H(16)—F(2), C(2)-H(2)—F(6) and C(13)-H(13)—O(1)) and
anion-π contacts (PF6–-ppy) are found and they are listed in Tables 7.S6 and
7.S7, Supporting Information.
7.2.3 UV-vis Absorption Spectra
Photophysical properties of the complexes were analysed in water. The absorp-
tion spectra of the complexes are drawn in Figure 7.8.
Figure 7.8: UV-vis absorption spectra of the metal complexes in water. (A) Ir com-
plexes. (B) Rh complexes.
The main peaks of the absorption spectra are reported in Table 7.3.
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Table 7.3: Wavelengths of the absorption maxima of the metal complexes; the corres-
ponding molar absorption are reported in brackets. sh=shoulder, t=tail.
Complex λ, nm (10−4ε, M−1cm−1)
[Ir-2]Cl 253 (4.0), 324 (2.1), 373sh (0.8), 463t (0.1)
[Ir-3]Cl 256 (4.4), 298(2.5), 359(2.2), 369(2.3), 488t (0.1)
[Ir-4]Cl 233 (4.6), 290 (3.1), 331 (2.5), 373sh (1.2), 429 (0.6), 525t (0.1)
[Ir-5]Cl 258 (3.9), 297 (3.2), 354 (2.9), 370 (2.7), 420sh (1.0), 530t (0.2)
[Rh-2]Cl 257 (3.7), 312 (2.3), 334 (2.1)
[Rh-4]Cl 230sh (6.4), 288 (3.4), 334 (3.1), 408 (0.8)
[Rh-5]Cl 230 (5.6), 289 (3.0), 350 (2.9), 405sh (0.7)
As we reported in Chapter 6, biscyclometalated complexes exhibit different
peaks associated to different electronic transitions [12]. Bands having molar
absorption coefficients higher than 30 000 M−1cm−1 at λ < 300 nm are related
to high energy spin allowed 1LC transitions, whereas peaks at λ > 300 nm are
due to spin allowed 1MLCT and spin forbidden 3LC. For longer wavelength
a very small and broad tail is visible for the iridium complexes (λ > 450 nm),
which is related to the spin forbidden 3MLCT band. For rhodium complexes no
3MLCT tail is visible above 450 nm and it is in agreement with the fact that
3LC is in general the lowest state of Rh complexes, whereas Ir complexes exhibit
a mixing of both 3MLCT and 3LC transitions [13]. From the collected data,
the CN piqi and NN qibtz ligands have the absorption spectra shifted to longer
wavelengths, due to the extension of the aromaticity of the system.
7.2.4 Luminescence
Normalized emission spectra are reported in Figure 7.9.
Figure 7.9: Emission spectra of the metal complexes in water. λex=340 nm
[Ir-2]Cl, 369 nm [Ir-3]Cl, 365 nm [Ir-4]Cl, 360 nm [Ir-5]Cl, 340 nm [Rh-2]Cl, 370 nm
[Rh-4]Cl, 390 nm [Rh-5]Cl.
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Concerning the emissive properties, they are listed in Table 7.4
Table 7.4: Luminescence properties of metal complexes in water. Φ is the fluorescence
quantum yield, τ is the fluorescence lifetime (in brackets the fractional intensity calcu-
lated according to Equation (7.2)). For the lifetime measurements, λexc=331 nm for
[Ir-2]Cl, [Ir-4]Cl, [Rh-2]Cl and [Rh-4]Cl; λexc=373 nm for [Ir-3]Cl and [Ir-5]Cl.
Complex λex, nm λem,nm Φ τ,ns
[Ir-2]Cl 335 620 0.0023 13.1 (0.72), 320 (0.28)
[Ir-3]Cl 357, 369 665 0.0010 15.9 (0.92), 130 (0.08)
[Ir-4]Cl 335 625 0.0028 31.1 (0.79), 389 (0.21)
[Ir-5]Cl 358 675 0.0023 15.5 (0.90), 172 (0.10)
[Rh-2]Cl 312, 332 556 0.0048 1470
[Rh-4]Cl 335 578, 613 0.0026 2150
[Rh-5]Cl 350 585, 614 0.0004 n.d.
Changing the metal centre, the CN cyclometalated ligand and the NN ancil-
lary ligand allows tuning the emission maximum of the complexes from 540 to
675 nm. In particular, Ir complexes exhibit fluorescence at longer wavelengths.
Comparing the spectra of [Ir-2]Cl, [Ir-3]Cl, [Ir-4]Cl and [Ir-5]Cl, qibtz ligand
shifts the fluorescence at longer wavelengths compared to pybtz. It agrees with
the increase of the electron-acceptor character of the NN ligand. Actually the in-
crease of the aromaticity of the ancillary ligand can better delocalize the electron
in the MLCT transition, diminishing the energy of the excited state, as recently
observed for other iridium complexes [14]. Interestingly, from our data set, the
NN ancillary ligand has stronger influence on the fluorescence of the Ir complex
compared to the cyclometalated ligand. On the contrary, the CN ligand mostly
affects the shift of emission peak for the Rh complexes. This result agrees with
literature data, where a large effect is observed for rhodium complexes changing
the CN ligand [15] and low modification is obtained varying the ancillary NN
moiety [16, 17]. So, the ancillary ligand plays an important role in the excited
state of the Ir complexes, whereas the CN ligand influences the excited state of
the Rh species. In addition, Rh complexes exhibit structured peaks, whereas Ir
complexes have a broad band.
All these differences support the diversity in the excited states for the Ir and
Rh centers. Actually, the metal center greatly influences the excited state of an
organometallic complex: the different nature of the metal and its intrinsic pro-
perties (oxidation number and orbital size) mainly determines the lowest excited
state (MC or MLCT) [18]. Mutually, ligands can also influence the excited state
of a species, concurring to the splitting ∆ of the metal orbitals (Figure 7.10A),
following the spectrochemical series. Hence, the ligand can influence the MC or
the MLCT states, or promote other transitions, such as the LLCT and LC ones.
Figure 7.10 outlines the excitation and emission pathways of a metal complex.
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Figure 7.10: Possible absorption and emission mechanisms of a metal complex.
Structured peaks are typical of spin forbidden 3LC transition, and broad bands
of 3MLCT transition. So, for the Rh complexes the lowest excited state seems to
be a 3LC transition, as generally observed for the cyclometalated Rh species [19].
For Ir complexes, a 3MLCT process is hypothesized to be the lowest energy
transition. Actually, a recent published work reports that the new synthesized
[Ir-2]PF6 complex has 3MLCT/3LLCT as lowest excited state [3].
The fluorescence quantum yield was determined by comparison with the emission
of a reference (Ru(bpy)32+, Φ = 0.028) under the same experimental conditions.
Quantum yield in air-equilibrated water is low for all the complexes (Table 7.4).
Interestingly lifetime data of the complexes show that a different trend occurs for
Rh and Ir complexes: the Rh [Rh-2]Cl and [Rh-4]Cl complexes exhibited the
longest lifetimes. Notably, the change of the heteroatom from oxygen to sulphur
greatly influences the lifetime, being τ = 540 ns for [Rh-1]Cl (from Chapter 6)
and τ = 1470 ns for [Rh-2]Cl.
Another found difference is the variation of the lifetime in different solvents.
For Ir complexes, an increase of the lifetime occurs following the trend H2O <
CH3CN < CH2Cl2 (Figure 7.11A). On the other hand, Rh complexes display
an opposite behaviour (Figure 7.11B).
Figure 7.11: Examples of fluorescence decays in different solvents. (A) [Ir-3]Cl. (B)
[Rh-2]Cl.
Table 7.5 reports the lifetimes of the metal complexes in different solvents.
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Table 7.5: Fluorescence lifetimes of the metal complexes in different solvents (τ , ns; in
brackets the fractional intensity calculated according to Equation (7.2)). λexc=331 nm
for [Ir-1]Cl, [Ir-2]Cl, [Ir-4]Cl, [Rh-1]Cl, [Rh-2]Cl and [Rh-4]Cl; λexc=373 nm for
[Ir-3]Cl and [Ir-5]Cl.
Complex H2O CH3CN CH2Cl2
[Ir-1]Cl(1) 10.3 (0.90), 217 (0.10) 42.3 110
[Ir-2]Cl 13.1 (0.72), 320 (0.28) 58.5 (0.79), 303 (0.21) 170
[Ir-3]Cl 15.9 (0.92), 130 (0.08) 91 222
[Ir-4]Cl 31.1 (0.79), 389 (0.21) 89 185
[Ir-5]Cl 15.5 (0.90), 172 (0.10) 81.2 198
[Rh-1]Cl(1) 540 165 155
[Rh-2]Cl 1470 480 870
[Rh-4]Cl 2150 338 874
(1) from Chapter 6
These results concur well with the nature of the lowest electronic states of
the complexes, as fluorescence lifetimes from ligand centered transitions increase
with the solvent polarity, and lifetimes from CT transitions decrease with solvent
polarity [20]. In addition, emission spectra of Ir complexes are less broad in
apolar solvents, whereas the Rh species have little changes in the structured
peaks and they do not change their broadness (Figure 7.S2).
An important point is the dual emission observed for Ir complexes. The Ir
dual emission can hardly be associated to impurity. First of all because dual
emission is lost in organic solvent (it is still present only for [Ir-2]Cl in CH3CN).
Another indication that impurity can be ruled out is the unchanging of excitation
spectra varying the emission wavelength (an example is reported in Figure 7.S3
for [Ir-4]Cl) [21]. Two lifetimes could be accountable to an aggregation effect
in water, but absorption study excludes it at low concentration (see Section
7.2.6). Dual emission of cyclometalated complexes is a controversial theme in
literature: two lifetimes for Ir biscyclometalated complexes and only one for Rh
complexes are often reported in literature [22,23], but total agreement cannot be
found [13,24,25]. However, in the last years several articles have been published
reporting dual phosphorescence of Ir complexes [21,26]. Dual emission seems to
occur for the very close energy of the 3LC and 3MLCT states [21]. The energy
difference between the states strongly depends on the solvent, and changing it
can provoke a variation of the energy of the LC and MLCT excited electronic
states [27, 28]. In effect, our results show two lifetimes having one order of
magnitude difference, and it has been reported in literature that the relaxation
of 3LC is approximately ten-fold slower than the relaxation of 3MLCT [29].
7.2.5 Singlet Oxygen Production
Detection of singlet oxygen was carried out in the ISOF center of Bologna, under
the supervision of Dr. Ilse Manet. Singlet oxygen production was estimated by
detection of phosphorescence at 1270 nm in D2O, irradiating the metal complex
solutions at 325 nm (HeCd laser). The absorption was 0.30 at 325 nm for the
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samples and the reference (phenalonone, whose singlet oxygen quantum yield is
Φ1∆g = 1.0 [30]), ensuring an equal amount of absorbed photon. For [Rh-5]Cl
it was not possible to obtain any spectra because of its low solubility in water,
while for [Ir-5]Cl it was not measured. The highest Φ1∆g values were obtained
for [Rh-2]Cl and [Rh-4]Cl (Figure 7.12A and Table 7.6), while for iridium
complexes the signal was lower or absent.
Figure 7.12: (A) Singlet oxygen phosphorescence in the presence of rhodium metal
complexes in D2O. (B) Correlation between fluorescence lifetime and singlet oxy-
gen production; Φ1∆g value of [Rh-1]Cl is taken from Chapter 6, Ru(bpy)3
2+ and
Ru(phen)32+ Φ1∆g values are taken from [31].





(1) from Chapter 6
This result is noteworthy for the reason that the highest values of singlet oxygen
quantum yield are obtained for the complexes displaying the largest lifetime in
the set (see Table 7.4). In effect, a linear correspondence between the lifetime and
the Φ1∆g was found (Figure 7.12B), agreeing well, also, with the singlet oxygen
production of two well known compounds, namely Ru(bpy)32+ (Φ1∆g = 0.22
with τ = 1.0 µs) and Ru(phen)32+ (Φ1∆g = 0.24 with τ = 1.1 µs) in the same
solvent (D2O) [31]. Note that a long lifetime means an enhancement of the
probability that the metal complex strikes an oxygen molecule in its excited
state.
7.2.6 Dimerization
Dimerization tests in buffer were carried out to observe the presence of possible
dimer/aggregate for high complex concentrations. At I = 6.5 mM no deviation
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in the absorbance linearity or in the shape of the absorption spectra was detected
for [Ir-2]Cl, [Ir-3]Cl and [Rh-2]Cl (Figure 7.S4) and small variations were ob-
served for [Ir-4]Cl and [Rh-4]Cl. However, important variations in the spectra
appeared for the [Ir-5]Cl and [Rh-5]Cl complexes for increasing CD, and the
data treatment by means of Equation (2.67) revealed a dimerization process
(Figure 7.S5). In effect, X-Ray structure showed stacking interactions between
the aromatic rings for [Ir-5]Cl (see Table 7.S2), whereas, such interaction was
not observed for [Rh-2]Cl. Although direct relationship between crystalline and
solute states cannot be advanced, this result could confirm the tendency of larger
aromatic compounds to associate to give dimeric systems.
Data treatment was performed by means of the dimerization equation derived
in Chapter 2, Section 2.2.16, considering the Reaction (7.4).
2 D
Kagg−−−→←−−− D2 (7.4)
Table 7.7 reports the obtained dimerization constants (Kagg).
Table 7.7: Dimerization constants of the complexes obtained by Equation (2.67), Chap-









High dimerization constants were obtained for the [Ir-5]Cl and [Rh-5]Cl, which
are one order higher respect to the Kagg of [Ir-4]Cl and [Rh-4]Cl. However,
the low concentrations employed in the photoreactivity experiments and in the
titrations guarantee that the predominant species in solution are the monomeric
forms.
7.2.7 Photoreactivity
7.2.7.1 Photocleavage of pUC18 Plasmid DNA
The photoreactivity of the metal complexes was evaluated by the conversion of
the supercoiled natural form (Form I) of plasmid pUC18 DNA to the circular
(Form II) and linear (Form III) forms, detected by electrophoresis. Irradiation
was carried out at 365 nm (UV region, Figure 7.13), 435 nm (visible blue region,
Figure 7.14) and 500 nm (visible cyano-green region, Figure 7.15) and tirr =
100 min (CDCP = 1, with CP = 20 µM in nitrogenous bases). The quantification
of the cleavage by means of Equation (2.31), Chapter 2, is reported in Figure
7.16. Two independent electrophoretic assays were performed at every irradiation
wavelength and a mean value is reported.
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Figure 7.13: Photocleavage of the metal complexes/pUC18 systems in the dark (D) and
irradiated (I) at λ = 365 nm and tirr = 100 min. Lane 1: Control in the dark. Lane 2:
Irradiated control. Lane 3-4: [Ir-2]Cl. Lane 5-6: [Ir-3]Cl. Lane 7-8: [Rh-2]Cl. Lane
9-10: [Rh-4]Cl. Lane 11-12: [Rh-5]Cl. Lane 13-14: [Ir-4]Cl. Lane 15-16: [Ir-5]Cl.
CD=20 µM; CP=20 µM; [NaCl]=4.0 mM; [NaCac]=2.5 mM.
Figure 7.14: Photocleavage of the metal complexes/pUC18 systems in the dark (D) and
irradiated (I) at λ = 435 nm and tirr = 100 min. Lane 1: Control in the dark. Lane 2:
Irradiated control. Lane 3-4: [Ir-2]Cl. Lane 5-6: [Ir-3]Cl. Lane 7-8: [Rh-2]Cl. Lane
9-10: [Rh-4]Cl. Lane 11-12: [Rh-5]Cl. Lane 13-14: [Ir-4]Cl. Lane 15-16: [Ir-5]Cl.
CD=20 µM; CP=20 µM; [NaCl]=4.0 mM; [NaCac]=2.5 mM.
Figure 7.15: Photocleavage of the metal complexes/pUC18 systems in the dark (D) and
irradiated (I) at λ = 500 nm and tirr = 100 min. Lane 1: Control in the dark. Lane 2:
Irradiated control. Lane 3-4: [Ir-2]Cl. Lane 5-6: [Ir-3]Cl. Lane 7-8: [Rh-2]Cl. Lane
9-10: [Rh-4]Cl. Lane 11-12: [Rh-5]Cl. Lane 13-14: [Ir-4]Cl. Lane 15-16: [Ir-5]Cl.
CD=20 µM; CP=20 µM; [NaCl]=4.0 mM; [NaCac]=2.5 mM.
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Figure 7.16: Quantification of the cleavage at λirr=365 nm, 435 nm and 500 nm,
tirr=100 min. CD=20 µM; CP=20 µM; [NaCl]=4.0 mM; [NaCac]=2.5 mM.
From the collected experiments, we found that:
• at 365 nm high cleavage was observed in the presence of all the complexes
except for the [Ir-2]Cl iridium complexes. In particular, high cleavage was
observed for all the Rh complexes, with significant formation of Form III
of plasmid DNA. It concurs well with the fact that we found the highest
singlet-oxygen production. High cleavage was obtained also in the presence
of [Ir-5]Cl, with a very high formation of Form III;
• at 435 nm significant cleavage of plasmid DNA is still present for both Ir
and Rh species;
• at 500 nm the decrease of the cleavage is relevant for samples containing
the Rh complexes, whereas for the solutions with Ir complexes significant
cleavage is still present. Activation in the green visible region is possible
thanks to the presence of the above mentioned tail in the absorption spectra
of the Ir complexes, in the 500 nm region (Figure 7.8A).
Hence, despite the Rh complexes displayed the highest values of singlet oxygen
quantum yield, their absorption spectra is not compatible with photoactivation
above λ = 450 nm. On the contrary, for Ir complexes the singlet oxygen quantum
yield is lower, but the higher molar absorption coefficient associated to the
3MLCT transition, allows the activation in the green region, more interesting
for PDT.
7.2.7.2 Photoreactivity with Cell Line and Cellular Uptake
The complexes have been tested with the SW480 cancer cell line under irradiation
in the ultraviolet region with a lamp (maximum around 365 nm), while the
control consisted of treated cell kept in the dark. The proofs were performed by
Dr. Natalia Busto from the Physical Chemistry laboratory of Universidad de
Burgos. An increase in the cytotoxic effect was observed upon irradiation for the
majority of the complexes, in particular for the [Ir-3]Cl and [Rh-4]Cl (Table
7.8). However, the IC50 values are also low in dark conditions, an undesirable
property for a photosensitizer.
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Table 7.8: Cytotoxic activity of the metal complexes in the dark (IC50DARK) and
upon irradiation (IC50IRR) for 20 min at 365 nm (20 mWcm−1) and Photoindex value
(PI). 1 × 104 cells, incubation 24 h.
Compound IC50DARK, µM IC50IRR, µM PI
[Ir-2]Cl 1.6± 0.2 0.5± 0.1 3
[Ir-3]Cl 1.4± 0.2 0.3± 0.1 5
[Ir-4]Cl 1.8± 0.1 0.5± 0.3 3
[Ir-5]Cl 1.2± 0.3 pending -
[Rh-1]Cl 2.5± 0.3 0.7± 0.2 4
[Rh-4]Cl 1.8± 0.2 0.4± 0.1 5
[Rh-5]Cl 2.2± 0.6 1.2± 0.5 2
Finally, cellular uptake was monitored by means of fluorescence. The clearest
images are obtained for the iridium complexes, which exhibited orange fluore-
scence. From the comparison of the reported images (phase contrast, orange
emission and their overlay) in Figure 7.17 and 7.18 we verified that iridium
complexes enter inside the cell, even though it seems that they predominantly
remains outside the nucleus, because of the low fluorescence intensity in this
region.
Figure 7.17: Image of SW480 cells treated with 50 µM of [Ir-2]Cl after 30 min incuba-
tion. (A) Phase contrast, (B) orange emission (λex = 469 nm and λem = 647 nm) and
(C) overlay.
Figure 7.18: Image of SW480 cells treated with 50 µM of [Ir-3]Cl after 30 min incuba-
tion. (A) Phase contrast, (B) orange emission (λex = 469 nm and λem = 647 nm) and
(C) overlay.
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It is noteworthy to point out that such a method only allows to verify that the
metal drugs enter inside the cell, but we cannot obtain reliabale information
about the amount of drugs that passes through the membrane or where it is
placed.
7.2.8 Binding study to G-Quadruplexes
7.2.8.1 Titrations with Oligonucleotides
Following the photoreactivity tests on our complexes, we completed their study
addressing the affinity of the metal complexes for G-Quadruplexes of G-rich DNA.
Regarding the polynucleotides, double-stranded DNA of self-complementary 26-
mer (52B), G4 c-myc (Pu22) and human telomere (Tel22) sequences were used.
Titrations were performed in the ISOF center, in Bologna, under the supervision
of Dr. Ilse Manet.
We checked the interaction of three Ir complexes ([Ir-2]Cl, [Ir-3]Cl and [Ir-4]Cl).
Since the chosen iridium species are different for the ancillary and the cyclome-
talating ligand, we can try to associate the difference in the affinity with the
structure of the cyclometalated metal complex.
Why we tested the Ir complexes and not the Rh ones?:
• as observed in Chapter 6, the presence of a polynucleotide switched the
fluorescence of the [Ir-1]Cl complex on, whereas no important variation
was observed for [Rh-1]Cl. To verify if such result was a general behaviour
of our complex family, we checked the fluorescence in the presence of an
excess of CT-DNA. What we found agrees with our hypothesis: light
switch on behaviour was displayed for all the Ir complexes, whereas for
the Rh systems either decrease or very small increase of the fluorescence
intensity was observed (Figure 7.19).
Figure 7.19: Light-switch on behaviour in the presence of an excess of CT-DNA.
CD=5.0 × 10−6 M, CP=1.0 × 10−4 M (in basepairs), I=6.5 mM (NaCl), pH=7.0
(NaCac) and T=25.0 ◦C.
This result likely is related to the nature of the excited states, which behave
differently once the molecules interact with the nucleic acids; as to the
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Rh complexes the LC excited states are expected to be better electron
acceptors than the ground state, and independently of the nature of the
ligand all complexes may be quenched by electron transfer from the DNA
to ligand in the complex. We observe different turn on efficiencies for the
Ir complexes in line with the emitting state being a MLCT state. In the
presence of DNA emission from the MLCT state depends not only on the
nature of the ligand, but also on the involvement or not of the ligand in
the binding process.
• the previous reported results of cellular uptake show that iridium complexes
can be observed inside the cell, whereas no image has been obtained for
the rhodium ones. Consequently, the most interesting species seem to be
the iridium complexes;
• finally, the previous proofs with [Ir-1]Cl and [Rh-1]Cl (Chapter 6) verified
similar mode of binding to DNA and, as the oligonucleotides are rather
expensive, we focused only on one metal center.
UV-vis absorption, circular dichroism in the ultraviolet and visible region, ex-
citation profiles, fluorescence steady-state and fluorescence decays have been
employed to study the interaction of the metal compounds towards the oligo.
The results of the titrations between the iridium complexes and the oligonu-
cleotides are reported in Supporting Information (Figure 7.S6-7.S14).
Regarding the UV-vis titrations (Figures A in 7.S6-7.S14), the interaction of
double-stranded (ds) DNA and the metal complexes provoked small changes in
the spectra of the metal compounds. In particular, no remarkable hypochromic
effect and/or red shift of the bands is visualized, ruling out intercalation as a
possible mechanism of interaction. On the other side, variations of the spectra
are more evident in the interaction with G4 structures.
The circular dichroism of the duplex and quadruplex structure were not greatly
affected by the binding of the metal complexes (Figures B in 7.S6-7.S14), even
though decrease of the band intensity is observed for some systems, in particular
for the c-myc G4 dichroic signals once interacting with [Ir-3]Cl and [Ir-4]Cl. It
should mean that the binders did not significantly modify the native quadruplex
structures.
The binding of the metal complex provoked in some cases weak induced CD
signal in the visible region due to the Ir complex. In Figures 7.S6-7.S14 we show
the visible CD of the Ir-complexes that are endowed with a signal upon DNA
binding.
But the most interesting results are obtained with the fluorescence titrations.
Actually, a fluorescence intensity increase was visualized for all the metal com-
plexes (Figure 7.20). Interestingly, for some systems this variation was not high
(2-fold), while a more than 30-fold fluorescence intensity increase was observed
for others. In particular, the lowest light-switch on was visualized for the inte-
raction with ds DNA for all the complexes in the data set.
From the experimental data, we observed that
• [Ir-2]Cl: the interaction with ds DNA and telomere G4 increased the
fluorescence of 2-fold in the presence of excess DNA. On the other hand,
a nine-fold increase was obtained in the presence of the c-myc G4. For
[Ir-2]Cl the plots suggest the formation of only one adduct with the oligonu-
cleotides with 1:1 stoichiometry;
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• [Ir-3]Cl: slight fluorescence increase was obtained in the presence ds DNA
and telomere G4 and the results suggest the formation of a 1:1 adduct. On
the other hand the interaction with c-myc G4 caused a 15-fold fluorescence
intensity increase. In addition induced dichroism, steady-state fluorescence
and lifetime study suggest two different modes of binding, the first one
obtained in defect of oligonucleotides (maybe a 2:1 adduct) and the second
one in equimolar conditions (1:1 adduct);
• [Ir-4]Cl: a relevant fluorescence light-switch is obtained in the presence
of all the oligonucleotides, with the highest increase displayed by the
[Ir-4]Cl/c-myc G4 system, showing a 32-fold fluorescence enhancement.
A plausible reason may be the breakdown of complex dimers by the DNA
with the amount of monomeric complexes increasing together with the
upset of the adduct in solution. For [Ir-4]Cl the interactions with all the
oligonucleotides seem to involve two types of adducts, the 2:1 and the 1:1
ones.
Figure 7.20: Fluorescence enhancement in the presence of oligonucleotides. (A) [Ir-2]Cl.
(B) [Ir-3]Cl. (C) [Ir-4]Cl. CD=7.5 × 10−6 M, CP=2.2 × 10−5 M, I=0.1 M (KCl),
pH=7.0 (phosphate buffer) and T=25.0 ◦C.
Fluorescence enhancement has been previously reported by Castor et al. for
other Ir biscylometalated complexes interacting with quadruplex structures [32].
In fact, many compounds display a fluorescence light switch together with a
blue shift of the maximum by interaction with G-Quadruplexes, as we observed
[33,34]. This behaviour was ascribed to the shielding of the metal complex by
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the oligonucleotide, placing the complex from a polar aqueous environment to an
apolar surrounding. Interestingly, direct correlation between the maximum blue
shift (∆λmax) and fluorescence enhancement has been recently reported [34], in
agreement with our results.
Differently, Castor et al. observed the highest fluorescence switch-on in the
presence of telomeric G4 structure and a minor increase in the presence of the
c-myc moiety. In our case we observed the opposite results, with the highest
fluorescence enhancement observed in the presence of the c-myc G4. Such result
is probably due to the different folding of the G-Quadruplex structures (c-myc
G4 has a parallel conformation [35,36], whereas telomere G4 has hybrid structure
in potassium aqueous medium [37]).
Note that the same explanation can be advanced for the lifetime measurements
[38], as a correlation between fluorescence enhancement and increase in the
fluorescence lifetime was found. The cited values are listed in Table 7.9.
Table 7.9: Obtained parameter of the luminescence of the interaction between the
biscyclometalated complexes with the oligonucleotides.
Complex Oligo FF0 ∆λ
max
em , nm τadduct, ns
[Ir-2]Cl 52B 2 0 128 (1:1)
Pu22 7 −4 nm 109 (1:1)
Tel22 2 −2 nm 85 (1:1)
[Ir-3]Cl 52B 1.5 −3 nm 57 (1:1)
Pu22 15 −20 nm 109 (2:1),377 (1:1)
Tel22 3 −10 nm 74 (1:1)
[Ir-4]Cl 52B 5 −20 nm 120 (2:1)
Pu22 32 −25 nm 133 (2:1), 1732 (1:1)
Tel22 16 −25 nm 140 (1:1), 1430 (2:1)
Concerning the interaction of a small molecule with G-Quadruplex, various
modes of binding are viable (external, groove/loop binding, intercalation, end
stacking) [39–41]. For many octahedral compounds the end-stacking interaction
has been proposed [32,34]. However, for part of the examined systems two types
of adduct have been hypothesized from the experimental tracks in fluorescence
and the appearance of two very different new lifetimes. A dual mode of binding
was observed for other cyclometalated complexes towards interaction with DNA
by means of calorimetry and/or lifetime measurements [42,43]. Interestingly, for
the systems exhibiting two modes of binding, at the first point of the titration
the prevailing complex (which reasonably is a 2:1 complex) has a faster lifetime
respect to the species prevailing at higher concentration of oligonucleotide (1:1
complex). It could agree with the fact that the presence of more than one metal
complex bound to the same oligonucleotide can provoke mutual quenching of the
fluorescence, with a decrease of the lifetime. However, in equimolar conditions
of metal complex/oligonucleotide, all the metal complexes can insert inside the
G-Quadruplex structure and the resulting species will have a longer lifetime
because it will be shielded more efficiently by the solvent molecules and it is free
from intermolecular interactions between other metal complexes.
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Multiwavelength global analysis of the titration data was carried out by means
of the ReactLab program. ReactLab calculates the equilibrium constant
of adducts between the metal complex and the oligonucleotides as well as the
spectra of the adducts with the different stoichiometries. The program requires
as input all spectra, total concentration of complex (CD) and DNA (CP ) in all
mixtures and a binding model. Analysing the data, different models have been
used, with a single adduct having 1:1 or 2:1 stoichiometry (complex:DNA) or
two adducts forming contemporarily with 1:1 or 2:1 stoichiometry. Statistical
parameters are indicative of the goodness of the fitting model.
The choice of the binding model (1:1) or (2:1) was further compared with the
lifetime measurements. When the lifetime measurements suggested the presence
of more than one adduct, we fitted the spectra including the formation of two




M + 2 L
K1K2−−−−→←−−−− ML2 (7.6)
Table 7.10 reports the equilibrium constants obtained by ReactLab analysis
from the different employed techniques. The obtained equilibrium constants
demonstrate a selectivity towards G-Quadruplex; in particular a strong inte-
raction with the c-myc G4 was found for all the complexes, having the highest
equilibrium constants in the titrations set.
Table 7.10: Logarithmic values of the equilibrium constants (K1 for 1:1 stoichiometry
and K1K2 for 2:1 stoichiometry) of the interaction between the metal complexes and
the oligonucleotides. I=0.1 M (KCl), pH=7.0 (phosphate buffer). Kinetic constants
obtained from (1) fluorescence titrations; (2) induced circular dichroism of the complex.
Complex ds DNA c-myc G4 telomeric G4
[Ir-2]Cl 4.5(1 : 1)
(1) 5.3(1 : 1)(1) 4.3(1 : 1)(1)
4.4(1 : 1)(2) 5.1(1 : 1)(2)
[Ir-3]Cl - 6.4(1 : 1), 11.5(2 : 1)
(1) 4.2(1 : 1)(1)
6.6(1 : 1), 11.4(2 : 1)(2)
[Ir-4]Cl Not Calculated 6.3(1 : 1), 11.4(2 : 1)
(1) 4.5(1 : 1), 10.4(2 : 1)(1)
5.5(1 : 1), 10.3(2 : 1)(2) 4.4(1 : 1), 10.0(2 : 1)(2)
7.2.8.2 FRET Analysis
Stabilization proofs of oligonucleotides secondary structures were performed by
means of FRET analysis. Excess of metal complex (50-fold, saturation condition)
was used in the presence of different oligonucleotides covalently linked by a
fluorophore (Fluorescein, F) and an acceptor (TAMRA, T) at both terminals
of the chain. Proofs were performed in I = 0.11 M and pH = 7.2 ([LiCl] =
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90 mM, [KCl] = 10 mM, [LiCac] = 10 mM); in such a condition the studied
oligonucleotides fold to form different Quadruplex structures, which are listed
in Table 7.11 [44]. In addition, an intramolecular duplex structure (FdxT) was
tested, as well.
Table 7.11: Oligonucleotides covalently linked to fluorescein (F) and TAMRA (T).
Primary and secondary structures formed in the experimental conditions and melting
temperature [44]. [LiCl]=90 mM, [KCl]=10 mM, I=0.1 M, pH=7.2.
Oligonucleotide Sequence Tm, ◦C
F21T mayor human hybrid-telomeric DNA 53.1GGG TTA GGG TTA GGG TTA GGG
F21RT human parallel-telomeric RNA 59GGG UUA GGG UUA GGG UUA GGG
F25CebT human-parallel DNA mini satellite with large loop 68.7A GGG T GGG TGT AAGTGT GGG T GGG T
F21CTAT human parallel telomeric DNA 57.9GGG CTA GGG CTA GGG CTA GGG
FmycT parallel proto-oncogene 65.5TTGA GGG T GGG TA GGG T GGG TAA
FBom17T 2tetrads of Bombix-antiparallel telomeric DNA 48.8GG TTA GG TTA GG TTA GG
FTBAT trombin binding aptamer-2antiparallel tetrads 51.6GG TT GG TGT GG TT GG
FdxT duplex intramolecular 66.1TATAGCTAT-hexaetilenglycol-TATAGCTATA
Concerning Ir complexes, increase of the melting temperature of the G4 struc-
tures was observed in the presence of all complexes (Figure 7.21).
Figure 7.21: ∆Tm increase for quadruplex and duplex structures in the presence of Ir
complexes. CP=0.2 µM, CD=10 µM, [LiCl]=90 mM, [KCl]=10 mM, [LiCac]=10 mM,
I=0.11 M, pH=7.2.
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In particular, the stabilization effect increased with the aromatic extension of
the CN and the NN ligands, ensuing the following order: [Ir-5]Cl ≈ [Ir-4]Cl >
[Ir-3]Cl > [Ir-2]Cl. Although the stabilization effect provided by the [Ir-5]Cl
and [Ir-4]Cl complexes was similar, [Ir-5]Cl did not stabilize the ds DNA,
whereas [Ir-4]Cl did.
High values of thermal stabilization were detected for the telomeric F21T, F21RT
and F21CTAT quadruplexes, and for FBom17T and FTBAT, whereas less sta-
bilization was reached for c-myc structure. However, it should be pointed out
that telomeric structures exhibit lower melting temperature respect to c-myc
structure, which has high Tm even in the absence of the metal drug under the
employed experimental conditions (see Table 7.11).
Proofs were performed with the Rh complexes, as well (Figure 7.22). [Rh-2]Cl
and [Rh-4]Cl complexes show very similar results compared to their [Ir-2]Cl
and [Ir-4]Cl analogues. On the other hand, low stabilization effect is observed
in the presence of the [Rh-5]Cl complex.
Figure 7.22: ∆Tm increase for quadruplex and duplex structures in the presence of Rh
complexes. CP=0.2 µM, CD=10 µM, [LiCl]=90 mM, [KCl]=10 mM, [LiCac]=10 mM,
I=0.11 M, pH=7.2.
It is noteworthy to recall here that the proofs performed with the FRET analysis
were in a large excess of metal complex. Further studies will be addressed to
stabilization tests for lower CDCP ratios. In addition, competition proofs in the
presence of quadruplex and duplex could be useful in order to observe if the
complexes are able to selectively stabilize the G4 forms, even in the presence of
ds structures.
7.3 Conclusions
From Chapter 6 we found interesting differences between two biscyclometalated
complexes, differing only by the metal center (iridium and rhodium). In Chapter
7 we planned the synthesis of new complexes to observe how such differences can
be tuned varying the ligands. More than that, in this Chapter we wanted to go
one step further, and a study on the selectivity towards different DNA structu-
res, namely G-Quadruplex structures and ds DNA, was carried out. Our study
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showed that Rh complexes had the highest singlet oxygen quantum yield, a pro-
perty which we related to the longest lifetime, in agreement with literature data,
but they absorb only below 450 nm. The absorption bands at longer wavelength
found for the Ir complex make them more attractive as photosensitizer because,
even if they exhibit lower singlet oxygen production, they can be activated in a
more appropriate region for PDT. In this context, the ligands play an important
role, shifting the absorption to red region. In addition, Ir complexes exhibited
emission switch on, whereas Rh complexes did not, in agreement with our result
in Chapter 6. Such fluorescence allowed to observe the Ir complexes inside the
cell. Our results also showed that ligands not only influence the photoproperties
of the biscylometalated complexes, but we verified that they are decisive for
the affinity towards DNA. In particular, higher affinity for G-Quadruplex was
revealed by different techniques. Interestingly the highest fluorescence switch on
was observed in the presence of c-myc G-Quadruplex. Stabilization of the G4
was found in the presence of both Ir and Rh species, corroborating the results
of recent papers reporting that even octahedral compounds are able to stabilize
G-Quadruplex structures.
7.4 Synthesis and Characterization Data
7.4.1 2-(2’-pyridyl)benzothiazole (pybtz)
2-aminothiophenol (0.250 g, 2.00 mmol) and 2-pyridylcarboxaldheyde (0.228 mL,
0.257 g, 2.40 mmol) were inserted in a schlank with DMSO (7 mL), and the
mixture was stirred at 60 ◦C for 6 h under air atmosphere. H2O was added
(7 mL) and the product was extracted with ethylacetate (AcOEt, 3×20 mL).
Then, MgSO4 was added and the solution was filtered and evaporated under
vacuum. The purification of the product was achieved by means of a silica gel
column; the eluting phase was AcOEt:Hexane 1:1. The aliquots of the product
were collected, added MgSO4, filtered and evaporated in vacuum. The resulting
white solid was dried under vacuum. Yield: 111.0 mg (0.523 mmol, 26.2 %).
1H-NMR (400 MHz, DMSO−d6, 25.0 ◦C): δ 8.74 (d, J = 4.7 Hz, 1H), 8.34
(d, J = 7.9 Hz, 1H), 8.18 (d, J = 8.0 Hz, 1H), 8.11 (d, J = 8.1 Hz, 1H), 8.05 (t,
J = 7.7 Hz, 1H), 7.63–7.55 (m, 2H), 7.51 (t, J = 8.0 Hz, 1H) ppm.
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7.4.2 2-(2’-quinolinyl)benzothiazole (qibtz)
2-aminothiophenol (0.250 g, 2.00 mmol) and 2-quinolinylcarboxaldheyde (0.381 g,
2.42 mmol) were inserted in a schlank with DMSO (6 mL), and the mixture was
stirred at 60 ◦C for 6 h under air atmosphere. H2O was added (6 mL) and the
product was extracted with ethylacetate (AcOEt, 3×20 mL). Then, MgSO4
was added and the solution was filtered and evaporated under vacuum. The
purification of the product was achieved by means of a silica gel column; the
eluting phase was AcOEt:Hexane 1:1. The aliquots of the product were collected,
added MgSO4, filtered and evaporated in vacuum. The resulting yellowish solid
was dried under vacuum. Yield: 264.4 mg (0.101 mmol, 51 %).
1H-NMR (400 MHz, CDCl3−d, 25.0 ◦C): δ 8.51 (d, J = 8.5 Hz, 1H), 8.32
(d, J = 8.5 Hz, 1H), 8.21 (d, J = 8.5 Hz, 1H), 8.15 (d, J = 8.1 Hz, 1H), 8.00 (d,
J = 8.0 Hz, 1H), 7.88 (d, J = 8.3 Hz, 1H), 7.81–7.76 (t, 1H), 7.64–7.58 (t, 1H),
7.56–7.51 (t, 1H), 7.48–7.43 (t, 1H) ppm.
7.4.3 2-phenylisoquinoline (piqi)
1-bromoisoquinoline (0.500 g, 2.403 mmol) was added in a schlenk in the pre-
sence of a solution of phenylboronic acid (0.352 g, 2.88 mmol), K2CO3 (0.795 g,
4.81 mmol) and 2.2 mg PdCl2 (catalyst) with 10 mL of EtOH and 10 mL of H2O
(EtOH:H2O 1:1). The solution was stirred and heated at 90 ◦C for 6 h under
nitrogen atmosphere. A saturated solution of NaCl (60 mL) was added and
the complex was extracted with diethylether (3×20 mL). The resulting solu-
tion was washed with 20 mL of water and dried with MgSO4. The solvent was
evaporated and, then, hexane was added. The solution was passed through a
silica gel column (AcOEt:Hexane 30:70), collected the aliquots, dried again with
MgSO4, filtered and the solvent was evaporated under vacuum. Yield: 274.8 mg
(1.67 mmol, 58 %).
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1H-NMR (400 MHz, CDCl3−d, 25.0 ◦C): δ 8.62 (d, J = 5.6 Hz, 1H), 8.11
(d, J = 8.4 Hz, 1H), 7.89 (d, J = 8.3 Hz, 1H), 7.73–7.68 (m, 3H), 7.66 (d,
J = 5.8 Hz, 7H), 7.57–7.46 (m, 4H) ppm.
7.4.4 Ir2(ppy)4Cl2
2-phenylpyridine (1.00 mL, 1.09 g, 7.01 mmol) was added to a solution of IrCl3 ·
3H2O (1.00 g, 2.83 mmol) in a schlank with 20 mL of ethoxyethanol and 6.7 mL of
H2O, and the mixture was stirred at 110 ◦C for 24 h under a nitrogen atmosphere.
The product was washed with diethyl ether, filtered and washed with a solution
EtOH (3 mL) and acetone (3 mL). The resulting yellow powder was dried under
vacuum. Yield: 1188.7 mg (1.109 mmol, 78 %).
1H-NMR (400 MHz, CDCl3−d, 25.0 ◦C) δ 9.24 (d, J = 5.7 Hz, 4H), 7.87 (d,
J = 7.7 Hz, 4H), 7.73 (t, J = 7.6 Hz, 4H), 7.48 (d, J = 7.9 Hz, 4H), 6.87–6.68
(m, 8H), 6.56 (t, J = 7.5 Hz, 4H), 5.93 (d, J = 7.8 Hz, 4H) ppm.
7.4.5 Rh2(ppy)4Cl2
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2-phenylpyridyne (2.82 mL, 3.07 g, 19.8 mmol) was added to a solution of RhCl3 ·
3H2O (2.09 g, 7.90 mmol) in a schlank with 15 mL of 2-methoxyethanol and
2.5 mL of H2O, and the mixture was stirred at 110 ◦C for 24 h under a nitrogen
atmosphere. The product was washed with diethyl ether, filtered and washed
with a solution EtOH (3×3 mL) and acetone (3×3 mL). The resulting yellow
powder was dried under vacuum. Yield: 2991.0 mg (3.348 mmol, 88 %).
1H-NMR (400 MHz, CDCl3−d, 25.0 ◦C) δ 9.24 (d, J = 5.7 Hz, 4H), 7.87 (d,
J = 7.7 Hz, 4H), 7.73 (t, J = 7.6 Hz, 4H), 7.48 (d, J = 7.9 Hz, 4H), 6.87–6.68
(m, 8H), 6.56 (t, J = 7.5 Hz, 4H), 5.93 (d, J = 7.8 Hz, 4H) ppm.
7.4.6 Ir2(piqi)4Cl2
2-phenylisoquinoline (0.264 g, 1.285 mmol) was added to a solution of IrCl3 ·
3H2O (0.189 g, 0.537 mmol) in a schlank with 15 mL of ethoxyethanol and 5 mL
H2O, and the mixture was stirred at 110 ◦C for 24 h under a nitrogen atmosphere.
15 mL of water were added and the solvent was filtered, the powder was washed
with 4 mL of Acetone, 4 mL of EtOH and 4 mL of Et2O. The resulting red
powder was dried under vacuum. Yield: 216.3 mg (0.170 mmol, 63 %).
1H-NMR (400 MHz, CDCl3−d, 25.0 ◦C): δ 9.05 (d, J = 6.4 Hz, 4H), 8.97 (d,
J = 8.1 Hz, 4H), 8.12 (d, J = 8.0 Hz, 4H), 7.83 (m, J = 8.7 Hz, 8H), 7.79–7.69
(t, 4H), 6.81 (t, J = 8.1 Hz, 4H), 6.55 (d, J = 6.5 Hz, 4H), 6.50 (t, J = 7.5 Hz,
4H), 6.03 (d, J = 7.8 Hz, 4H) ppm.
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7.4.7 Rh2(piqi)4Cl2
2-phenylisoquinoline (0.275 g, 1.34 mmol) was added to a solution of RhCl3 ·
3H2O (0.117 g, 0.4466 mmol) in a schlank with 15 mL of 2-methoxyethanol and
2.5 mL H2O, and the mixture was stirred at 120 ◦C for 24 h under a nitrogen
atmosphere. The product was washed with ethanol (2×4 mL) and diethyl ether
(2×4 mL) and filtered. The resulting green powder was dried under vacuum.
Yield: 127.6 mg (0.117 mmol, 52 %).
1H-NMR (400 MHz, CDCl3−d, 25.0 ◦C): δ 9.16 (d, J = 6.2 Hz, 4H, H
10),
8.96 (d, J = 8.6 Hz, 4H, H4), 8.16 (d, J = 7.4 Hz, 4H, H13), 7.91–7.81 (m, 8H,
H6,H7), 7.74 (ddd, J = 8.2, 5.9, 2.3 Hz, 4H, H5), 6.88 (t, J = 7.6 Hz, 4H, H14),
6.72 (d, J = 6.4 Hz, 4H, H9), 6.60 (t, J = 6.8 Hz, 4H, H15), 5.98 (d, J = 7.9 Hz,
4H, H16) ppm. 13C-NMR (101 MHz, CDCl3−d, 25.0 ◦C) δ 169.85 (d, 4C,
C11), 165.95 (s, 4C, C2), 145.72 (s, 4C, C12), 144.52 (s, 4C, C10), 137.09 (s,
4C, C8), 132.84 (s, 4C, C16), 130.75 (s, 4C, C6), 129.33 (s, 4C, C13), 128.82 (s,
4C, C15), 127.81 (s, 4C, C5), 127.42 (s, 4C, C7), 127.12 (s, 4C, C4), 126.27 (s,
4C, C3), 122.11 (s, 4C, C14), 119.43 (s, 4C, C9) ppm. Mass Spectrometry
(ESI-MS): mz = 511 (100) [(M−2Cl)]2+, 1057 (6) [M−Cl]+
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7.4.8 [Ir-2]Cl ([Ir(ppy)2(pybtz)]Cl)
2-(2’-pyridyl)benzothiazole (0.0424 g, 0.200 mmol) was added to a solution of
Ir2(ppy)4Cl2 (0.1006 g, 0.0938 mmol) in CH2Cl2:MeOH (4:5, 18 mL), and the
mixture was stirred at 60 ◦C overnight under a nitrogen atmosphere. The solvent
was completely evaporated under vacuum and n-hexane (10 mL) was added to
produce a crude solid that was washed with diethyl ether (2×5 mL). The resulting
orange powder was dried under vacuum. Yield: 91.5 mg (0.122 mmol, 65 %).
1H-NMR (400 MHz, DMSO−d6, 25.0 ◦C) δ 8.82 (d, J = 7.7 Hz, 1H, H
e), 8.40
(d, J = 8.2 Hz, 1H, Hj), 8.358.27 (m, 2H, Hk, H3’), 8.22 (d, J = 7.9 Hz, 1H, H3),
7.97-7.91 (m, 3H, H4’,H9, H9’), 7.91–7.83 (m, 2H, H4, Hb), 7.79–7.75 (m, 2H, H6,
Hc), 7.64 (d, J = 5.8 Hz, 1H,H6’), 7.58–7.53 (t, 1H,Hk), 7.22 (t, J = 7.7 Hz, 1H,
Hl), 7.17–7.03 (m, 4H, H5’, H5, H10’, H10), 6.99–6.90 (m, 2H, H11’, H11), 6.79
(d, J = 8.5 Hz, 1H, Hm), 6.27 (d, J = 7.5 Hz, 1H, H12’), 6.12 (d, J = 7.3 Hz, 1H,
H12) ppm. 13C-NMR (101 MHz, DMSO−d6, 25.0 ◦C) δ 170.59 (s, 1C, H
g),
166.88 (s, 1C, C2’), 166.29 (s, 1C, C2), 151.13 (s, 1C, Cf), 150.17 (s, 1C, C6’),
150.02 (s, 1C, Cn), 149.97 (s, 1C, Cb), 149.24 (s, 1C, C6), 147.62 (s, 1C, C7’),
147.57 (s, 1C, C7), 144.36 (s, 1C, C8’), 143.76 (s, 1C, C8), 140.25 (s, 1C, Cd),
138.86 (s, 1C, C4), 138.82 (s, 1C, C4’), 134.38 (s, 1C, Ci), 131.62 (s, 1C, C12’),
130.47 (s, 1C, C12), 130.36 (s, 1C, C11), 129.99 (s, 1C, C11’), 129.91 (s, 1C, Cc),
128.16 (s, 1C, Cl), 127.90 (s, 1C, Ck), 127.10 (s, 1C, Ce), 125.13 (s, 1C, C9),
125.10 (s, 1C, C9’), 124.35 (s, 1C, Cj), 124.24 (s, 1C, C5’), 123.92 (s, 1C, C5),
122.67 (s, 1C, C10), 122.44 (s, 1C, C10’), 121.20 (s, 1C, Cm), 120.13 (s, 1C, C3’),
119.81 (s, 1C, C3) ppm. Anal. Calcd for C34H24N4SClIr(CH2Cl2)0.6: C
51.99, H 3.18, N 7.01, S 4.01; Found: C 51.59, H 3.27, N 6.86, S 4.52. ATR-IR
(solid powder, cm−1) selected bands: 1605 1581-1560-1477-1437 (νC=C+νC=N )
1417, 1322 (νC−N ) 1268, 1161 (νC−C), 1063-1029 (m, δC−Hip) 1008, 759-730
(δC−Hoop+νC−S). Mass Spectrometry (ESI-MS): mz = 711 (100) [M−Cl]+.
Molar Conductivity (CH3CN): 115.4 Scm2mol−1. Solubility: soluble in
DMSO, CH3CN, CH2Cl2, EtOH, partially soluble in MeOH, H2O, insoluble in
Et2O and hexane.
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7.4.9 [Ir-3]Cl ([Ir(ppy)2(qibtz)]Cl)
2-(2’-quinolinyl)benzothiazole (0.0526 g, 0.200 mmol) was added to a solution
of Ir2(ppy)4Cl2 (0.1006 g, 0.0938 mmol) in CH2Cl2:MeOH (4:5 18 mL), and the
mixture was stirred at 60 ◦C overnight under a nitrogen atmosphere. The solvents
were completely evaporated under vacuum and n-hexane (10 mL) was added to
produce a crude solid that was washed with diethyl ether (2×5 mL). The resulting
dark red powder was dried under vacuum. Yield: 111.8 mg (0.140 mmol, 75 %).
1H-NMR (400 MHz, DMSO-d6, 25.0 ◦C) δ 8.97 (d, J = 8.6 Hz, 1H, Hh),
8.82 (d, J = 8.6 Hz, 1H, Hi), 8.45 (d, J = 8.2 Hz, 1H, Hn), 8.29 (d, J = 8.6 Hz,
1H, H3), 8.20 (d, J = 8.5 Hz, 1H,Hf), 8.17 (d, J = 8.7 Hz, 1H, H3’), 7.97 (d,
J = 8.1 Hz, 2H, H9, Cc), 7.92 (t, J = 5.8 Hz, 1H, H4), 7.91–7.86 (m, 2H, H9’, H6),
7.82 (t, J = 7.8 Hz, 1H, H4’), 7.69 (d, J = 6.0 Hz, 1H, H6’), 7.66 (t, 1H, He), 7.56
(t, J = 7.7 Hz, 1H, Ho), 7.25 (t, 1H, Hd), 7.17 (t, 1H, Hp), 7.12 (t, 1H, H10’), 7.10-
7.03 (m, 3H, H10,H5,H5’), 6.98 (t, J = 7.4 Hz, 1H, H11), 6.94 (t, J = 7.5 Hz, 1H,
H11’), 6.59 (d, J = 8.6 Hz, 1H, Hq), 6.22 (d, J = 7.5 Hz, 1H, H12), 6.12 (d, J =
7.6 Hz, 1H, H12’) ppm. 13C-NMR (101 MHz, DMSO-d6, 25.0 ◦C) δ 172.45
(s, 1C, Ck), 166.58 (s, 1C, C2’), 166.26 (s, 1C, C2), 153.15 (s, 1C, Cj), 150.83 (s,
1C, C6), 150.60 (s, 1C, Cr), 149.45 (s, 1C, C6’), 149.00 (s, 1C, C7), 147.12 (s,
1C, Cb), 144.29 (s, 1C, C7’), 144.00 (s, 1C, C8’), 143.61 (s, 1C, C8), 142.05 (s,
1C, Ch), 138.87 (s, 1C, C4), 138.79 (s, 1C, C4’), 134.74 (s, 1C, Cm), 131.96 (s,
1C, Cd), 130.90 (s, 1C, C12’), 130.52 (s, 1C, C12), 130.30 (s, 1C, C11), 130.12 (s,
1C, C11’), 130.05 (s, 1C, Cg), 129.45 (s, 1C, Ce), 129.33 (s, 1C, Cf), 128.11 (s,
1C, Cp), 127.96 (s, 1C, Co), 127.25 (s, 1C, Cc), 125.27 (s, 1C, C9’), 125.20 (s,
1C, C9), 124.28 (s, 1C, Cn), 124.14 (s, 1C, C5), 123.82 (s, 1C, C5’), 122.86 (s,
1C, C10’), 122.46 (s, 2C, C10, Ci), 121.48 (s, 1C, Cq), 120.06 (s, 1C, C3), 119.95
(s, 1C, C3’) ppm. Anal. Calcd for C38H26N4SClIr(CH2Cl2)0.8: C 53.79,
H 3.21, N 6.47, S 3.70; Found: C 54.23, H 3.36, N 6.43, S 3.96. ATR-IR (solid
powder, cm−1) selected bands: 1604, 1581-1514-1476-1455 (νC=C+νC=N ), 1417,
1320 (νC−N ) 1268, 1249, 1161 (νC−C), 1090, 1056-1029 (m, δC−Hip), 950, 822,
758-729 (δC−Hoop+νC−S). Mass Spectrometry (ESI-MS): mz = 761 (100)
[M−Cl]+. Molar Conductivity (CH3CN): 117.5 Scm2mol−1. Solubility:
soluble in DMSO, CH3CN, CH2Cl2, EtOH, partially soluble in MeOH, H2O,
insoluble in Et2O and hexane.
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7.4.10 [Ir-4]Cl ([Ir(piqi)2(pybtz)]Cl)
2-(2’-pirydyl)benzothiazole (0.0208 g, 0.0982 mmol) was added to a solution of
[Ir(piqi)2Cl]2 (0.0500 g, 0.0393 mmol) in CH2Cl2:MeOH (4:5, 9 mL), and the
mixture was stirred at 60 ◦C for 23 h and under a nitrogen atmosphere. The so-
lution was completely evaporated and the product was precipitated with hexane.
The solvent was filtered and the solid was washed with diethyl ether (2×5 mL).
The resulting red powder was dried under vacuum. Yield: 52.9 mg (0.0624 mmol,
79 %).
1H-NMR (400 MHz, DMSO−d6, 25.0 ◦C) δ 9.03 (d, J = 6.4 Hz, 1H, H
4),
8.95 (d, J = 5.0 Hz, 1H, H4’), 8.87 (d, J = 7.7 Hz, 1H, He), 8.39 (d, J = 8.2 Hz,
3H, H13, H13’, Hj), 8.33 (t, J = 7.6 Hz, 1H, Hd), 8.13–8.04 (m, 2H, H7, H7’),
7.94–7.89 (m, 2H, H6,H5), 7.86 (m, 2H, H6’, H5’), 7.74 (t, J = 5.1 Hz, 1H, Hc),
7.71 (d, J = 6.6 Hz, 1H, H10’), 7.69 (d, J = 5.3 Hz, 1H, Hb), 7.60 (d, J = 3.8 Hz,
2H, H9’, H9), 7.53 (m, 2H, H10, Hk), 7.22 (t, J = 7.7 Hz, 1H, H14’), 7.17 (t,
J = 7.9 Hz, 2H, H14, Hl), 6.97 (t, J = 5.6 Hz, 1H, H15’), 6.93 (t, J = 5.6 Hz,
1H, H15), 6.51 (d, J = 8.7 Hz, 1H, Hm), 6.27 (d, J = 7.7 Hz, 1H, H16’), 6.12
(d, J = 7.6 Hz, 1H, H16) ppm. 13C-NMR (101 MHz, DMSO−d6, 25.0 ◦C)
δ 170.61 (s, 1C, Cg), 167.74 (s, 1C, C2), 167.23 (s, 1C, C2’), 151.11 (s, 1C,
C11’), 151.00 (s, 1C, Cf), 150.87 (s, 1C, C11), 149.91 (s, 1C, Cb), 149.81 (s, 1C,
Cn), 145.73 (s, 1C, C12’), 145.12 (s, 1C, C12), 141.70 (s, 1C, C10’), 140.77 (s,
1C, C10), 140.32 (s, 1C, Cd), 136.57 (s, 1C, C8’), 136.49 (s, 1C, C8), 134.40
(s, 1C, Ci), 132.13 (s, 3C, C16’, C6, C6’), 130.93 (s, 1C, C16), 130.67 (s, 1C,
C13), 130.63 (s, 1C, C15), 130.60 (s, 1C, C13’), 130.15 (s, 1C, C15’), 129.91 (s,
1C, Cc), 129.51 (s, 1C, C5), 129.42 (s, 1C,C5’), 128.10 (s, 1C, Cl), 127.86 (s,
1C, Ck), 127.78 (s, 1C, C7), 127.69 (s, 1C, C7’), 127.25 (s, 1C, Ce), 126.32
(s, 2C, C4, C4’), 125.57 (s, 1C, C3’), 125.32 (s, 1C, C3), 124.36 (s, 1C, Cj),
122.67 (s, 1C, C14), 122.60 (s, 1C, C9’), 122.38 (s, 1C, C14’), 122.26 (s, 1C, C9),
121.07 (s, 1C, Cm) ppm. Anal. Calcd for C42H28N4SClIr(CH2Cl2)1.2:
C 54.60, H 3.22, N 5.90, S 3.37; Found: C 54.40, H 3.25, N 5.83, S 3.37.
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ATR-IR (solid powder, cm−1) selected bands: 3028 (w, νC=CH), 2970, 2355,
1574-1539-1447 (νC=C+νC=N ), 1433, 1374, 1351, 1323 (νCN ), 1296, 1268, 1228,
1217, 1155 (νC−C), 1040-1028 (m, δC−Hip), 876, 814-757-742 (δC−Hoop+νC−S).
Mass Spectrometry (ESI-MS): mz = 813 (100) [M−Cl]+. Molar Conduc-
tivity (CH3CN): 117.4 Scm2mol−1. Solubility: soluble in DMSO, CH3CN,
CH2Cl2, EtOH, insoluble in Et2O and hexane.
7.4.11 [Ir-5]Cl ([Ir(piqi)2(qibtz)]Cl)
2-(2’-quinolinyl)benzothiazole (0.0248 g, 0.0947 mmol) was added to a solution
of [Ir(piqi)2Cl]2 (0.0509 g, 0.040 mmol) in CH2Cl2:CH3OH (4:5, 18 mL), and the
mixture was stirred at 60 ◦C for 48 h under a nitrogen atmosphere. Then, the
volume was reduced and the complex was precipitated by diethyl ether. The
solvent was filtered and the solid was washed with diethylether (2×5 mL). The
resulting red powder was dried under vacuum. Yield: 39.4 mg (0.0439 mmol,
55 %).
1H-NMR (400 MHz, DMSO−d6, 25.0 ◦C) δ 9.03 (d, J = 7.0 Hz, 1H, H
4),
8.96 (d, J = 8.8 Hz, 1H, Hh), 8.87 (d, J = 9.8 Hz, 1H, H4’), 8.84 (d, J = 8.9 Hz,
1H, Hi), 8.45 (d, J = 9.0 Hz, 1H, H13’), 8.43 (d, J = 8.0 Hz, 1H, Hn), 8.34 (d,
J = 8.5 Hz, 1H, H13), 8.15 (d, J = 7.2 Hz, 1H, Hf), 8.06 (d, J = 4.4 Hz, 1H, H7),
8.00 (d, J = 7.8 Hz, 1H, H7’), 7.93–7.86 (m, 3H, H10’, H6, H5), 7.85–7.76 (m, 3H,
H6’, H5’, Hc), 7.67–7.59 (m, 2H, H10, He), 7.53 (m, 3H, H9’, Ho, H9), 7.31–7.19
(m, 2H, H14’, Hd), 7.19–7.08 (m, 2H, H14, Hp), 7.03–6.92 (m, 2H, H15, H15’),
6.29 (d, J = 8.4 Hz, 1H, Hq), 6.24 (d, J = 6.4 Hz, 1H, H16), 6.22 (d, J = 6.4 Hz,
1H, H16’) ppm. 13C-NMR (101 MHz, DMSO−d6, 25.0 ◦C) δ 172.49 (s, 1C,
Ck), 167.43 (s, 1C, C2), 167.04 (s, 1C, C2’), 153.10 (s, 1C, Cj), 152.07 (s, 1C,
C11), 150.39 (s, 1C, Cr), 147.86 (s, 1C, C11’), 146.88 (s, 1C, Cb), 145.40 (s, 1C,
C12’), 144.99 (s, 1C, C12), 142.49 (s, 1C, C10’), 142.10 (s, 1C, Ch), 140.90 (s,
1C, C10), 136.55 (s, 1C, C8’), 136.38 (s, 1C, C8), 134.73 (s, 1C, Cm), 132.18 (s,
1C, C6), 132.10 (s, 1C, C6’), 131.93 (s, 1C, Cd), 131.46 (s, 1C, C16), 130.75 (s,
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2C, C16, C13’), 130.68 (s, 1C, C13), 130.48 (s, 1C, C15), 130.35 (s, 1C, C15’),
130.04 (s, 1C, Cg), 129.63 (s, 1C, C5), 129.42 (s, 2C, C5’, Ce), 129.33 (s, 1C,
Cf), 128.11 (s, 1C, Cp), 127.96 (s, 1C, Co), 127.82 (s, 1C, C7), 127.66 (s, 1C,
C7’), 127.13 (s, 1C, Cc), 126.19 (s, 2C, C4, C4’), 125.56 (s, 1C, C3’), 125.30 (s,
1C, C3), 124.27 (s, 1C, Cn), 122.87 (s, 1C, C14’), 122.51 (s, 1C, C14), 122.47 (s,
1C, Ci), 122.43 (s, 1C, C9’), 122.10 (s, 1C, C9), 121.40 (s, 1C, Cq) ppm. Anal.
Calcd for C46H30N4SClIr(CH2Cl2)0.5: C 59.36, H 3.32, N 5.96, S 3.41;
Found: C 59.26, H 3.30, N 5.80, S 3.43. Mass Spectrometry (ESI-MS):
m
z = 863 (100) [M−Cl]+. Molar Conductivity (CH3CN): 116.3 Scm2mol−1.
Solubility: soluble in DMSO, CH3CN, CH2Cl2, EtOH, insoluble in Et2O and
hexane.
7.4.12 [Rh-2]Cl ([Rh(ppy)2(pybtz)]Cl)
2-(2’-pirydyl)benzothiazole (0.0424 g, 0.200 mmol) was added to a solution of
[Rh(ppy)2Cl]2 (0.0840 g, 0.0940 mmol) in CH2Cl2:MeOH (1:1, 18 mL), and the
mixture was stirred at 50 ◦C for 20 h and under a nitrogen atmosphere. The
volume was reduced and hexane was used to precipitate the product. Solvent
was filtered and ethanol was added in order to dissolve the product while the
impurities, as the dimeric reagent, are not soluble. The solution was filtered and
evaporated. A yellow powder was formed. Yield: 55.7 mg (0.0845 mmol, 45 %).
1H-NMR (400 MHz, CDCl3−d, 25.0 ◦C) δ 9.08 (d, J = 7.9 Hz, 1H, H
e), 8.52
(t, J = 7.5 Hz, 1H, Hd), 8.14 (d, J = 8.3 Hz, 1H, Hj), 7.95 (d, J = 8.3 Hz,
1H, H3), 7.90–7.84 (m, 3H, H4, H3, Hb), 7.82 (t, J = 8.3 Hz, 1H, H4’), 7.73
(d, J = 7.8 Hz, 2H, H9, H9’), 7.63–7.59 (t, 1H, Hc), 7.57 (d, J = 5.6 Hz, 1H,
H6), 7.48-7.43 (m, 2H, H6’, Hk) 7.21-7.14 (m, 2H, Hl, H10’), 7.13-7.07 (m, 2H,
H10, H5’), 7.06-6.99 (m, 2H, H5, H11’ ), 6.97 (t, 1H, H11), 6.82 (d, J = 8.5 Hz,
1H, Hm), 6.39 (d, J = 7.2 Hz, 1H, H12’), 6.25 (d, J = 7.3 Hz, 1H, HH12) ppm.
13C-NMR (101 MHz, CDCl3−d, 25.0 ◦C) δ 168.41 (s, 1C, C
g), 166.84 (d,1C,
C7), 165.19 (s, 1C, C2’), 165.18 (d, 1C, H7’), 164.65 (s, 1C, C2), 150.70 (s, 1C,
Cn), 150.43 (s, 1C, Cf), 149.91 (s, 1C, Cb), 149.42 (s, 1C, C6), 148.76 (s, 1C,
C6’), 144.18 (s, 1C, C8’), 143.37 (s, 1C, C8), 141.78 (s, 1C, Cd), 138.56 (s, 1C,
C4), 138.50 (s, 1C, C4’), 135.13 (s, 1C, Ci), 133.50 (s, 1C, C12’), 132.49 (s,
1C, C12), 130.92 (s, 1C, C11), 130.42 (s, 1C, C11’), 129.01 (s, 1C, Cc), 128.45
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(s, 1C, Cl), 127.90 (s, 1C, Ck), 127.77 (s, 1C, Ce), 124.85 (s, 1C, C9’), 124.74
(s, 1C, C9), 124.04 (s, 2C, C10, C10’), 123.91 (s, 1C, Cj), 123.74 (s, 1C, C5’),
123.69 (s, 1C, C5), 122.46 (s, 1C, Cm), 120.05 (s, 1C, C3), 119.89 (s, 1C, C3’)
ppm. Anal. Calcd for C34H24N4SClRh(CH2Cl2): C 56.51, H 3.52, N
7.53; Found: C 56.58, H 3.48, N 7.77. ATR-IR (solid powder, cm−1) selected
bands: 3366 (water), 3039 (w, νC=CH), 1604-1577-1479 (m, νC=C+C=N ), 1456,
1436, 1417, 1319 (νC−N ), 1269, 1254, 1160 (m, νC−C), 1059-1024-1004 (m,
δC−Hip), 792-756-741 (δC−Hoop + νC−S). Mass Spectrometry (ESI-MS):
m
z = 623 (100) [M−Cl]+, 411 (58) [M−Cl−pybtz]+. Molar Conductivity
(CH3CN): 127.1 Scm2mol−1. Solubility: soluble in EtOH, CHCl3, CH2Cl2,
partially soluble in H2O, insoluble in Et2O and hexane, instable in DMSO.
7.4.13 [Rh-4]Cl ([Rh(piqi)2(pybtz)]Cl)
2-(2’-pirydyl)benzothiazole (0.0251 g, 0.1182 mmol) was added to a solution of
[Rh(piqi)2Cl]2 (0.0500 g, 0.047 25 mmol) in CH2Cl2:CH3OH (4:5 9 mL), and the
mixture was stirred at 60 ◦C for 23 h under a nitrogen atmosphere. The complex
was precipitated with hexane, dried under vacuum and the solid was washed
with diethyl ether (2×5 mL). A green powder was obtained. Yield: 46.5 mg
(0.0613 mmol, 65 %).
1H-NMR (400 MHz, CDCl3−d, 25.0 ◦C) δ 9.23 (d, J = 8.0 Hz, 1H, He), 8.95
(d, J = 7.9 Hz, 1H, H4), 8.89 (d, J = 8.5 Hz, 1H, H4’), 8.55 (t, J = 7.2 Hz,
1H, Hd), 8.33 (d, J = 7.5 Hz, 1H, H13), 8.30 (d, J = 7.5 Hz, 1H, H13’), 8.13
(d, J = 8.4 Hz, 1H, Hj), 7.94–7.89 (m, 2H, H7, H7’), 7.85–7.72 (m, 4H, H6’, H6,
H5’, H5), 7.64 (d, J = 5.2 Hz, 1H, Hb), 7.55 (t, J = 7.6 Hz, 1H, Hc), 7.52 (d,
J = 6.5 Hz, 1H, H10), 7.46 (d, J = 6.5 Hz, 1H, H9’), 7.45–7.39 (m, 2H, H9, Hk),
7.37 (d, J = 6.3 Hz, 1H, H10’), 7.26 (t, J = 7.6 Hz, 1H, H14’), 7.20 (t, J = 7.6 Hz,
1H, H14), 7.12 (t, J = 7.9 Hz, 1H, Hl), 7.02-6.96 (m, 2H, H15’, H15), 6.48 (d,
J = 8.6 Hz, 1H, Hm), 6.33 (d, J = 7.8 Hz, 1H, H16’), 6.19 (d, J = 7.8 Hz, 1H,
H16) ppm. 13C-NMR (101 MHz, CDCl3−d, 25.0 ◦C) δ 169.06 (d, 1C, C11),
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168.61 (d, 1C, C11’), 168.57 (s, 1C, Cg), 166.08 (s, 1C, C2’), 165.51 (s, 1C, C2),
150.64 (s, 1C, Cn), 150.44 (s, 1C, Cf), 149.76 (s, 1C, Cb), 146.38 (s, 1C, C12’),
145.52 (s, 1C, C12), 141.83 (s, 1C, Cd), 140.78 (s, 1C, C10), 140.11 (s, 1C, C10’),
137.31 (s, 1C, C8), 137.28 (s, 1C, C8’), 135.22 (s, 1C, Ci), 133.86 (s, 1C, C16’),
132.77 (s, 1C, C16), 131.88 (s, 1C, C6), 131.79 (s, 1C, C6’), 130.81 (s, 1C, C15),
130.42 (s, 1C, C13), 130.39 (s, 1C, C13’), 130.12 (s, 1C, C15’), 129.25 (s, 1C,
C5), 129.07 (s, 1C, C5’), 128.90 (s, 1C, Cc), 128.27 (s, 1C, Cl), 128.11 (s, 1C,
C7), 128.06 (s, 2C, C7’, Ce), 127.79 (s, 1C, Ck), 126.71 (s, 1C, C4), 126.62 (s,
1C, C4’), 126.56 (s, 1C, C3), 126.47 (s, 1C, C3’), 123.79 (s, 1C, C14), 123.70
(s, 1C, C14’), 123.58 (s, 1C, Cj), 122.40 (s, 1C, Cm), 122.20 (s, 1C, C9), 122.13
(s, 1C, C9’) ppm. Anal. Calcd for C42H28N4SClRh(CH2Cl2): C 61.19, H
3.58, N 6.64; Found: C 61.32, H 3.47, N 6.98. ATR-IR (solid powder, cm−1)
selected bands: 3029 (w, νC=CH , 2361, 1570-1540-1488 (m, νC=C+νC=N ), 1450,
1433, 1375, 1352, 1323 (νC−C), 1296, 1271, 1217, 1158 (νC−N ), 1005 (δC−Hip),
874, 815, 772-755-739 (δC−Hoop + νC−S). Mass Spectrometry (ESI-MS):
m
z = 723 (100) [M−Cl]+. Molar Conductivity (CH3CN): 122.5 Scm2mol−1.
Solubility: soluble in EtOH, CHCl3, CH2Cl2, insoluble in Et2O and hexane,
instable in DMSO.
7.4.14 [Rh-5]Cl ([Rh(piqi)2(qibtz)]Cl)
2-(2’-quinolinyl)benzothiazole (0.0318 g, 0.121 mmol) was added to a solution
of [Rh(ppy)2Cl]2 (0.0500 g, 0.047 25 mmol) in a mixture of CH2Cl2/MeOH (4:5
18 mL), and the mixture was stirred at 60 ◦C for 23 h and under a nitrogen
atmosphere. The solution was precipitated with hexane. The solvent was filtered
and the solid was washed with diethylether (2×3 mL). The resulting greenish
powder was dried under vacuum. Yield: 60.8 mg (0.0754 mmol, 80 %).
1H-NMR (400 MHz, CDCl3−d, 25.0 ◦C) δ 9.14 (d, J = 8.7 Hz, 1H, H
i), 9.03
(d, J = 8.2 Hz, 1H, Hh), 8.94 (d, J = 8.0 Hz, 1H, H4), 8.84 (d, J = 9.3 Hz,
1H, H4’), 8.36 (d, J = 7.8 Hz, 1H, H13), 8.29 (d, J = 8.2 Hz, 1H, H13’), 8.23
7.4. SYNTHESIS AND CHARACTERIZATION DATA 235
(d, J = 7.5 Hz, 1H, Hn), 8.02 (d, J = 8.2 Hz, 1H, Hf), 7.91 (d, J = 7.2 Hz,
1H, H7’), 7.86 (d, J = 7.6 Hz, 1H, H7), 7.83–7.71 (m, 4H, H6, H5, H6’, H5’),
7.69 (d, J = 6.6 Hz, 1H, H10’), 7.64 (d, J = 9.1 Hz, 1H, Hc), 7.49 (m, 2H, He,
H10), 7.45–7.34 (m, 3H, Ho, H9’, H9), 7.30-7.16 (m, 3H, H14, H14’, Hd), 7.08
(t, 1H, Hp), 6.99 (dt, J = 6.5 Hz, 2H, H15’, H15), 6.32 (d, J = 7.7 Hz, 2H, H16,
H16’), 6.28 (d, J = 8.5 Hz, 1H, Hq) ppm. 13C-NMR (101 MHz, CDCl3−d,
25.0 ◦C) δ 170.06 (s, 1C, Ck), 169.5 (d, 1C, C11’), 167.35 (d, 1C, C11), 165.75
(d, 1C, J = 2.0 Hz, C2), 165.24 (d, 1C, J = 2.4 Hz, C2’), 151.56 (s, 1C, Cj),
151.37 (s, 1C, Cr), 147.74 (s, 1C, Cb), 146.00 (s, 1C, C12), 145.93 (s, 1C, C12’),
142.87 (s, 1C, Ch), 141.25 (s, 1C, C10’), 140.19 (s, 1C, C10), 137.33 (s, 1C,
C8’), 137.25 (s, 1C, C8), 135.43 (s, 1C, Cm) , 133.32 (s, 1C, C16’), 133.08 (s,
1C, C16), 132.12 (s, 1C, Cd), 131.84 (s, 1C, C6’), 131.79 (s, 1C, C6), 130.65
(s, 1C, C13’), 130.52 (s, 2C, C15’, Cg), 130.49 (s, 2C, C15, C13), 129.46 (s,
1C, Cf), 129.23 (s, 1C, C5), 129.13 (s, 1C, Ce), 129.07 (s, 1C, C5’), 128.20 (s,
1C, Cp), 128.19 (s, 1C, C7’), 128.06 (s, 1C, C7), 127.90 (s, 1C, Cc), 127.80 (s,
1C, Co), 126.70 (d, 1C, J = 1.6 Hz, C3’), 126.54 (s, 1C, C4’), 126.52 (d, 1C,
J = 1.7 Hz, C3), 126.42 (s, 1C, C4), 123.83 (s, 2C, C14, Cn), 123.64 (s, 1C,
C14’), 123.48 (s, 1C, Ci), 122.65 (s, 1C, Cq), 122.16 (s, 1C, C9’), 121.94 (s, 1C,
C9) ppm. Anal. Calcd for C46H30N4SClRh(CH2Cl2): C 63.14, H 3.61, N
6.27; Found: C 62.78, H 3.44, N 6.47. ATR-IR (solid powder, cm-1) selected
bands: 3047 (w, νC=CH), 2352, 1617-1591-1572-1541-1515 (m, νC=C+νC=N ),
1454, 1434, 1379, 1348, 1271, 1216, 1148 (νC−C), 1088-1052-1034 (δC−Hip),
821, 759-732 (δC−Hoop + νC−S). Mass Spectrometry (ESI-MS): mz = 773
(100) [M−Cl]+. Molar Conductivity (CH3CN): 93.7 Scm2mol−1. Solubility:
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Table 7.S1: Crystal data and structure refinement for [Ir-5]PF6 · CH2Cl2 and
[Rh-2]PF6 · CH3OH.
[Ir-5]PF6 · CH2Cl2 [Rh-2]PF6 · CH3OH
Empirical Formula C47H32Cl2F6IrN4PS C35H28F6N4OPRhS
Molecular Weight 1092.89 800.55
Temperature, K 173(2) 173(2)
Wavelength, Å 0.710 73 0.710 73
Crystal System Monoclinic Monoclinic
Space Group P21/n P21/n
a, Å 14.0138(15) 14.697(6)
b, Å 15.7590(17) 14.035(6)
c, Å 19.008(2) 16.550(7)
α, ° 90 90
β, ° 102.516(2) 106.962(7)
γ, ° 90 90
Volume, Å3 4098.1(8) 3265(2)
Z 4 4
Density (Calc.), g cm−3 1.771 1.628
Abs Coeff., mm−1 0.3548 0.707
F(000) 2152 1616
Crystal Size, mm3 0.5 × 0.2 × 0.2 0.390 × 0.320 × 0.110
Theta Range for 1.647 to 28.220 1.633 to 28.153
data Coll., °
Index Ranges −18 < h < 18 −18 < h < 19
−20 < k < 20 −18 < k < 18
−25 < l < 24 −20 < l < 21
Reflections Collected 46 597 36 242
Independent Reflections 9423 [R(int)=0.0950] 7473 [R(int)=0.0787]
Completeness Theta 99.8 % 99.8 %
=25.242°
Abs. Correction Semi-empirical from Semi-empirical from
equivalents equivalents
Max. and Min. 0.746 and 0.444 0.746 and 0.527
Transmission
Refinement Method Full-matrix least-squares Full-matrix least-squares
on F2 on F2
Data/Restraints 9423/15/598 7473/0/444
/Parameters
Goodness-of-fit on F2 0.833 1.334
Final R Indices R1=0.0401, wR2=0.1082 R1=0.0551, wR2=0.1089
[I>2sigma(I)]
R Indices (all data) R1=0.0514, wR2=0.1135 R1=0.0901, wR2=0.1165
Extinction Coefficient n/a n/a
Largest Diff. Peak 2.315 and −1.760 1.504 and −0.854
and Hole, eÅ3
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Table 7.S2: π − π stacking interaction in the crystal structure of [Ir-5]PF6 · CH2Cl2
by Mercury 3.0 program.
π − π Interaction (Rings) dcentr, Å α, ° dcentr−pl, Å β, ° doffset, Å
C(1)-C(6)—C(34)-C(39) 3.621 9.78 3.466 16.83 1.05
3.522 13.43 0.84
Table 7.S3: Hydrogen bonds for [Ir-5]PF6 · CH2Cl2 by Mercury 3.0 program.
Interaction (Rings) dD −−−A, Å dH −−−A, Å DHA, °
C(5)-H(5)—F(4) 3.154 2.421 133.73
C(37)-H(37)—F(4) 3.216 2.563 126.16
C(51)-H(51A)—F(3) 3.180 2.561 120.52
Table 7.S4: CH-π interaction in the crystal structure of [Ir-5]PF6 · CH2Cl2 by Mer-
cury 3.0 program.
π − π Interaction (Rings) dcentr, Å dH−ring, Å dH−centr, Å αCH−centr, °
C(30)-H(30)—C(34)-C(39) 3.593 2.850 2.657 168.7
Table 7.S5: Anion-π interaction in the crystal structure of [Ir-5]PF6 · CH2Cl2 by
Mercury 3.0 program.
π − π Interaction (Rings) dcentr, Å dpl, Å α, °
PF6—N(2)C(8)-C(12) 3.100 3.035 78.24
The PF−6 counterions show positional disorder for the four F atoms of an equa-
torial plane, meaning that each of these atoms are localized in two different
positions within the unit cells along the crystal network due to rotational dy-
namics.
The ancillary ligand also exhibits positional disorder in such a way that 60 %
of the cation complexes show disposition A and 40 % disposition B along the
crystal network.
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Figure 7.S1: Disposition A and B in the crystal structure.
Table 7.S6: Hydrogen bonds for [Rh-2]PF6 · CH2Cl2 by Mercury 3.0 program.
Interaction (Rings) dD −−−A, Å dH −−−A, Å DHA, °
C(15)-H(15)—F(2) 3.210 2.644 118.74
C(16)-H(16)—F(2) 3.135 2.471 126.84
C(2)-H(2)—F(6) 3.227 2.593 124.50
C(13)-H(13)—O(1) 2.836 2.536 127.93
Table 7.S7: Anion-π interaction in the crystal structure of [Rh-2]PF6 · CH2Cl2 by
Mercury 3.0 program.
π − π Interaction (Rings) dcentr, Å dpl, Å α, °
PF6—N(3)C(13)-C(16) 3.086 3.018 77.43
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Figure 7.S2: Emission spectra of the metal complexes in water, acetonitrile and
dichloromethane. (A) [Ir-2]Cl. (B) [Ir-3]Cl. (C) [Ir-4]Cl. (D) [Rh-2]Cl. (A)
[Rh-4]Cl. T=25.0 ◦C.
Figure 7.S3: Excitation profile of [Ir-4]Cl at two different emission wavelength,
λem=600 nm and λem=630 nm in water. T=25.0 ◦C.
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Figure 7.S4: Normalized spectra for dimerization; inset: absrobance track at increasing
CD. (A) [Ir-2]Cl. (B) [Ir-3]Cl. (C) [Ir-4]Cl. (D) [Ir-5]Cl. (E) [Rh-2]Cl. (F)
[Rh-4]Cl. (G) [Rh-5]Cl. I=6.5 × 10−3 M, pH=7.0 and T=25.0 ◦C.
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Figure 7.S5: Data treatment by means of Equation (2.67). (A) [Ir-4]Cl. (B) [Ir-5]Cl.
(C) [Rh-4]Cl. (D) [Rh-5]Cl. I=6.5 × 10−3 M, pH=7.0 and T=25.0 ◦C.
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Figure 7.S6: [Ir-2]Cl/52B titration. (A) Uv-vis absorption spectra. (B) UV circular
dichroism, CP=7.5 × 10−7 M, CD=7.5 × 10−6 M. (C) Induced Circular dichroism in
the UV-vis range. (D) Calculated circular dichroism of L and ML in the UV-vis
range. (E) Fluorescence titration, λex=340 nm; inset: track at λexc = 610 nm. (F)
Calculated emission spectra of L and ML. (G) Fluorescence decays, λex=331 nm,
λem=630 nm, peak preset 600 counts, time calibration 0.439 ns/channel, time range
1.6 µs. (H) Relative amplitudes of the lifetimes (for free [Ir-2]Cl τ=12.7, 335 ns).
CD=7.5 × 10−6 M, CP=0-2.2 × 10−5 M, I=0.1 M (KCl), pH=7.0 (phosphate buffer)
and T=25 ◦C.
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Figure 7.S7: [Ir-2]Cl/Pu22 titration. (A) Uv-vis absorption spectra. (B) UV circular
dichroism, CP=7.5 × 10−7 M, CD=7.5 × 10−6 M. (C) Induced Circular dichroism in
the UV-vis range. (D) Calculated circular dichroism of L and ML in the UV-vis
range. (E) Fluorescence titration, λex=375 nm; inset: track at λem=610 nm. (F)
Calculated emission spectra of L and ML. (G) Fluorescence decays, λex=373 nm,
λem=610 nm, peak preset 600 counts, time calibration 0.439 ns/channel, time range
1.6 µs. (H) Relative amplitudes of the lifetimes (for free [Ir-2]Cl τ=13.5 (fixed), 355 ns
(fixed)). CD=7.5 × 10−6 M, CP=0-2.2 × 10−5 M, I=0.1 M (KCl), pH=7.0 (phosphate
buffer) and T=25 ◦C.
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Figure 7.S8: [Ir-2]Cl/Tel22 titration. (A) Uv-vis absorption spectra. (B) UV circular
dichroism, CP=7.5 × 10−7 M, CD=7.5 × 10−6 M. (C) Induced Circular dichroism in
the UV-vis range. (D) Calculated circular dichroism of L and ML in the UV-vis
range. (E) Fluorescence titration, λex=375 nm; inset: track at λem=610 nm. (F)
Calculated emission spectra of L and ML. (G) Fluorescence decays, λex=373 nm,
λem=610 nm, peak preset 600 counts, time calibration 0.439 ns/channel, time range
1.6 µs. (H) Relative amplitudes of the lifetimes (for free [Ir-2]Cl τ=13.3 (fixed), 345 ns
(fixed)). CD=7.5 × 10−6 M, CP=0-2.2 × 10−5 M, I=0.1 M (KCl), pH=7.0 (phosphate
buffer) and T=25 ◦C.
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Figure 7.S9: [Ir-3]Cl/52B titration. (A) Uv-vis absorption spectra. (B) UV circular
dichroism, CP=5.0 × 10−7 M, CD=5.0 × 10−6 M. (C) Induced Circular dichroism in
the UV-vis range. (D) Fluorescence titration, λex=369 nm; inset: track at λem=660 nm.
(E) Fluorescence decays, λex=373 nm, λem=610 nm„ peak preset 600 counts, time cali-
bration 0.219 ns/channel, time range 0.8 µs. (F) Relative amplitudes of the lifetimes (for
free [Ir-3]Cl τ=16.0, 208 ns (fixed)). CD=5.0 × 10−6 M, CP=0-2.0 × 10−5 M, I=0.1 M
(KCl), pH=7.0 (phosphate buffer) and T=25 ◦C.
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Figure 7.S10: [Ir-3]Cl/Pu22 titration. (A) Uv-vis absorption spectra. (B) UV circular
dichroism, CP=7.5 × 10−7 M, CD=7.5 × 10−6 M. (C) Induced Circular dichroism in
the UV-vis range. (D) Calculated circular dichroism of L, ML and ML2 in the UV-
vis range. (E) Fluorescence titration, λex=400 nm; inset: track at λem=660 nm. (F)
Calculated emission spectra of L, ML and ML2. (G) Fluorescence decays, λex=373 nm,
λem=660 nm, peak preset 700 counts, time calibration 0.219 ns/channel, time range
0.8 µs. (F) Relative amplitudes of the lifetimes (for free [Ir-3]Cl τ=15.5 (fixed), 200 ns
(fixed)). CD=7.5 × 10−6 M, CP=0-2.2 × 10−5 M, I=0.1 M (KCl), pH=7.0 (phosphate
buffer) and T=25 ◦C.
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Figure 7.S11: [Ir-3]Cl/Tel22 titration. (A) Uv-vis absorption spectra. (B) UV circular
dichroism, CP=5.0 × 10−7 M, CD=5.0 × 10−6 M. (C) Induced Circular dichroism in
the UV-vis range. (D) Fluorescence titration, λex=400 nm; inset: track at λem=660 nm.
(E) Calculated emission spectra of L and ML. (F) Fluorescence decays, λex=373 nm,
λem=660 nm, peak preset 600 counts, time calibration 0.219 ns/channel, time range
0.8 µs. (G) Relative amplitudes of the lifetimes (for free [Ir-3]Cl τ=15.6, 230 ns).
CD=5.0 × 10−6 M, CP=0-1.5 × 10−5 M, I=0.1 M (KCl), pH=7.0 (phosphate buffer)
and T=25 ◦C.
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Figure 7.S12: [Ir-4]Cl/52B titration. (A) Uv-vis absorption spectra. (B) UV circular
dichroism, CP=7.5 × 10−7 M, CD=7.5 × 10−6 M. (C) Induced Circular dichroism in
the UV-vis range. (D) Fluorescence titration, λex=335 nm; inset: track at λem=630 nm.
(E) Fluorescence decays, λex=331 nm, λem=630 nm, peak preset 500 counts, time cali-
bration 0.439 ns/channel, time range 1.6 µs. (F) Relative amplitudes of the lifetimes (for
free [Ir-4]Cl τ=29.0 (fixed), 511 ns (fixed)). CD=7.5 × 10−6 M, CP=0-2.2 × 10−5 M,
I=0.1 M (KCl), pH=7.0 (phosphate buffer) and T=25 ◦C.
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Figure 7.S13: [Ir-4]Cl/Pu22 titration. (A) Uv-vis absorption spectra. (B) UV circular
dichroism, CP=7.5 × 10−7 M, CD=7.5 × 10−6 M. (C) Induced Circular dichroism in
the UV-vis range. (D) Calculated circular dichroism of L, ML and ML2 in the UV-
vis range. (E) Fluorescence titration, λex=438 nm; inset: track at λem=630 nm. (F)
Calculated emission spectra of L, ML and ML2. (G) Fluorescence decays, λex=373 nm,
λem=625 nm, peak preset 600 counts, time calibration 0.879 ns/channel, time range
3.2 µs. (H) Relative amplitudes of the lifetimes (for free [Ir-4]Cl τ=27.5, 439 ns).
CD=7.5 × 10−6 M, CP=0-2.2 × 10−5 M, I=0.1 M (KCl), pH=7.0 (phosphate buffer)
and T=25 ◦C.
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Figure 7.S14: [Ir-4]Cl/Tel22 titration. (A) Uv-vis absorption spectra. (B) UV circular
dichroism, CP=7.5 × 10−7 M, CD=7.5 × 10−6 M. (C) Induced Circular dichroism in
the UV-vis range. (D) Calculated circular dichroism of L and ML in the UV-vis
range. (E) Fluorescence titration, λex=438 nm; inset: track at λexc=610 nm. (F)
Calculated emission spectra of L, ML and ML2. (G) Fluorescence decays, λex=373 nm,
λem=625 nm, peak preset 600 counts, time calibration 0.879 ns/channel, time range
3.2 µs. (H) Relative amplitudes of the lifetimes (for free [Ir-4]Cl τ=36.5 (fixed), 381 ns
(fixed)). CD=7.5 × 10−6 M, CP=0-2.2 × 10−5 M, I=0.1 M (KCl), pH=7.0 (phosphate
buffer) and T=25 ◦C.
Overall Conclusions
In the present Thesis we treated the thermodynamic and kinetic interactions of
inorganic and organometallic species with nucleic acids, the most investigated
targets inside the cell.
In Part I, it is showed the stabilization study of aluminium ion in aqueous media
by means of the dimethylarsinate anion, with the formation of a dimeric species,
enabling aluminium to remain in solution (Chapter 3). This finding allowed
the study of aluminium with RNA and it has been observed how a trivalent
cation can modify the secondary structure of a polynucleotide (Chapter 4). In
particular, it has been demonstrated that aluminium can induce aggregation
even to RNA strands.
In Part II, we focused on the way of binding of organometallic complexes with
DNA. The importance of the metal center and the ligands bound to it is evident
by our studies. Ancillary ligands rules the reversible way of binding to DNA.
For example, for the ruthenium arene complex the ancillary ligand promotes the
minor groove binding (Chapter 5), whereas the benzoxazole ligand of the biscy-
clometalated complexes favours a partial intercalation of the systems (Chapter 6).
Moreover, we verified how the ligand can determine selectivity towards different
secondary structures of DNA (Chapter 7); in particular, for the new synthesized
family of biscyclometalated complexes, the increase of the aromatic size of the
cyclometalating and of the ancillary ligands enhances the selectivity towards
non-canonical G-Quadruplex structure, together with high thermal stabilization
of these forms. On the other side, the collected data suggest that the metal center
plays only a modest role in the reversible interaction with DNA. However, the
metal center is the main cause of the photophysical properties of the molecule.
Actually, it determines the lowest excited state, which is essential for the lumines-
cence processes. Ligands provide certain contribution on the emissive properties
(lifetime, quantum yield and so on), but it is minority respect to the metal ion.
But photophysical properties means also photoreactivity of the molecule, and
we observed how the metal center has a relevant role on it. Rhodium complexes
display promising singlet oxygen quantum yields in water, whereas Iridium does
not, and a relation between singlet oxygen production and lifetime in water was
found. Surely, the ligands can promote the photoreactivity of the metal complex,
as well, by increasing the absorption at longer wavelengths, the lifetime and,
overall, the interaction with the molecule. Actually, we have observed how the
increase of the affinity towards the target modifies the photophysical properties
of the molecules, namely its fluorescence and lifetime and, consequently, it could
have some influence on the photoreactivity. Hence, all the studied properties,
fluorescence, absorbance, affinity constants are closely linked together, and all
of them contribute to the overall reactivity. To conclude, between the Rh and
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Ir center, the Ir center seems to have the most promising properties. Actually,
even though Rh complexes exhibit the highest effect of photoreactivity in the
ultraviolet region, they lack the property which PDT is looking for, namely
the photoactivation at low-energetic wavelengths. On the other hand, Ir center
provides the molecule an interesting fluorescence, which can be switched-on by
interaction, and the presence of suitable ligands can improve the photoreactivity
of such species, even in the visible region (λex = 500 nm).
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